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                                                                                  Abstract 
 
Bacteriophages are viruses that specifically infect bacterial hosts to reproduce. At 
the end of the infection cycle, progeny virions are confronted with a rigid cell wall 
that impedes their release into the environment. Consequently, bacteriophages 
encode hydrolytic enzymes, called endolysins, to digest the peptidoglycan and 
cause bacteriolysis. 
In contrast to their extensively studied counterparts, active against Gram-
positives, endolysins from bacteriophages from a Gram-negative background 
remain less explored. This knowledge gap is largely due to their limited potential 
as an antimicrobial, which is related to the presence of an impermeable outer 
membrane in Gram-negatives that blocks the exogenous endolysin action. The 
experimental work developed in the scope of this thesis aimed at developing 
efficient strategies to potentiate the endolysin action against these pathogens. 
An extensive in silico analysis was performed to provide new insights about 
endolysins structure and function and bacteriophage-endolysin-host ecology. It 
was possible to identify and analyze 723 putative endolysins sequences from 5 
distinct bacteriophages families, infecting 64 different bacterial genera. These 
endolysins are tremendously diverse in terms of enzymatic function (24 different 
enzymatic and 13 binding domains), architecture arrangements (89 different types 
with either globular or modular design) and length (72 to 578 amino acid 
residues).  
Three different novel endolysins (Lys68, ABgp46 and PVP-SE1gp146) were studied 
in detail. Biochemical characterization of Lys68 (from a Salmonella-infecting 
bacteriophage) showed that it is highly thermostable, withstanding temperatures 
up to 100°C, and able to refold to its original conformation upon thermal 
denaturation. Lys68 was able to lyse a wide panel of Gram-negative bacteria in 
combination with outer membrane permeabilizers. While the Lys68/EDTA 
combination could only inactivate Pseudomonas strains, the use of citric or malic 
acid as permeabilizer broadened and increased its antibacterial effect. Particularly 
against Salmonella, the combinatory effect of malic or citric acid with Lys68 led to 
approximately 3 to 5 log reductions after 2 hours, respectively. During an acid-
promoted effect, weak acids permeabilized the lipopolysaccharide of most 
bacteria to Lys68, which retained a relative high activity under these acidic 
conditions. In case of EDTA, its chelation effect was only observed against 
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Pseudomonas membranes, where ionic interactions are crucial stabilizing forces. 
The endolysin ABgp46 (from an Acinetobacter-infecting bacteriophage) was shown 
to naturally inactivate 1 log of certain Acinetobacter strains. Tests in the presence 
of a number of weak acids (citric, malic, lactic, benzoic and acetic acid) resulted in 
a powerful antibacterial effect when combined with Abgp46. Higher bactericidal 
activity was consistently obtained when ABgp46 was combined with citric and 
malic acid, reducing all planktonic Cronobacter, Klebsiella and E. coli O157 
(reductions of 1 to 3 logs) and Pseudomonas, Acinetobacter and Salmonella 
(reduction of more than 4 logs) species tested. It can be speculated that the major 
weak acid differences observed are related to their acid dissociated constant, that 
seems to favor compounds (with lower pKa values) that tend be more ionized. The 
same combinations did not have significant antibacterial activity when applied 
against Pseudomonas and Acinetobacter biofilms. 
To enhance the activity of endolysins against Gram-negative cells, modified 
endolysins where constructed by fusing PVP-SE1gp146 (from a Salmonella-
infecting bacteriophage) with different LPS-destabilizing peptides of polycationic, 
hydrophobic and amphipathic nature. This strategy resulted in an improvement of 
the activity of the modified endolysin compared to the native one (1 log reduction 
on Pseudomonas and Salmonella cells was obtained). The bactericidal activity of all 
modified variants was increased further in the presence of EDTA. A polycationic 
nonapeptide was the most efficient tag (maximum reduction of 5 logs). With a 
different purpose, attempts of increasing the endolysin (in this case Lys68) action 
against Listeria monocytogenes cells, by inserting species-specific peptidoglycan-
binding peptides, did not result in a higher activity. 
From the moment their genetic identity became known, endolysins have sparked 
the interest as alternatives for existing antibiotics. Here it was shown that 
endolysins can be used to kill not only Gram-positive, but also Gram-negative 
bacterial pathogens. These obtained results underline the great potential of using 
an endolysin-based strategy for prevention and/or control of Gram-negative 
pathogens in foodstuff, food processing surfaces, veterinary and medical 
applications. 
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                                                                                 Sumário 
 
Os bacteriófagos são vírus que especificamente infectam bactérias para se 
reproduzirem. No fim do ciclo de infecção, os vírus descendentes são confrontados 
com uma parede celular rígida que impede a sua libertação para o meio ambiente. 
Consequentemente, os bacteriófagos codificam enzimas hidrolíticas, chamados 
endolisinas, para digerir o peptidoglicano e causar lise bacteriana. 
Em oposição às suas homólogas extensivamente estudadas contra bactérias Gram-
positivas, as endolisinas de bacteriófagos que infectam bactérias Gram-negativas 
permanecem menos exploradas. Este facto está relacionado com o seu potencial 
antibacteriano limitado, devido à presença de uma membrana externa que 
bloqueia a sua acção exógena. O trabalho desenvolvido nesta dissertação teve 
como objectivo o desenvolvimento de estratégias eficientes para potenciar a 
acção das endolisina contra estes agentes patogénicos. 
A partir de bibliotecas genómicas públicas, foi realizada uma extensa análise 
bioinformática sobre endolisinas e a ecologia estabelecida entre o bacteriófago-
endolisina-hospedeiro bacteriano. Foi possível analisar 723 sequências que 
codificam endolisinas de bacteriófagos de 5 famílias distintas e que infectam 64 
géneros bacterianos diferentes. Estas endolisinas são tremendamente diversas em 
termos de sua função enzimática (encontrados 24 domínios enzimáticos e 13 
domínios de ligação diferentes), estrutura molecular (89 tipos diferentes 
identificadas) e do seu tamanho (72-578 resíduos de aminoácidos). 
Foram estudados em detalhe três endolisinas diferentes (Lys68, ABgp46 e PVP-
SE1gp146). A Lys68 (isolada de um bacteriófago que infecta Salmonella) mostrou 
ser altamente termoestável, resistindo temperaturas até 100°C, sendo capaz de 
renaturar para a sua conformação original após um efeito térmico desnaturante. A 
Lys68 foi capaz de lisar um painel alargado de bactérias Gram-negativas, em 
combinação com permeabilizantes de membrana externa. Enquanto da 
combinação Lys68/EDTA apenas resultou na inactivação de estirpes de 
Pseudomonas, o uso de ácido cítrico ou ácido como permeabilizantes, aumentou e 
alargou o espetro da sua acção antibacteriana. Particularmente contra Salmonella, 
a combinação Lys68/cítrico e Lys68/málico levou a reduções aproximadamente de 
3 a 5 logs ao fim de 2 horas, respectivamente. Os ácidos fracos permeabilizam os 
lipopolissacáridos das bactérias, permitindo a entrada da Lys68 que permanece 
com uma elevada actividade nestas condições ácidas. No caso do EDTA, o seu 
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efeito quelante apenas é eficaz contra as membranas da Pseudomonas que são 
essencialmente estabilizadas por interacções iónicas. 
A endolisina ABgp46 (isolada de um bacteriófago que infecta Acinetobacter) 
mostrou ter uma capacidade natural de eliminar células de Acinetobacter. O seu 
efeito bactericida foi testado na presença de uma lista extensa de ácidos fracos 
(cítrico, málico, láctico, benzóico e ácido acético), mostrando ter um poderoso 
efeito antibacteriano. A actividade bactericida foi sempre superior quando ABgp46 
foi combinada com o ácido cítrico ou málico, reduzindo populações planctónicas 
pertencentes as células de Cronobacter, Klebsiella e E. coli O157 (reduções de 1 a 3 
logs) e de Pseudomonas, Acinetobacter e Salmonella (reduções de mais de 4 logs). 
Pensa-se que as diferenças observadas entre os ácidos fracos usados estão 
relacionados com a sua constante de dissociação, que parece favorecer os 
compostos (com valores mais baixos de pKa), que tendem ficar mais ionizados. As 
mesmas combinações não tiveram actividade antibacteriana significativa quando 
aplicada contra biofilmes de Pseudomonas e Acinetobacter. 
Para melhorar a actividade, a endolisina PVP-SE1gp146 (isolada de um 
bacteriófago que infecta Salmonella) foi geneticamente alterada, adicionando 
péptidos de natureza policatiónica, hidrofóbica e anfipática que destabilizam os 
lipopolissacáridos da membrana de células Gram-negativas. Estas proteínas 
quiméricas tiveram melhor actividade antibacteriana quando comparada com a 
proteína nativa (reduções de 1 log em células de Pseudomonas e Salmonella). A 
actividade bactericida foi ainda melhorada na presença de EDTA. O péptido 
policatiónico (contendo nove aminoácidos) foi a fusão mais eficiente (reduções 
máximas de 5 logs). Com um objectivo diferente, tentou-se melhorar a actividade 
da endolisina (neste caso a Lys68) contra células de Listeria monocytogenes, 
inserindo péptidos que especificamente reconhecem o peptidoglicano de células 
de Listeria, contudo sem nenhum efeito positivo alcançado. 
Desde o momento da sua descoberta, as endolisinas têm despertado o interesse 
como agentes antibacterianos alternativos. Aqui mostrou-se que as endolisinas 
podem não só ser usadas para matar bactérias Gram-positivas, mas também 
patogénicos Gram-negativos. Os resultados obtidos sublinham o grande potencial 
do uso de uma estratégia baseada em endolisinas para a prevenção e/ou controlo 
de patogénicos Gram-negativos em alimentos, superfícies de processamento 
alimentar, na veterinária e em aplicações médicas.  
xi 
                                                                 Table of contents 
 
Acknowledgments ................................................................................................. v 
Abstract .................................................................................................................. vii 
Sumário .................................................................................................................. ix 
List of publications ................................................................................................. xv 
List of abbreviations ............................................................................................... xvii 
List of figures and tables ........................................................................................ xix 
 
Chapter 1 - Introduction and background ................................................................. 1 
1.1 General introduction  ....................................................................................... 3 
1.1.1 The problem - Gram-negative infections ................................................. 3 
1.1.2 A “possible” solution - Bacteriophage lytic proteins ............................... 5 
1.2 Endolysin as murein hydrolases ....................................................................... 11 
1.2.1 Endolysins structure organization ........................................................... 11 
1.2.2 Endolysin biotechnological characteristics .............................................. 16 
1.3 Gram-negative outer membrane barrier for external endolysins ................... 23 
1.3.1 LPS structure and diversity ...................................................................... 23 
1.4 Strategies to cross the Gram-negative outer membrane ................................ 28 
1.4.1 Outer membrane permeabilizer agents .................................................. 28 
1.4.2 Covalent modification - inserting LPS-destabilizing peptides .................. 31 
 
Chapter 2 - Roadmap of the Thesis ..................................................................... 33 
 
Chapter 3 - In silico analysis of bacteriophage endolysins .................................... 37 
3.1 Introduction ..................................................................................................... 39 
3.2 Materials and methods .................................................................................... 40 
3.2.1 Endolysin search and database................................................................ 40 
3.2.2 Cladogram of bacteriophage-endolysin-host .......................................... 40 
3.3 Results .............................................................................................................. 42 
3.3.1 Outline - Endolysins structure diversity and distribution ........................ 42 
3.3.2 Enzymatic catalytic domains .................................................................... 44 
3.3.3 Cell binding domains ................................................................................ 48 
3.3.4 Cladogram bacteriophage-host-endolysin relationship .......................... 53 
3.4 Discussion ........................................................................................................ 55 
xii 
3.4.1 The enzymatic catalytic domains - Evolutionary claims .......................... 55 
3.4.2 The cell binding domains - Evolutionary claims ....................................... 56 
 
Chapter 4 - A highly thermostable Salmonella phage endolysin, Lys68, with broad anti-
Gram-negative activity in presence of weak acids ................................................ 61 
4.1 Introduction ..................................................................................................... 63 
4.2 Materials and methods .................................................................................... 64 
4.2.1 Bacterial strains, bacteriophage and chemicals....................................... 64 
4.2.2 In silico analysis ........................................................................................ 66 
4.2.3 Cloning, recombinant protein expression and purification ..................... 66 
4.2.4 Biochemical characterization ................................................................... 70 
4.2.5 Antibacterial assays.................................................................................. 74 
4.3 Results .............................................................................................................. 76 
4.3.1 In silico analysis ........................................................................................ 76 
4.3.2 Recombinant purification and substrate specificity ................................ 76 
4.3.3 Biochemical characterization ................................................................... 78 
4.3.4 In vitro antibacterial activity .................................................................... 84 
4.4 Discussion ......................................................................................................... 92 
 
Chapter 5 - Activity of an Acinetobacter phage endolysin, ABgp46, against Gram-
negative pathogens in planktonic and biofilm cultures ........................................ 97 
5.1 Introduction ..................................................................................................... 99 
5.2 Materials and methods .................................................................................... 100 
5.2.1 Bacterial strains, bacteriophage and chemicals....................................... 100 
5.2.2 In silico analysis ........................................................................................ 101 
5.2.3 Cloning, recombinant protein expression and purification ..................... 101 
5.2.4 Biochemical characterization ................................................................... 103 
5.2.5 Antibacterial assays.................................................................................. 103 
5.3 Results .............................................................................................................. 105 
5.3.1 In silico analysis ........................................................................................ 105 
5.3.2 Recombinant expression and purification ............................................... 105 
5.3.3 Biochemical characterization ................................................................... 106 
5.4.4 In vitro antibacterial activity .................................................................... 109 
5.4 Discussion ......................................................................................................... 114 
 
 
xiii 
Chapter 6 - Chimeric endolysins for better antibacterial performance ................. 119 
6.1 Introduction ..................................................................................................... 121 
6.2 Materials and methods .................................................................................... 124 
6.2.1 Bacterial strains, bacteriophage and chemicals ...................................... 124 
6.2.2 Cloning, recombinant protein expression and purification ..................... 125 
6.2.3 Antibacterial assays of endolysins with LPS-destabilizing peptides ........ 129 
6.2.4 Antibacterial assays of endolysins with cell binding domains ................. 129 
6.3 Results .............................................................................................................. 130 
6.3.1 Modified endolysins recombinant expression......................................... 130 
6.3.2 Antibacterial assays of endolysins with LPS-destabilizing peptides ........ 131 
6.3.3 Antibacterial assays of the endolysins with cell binding domains  .......... 133 
6.4 Discussion ........................................................................................................ 135 
 
Chapter 7 - General conclusions and future perspectives ..................................... 139 
7.1 General conclusions ......................................................................................... 141 
7.2 Future perspectives ......................................................................................... 144 
 
References .................................................................................................................. 151 
Supplemental Material .............................................................................................. 163 
 
 
 
 
 
 
 
 
 
xii 
 
 
xv 
                                                              List of publications  
 
 
Peer reviewed articles 
Submitted 
Oliveira H; Viruthachalam T; Walmagh M; Sillankorva S; Lavigne R; Petersen T; 
Kluskens LD; Azeredo J (2014). A highly thermostable Salmonella phage endolysin, 
Lys68, with broad anti-Gram-negative activity in the presence of weak acids. 
Briers Y; Walmagh M; Puyenbroeck V; Cornelissen A; Oliveira H; Azeredo J; 
Verween G; Pirnay JP; Miller S; Volckaert G; Lavigne R (2014). Engineered 
endolysin-based “Artilysins” to combat multidrug resistant Gram-negative 
pathogens. 
 
Published 
Oliveira H; Azeredo J; Lavigne R; Kluskens LD (2012). Bacteriophage endolysins as 
a response to emerging foodborne pathogens. Trends in Food Science & 
Technology 28: 103-115. 
Oliveira H; Melo L; Santos S; Nóbrega F; Ferreira E; Cerca N; Azeredo J; Kluskens, 
L (2013). Molecular aspects and comparative genomics of bacteriophage 
endolysins. J Virol 87: 4558-4570. 
 
 
xvi  
Other scientific output 
Oral presentations 
Oliveira H; Melo L; Santos S; Nóbrega F; Ferreira E; Cerca N; Azeredo, J; 
Kluskens L. Molecular and functional aspects of bacteriophage endolysins. 
BioMicroWorld 2013 - V International Conferenec on Environmental, Industrial 
and Applied Microbiology, Madrid, Spain, October 2-4th, 2013. 
 
Invited oral presentations 
Oliveira H. Development of Bacteriophage Endolysins to Control Gram-negative 
Pathogens, at the Istituto di Chimica del Riconoscimento Molecolare CNR, 
Milan, Italy, January 28th, 2014. 
 
Posters in conferences 
Oliveira H; Walmagh M; Kluskens LD; Sillankorva S; Lavigne R; Azeredo J. 
Biochemical and antibacterial characterization of a novel phage endolysin against 
the Gram-negative pathogen Pseudomonas aeruginosa. 19th Evergreen 
International Phage Biology Meeting, August 7-12th, 2011. 
Oliveira H; Walmagh M; Kluskens LD; Sillankorva S; Lavigne R; Azeredo J. 
Antibacterial activity on opportunistic Pseudomonas aeruginosa pathogen by a 
novel Salmonella phage endolysin. MicroBiotec'11 - Book of Abstracts, Braga, 
Portugal, 1-3th December, 2011. - Best poster prize 
Oliveira H; Melo, L; Nóbrega F; Santos SB; Cerca N; Ferreira EC; Azeredo J; 
Kluskens LD. Unraveling the insights into phage endolysin association. Viruses of 
Microbes - EMBO Conference, Brussels, Belgium, 16-20th July, 2012. 
 
xvii  
                                                         List of abbreviations  
 
AMP   Antimicrobial Peptide 
α4   α-helix 4 of T4 lysozyme (amino acids 143-155) 
bp   Base Pair(s) 
CBD   Cell Binding Domain 
CEB   Centre of Biological Engineering 
CD    Circular Dichroism 
CFU    Colony Forming Unit 
CHAP    Cysteine-, Histidine-dependent Aminohydrolase/Peptidase 
CPP   Cell-Penetrating Peptide 
dCTP   Deoxycytidine Triphosphate 
DNA    Desoxyribonucleic Acid 
ds   Double-stranded 
ECD   Enzymatic Catalytic Domain 
EDTA     Ethylene Diamine Tetra Acetic acid 
(E)GFP    (Enhanced) Green Fluorescent Protein 
G-/ G+    Gram-negative / Gram-positive  
GHxx    Glycoside Hydrolase xx family 
HEWL    Hen Egg White Lysozyme 
HEPES    4-(2-HydroxyEthyl)-1-Piperazine-EthaneSulfonic acid 
IPTG    Isopropyl-β-D-1-thiogalactopyranoside 
LB    Lysogeny Broth 
LIC   Ligation Independent Cloning 
LPS    Lipopolysaccharide 
kDa   Kilodalton 
NAG or GluNAc   N-acetylglucosamine 
NAM or MurNAc  N-acetylmuramic acid 
Ni2+-NTA  Nickel-Nitrilotriacetic Acid 
OD xxxnm   Optical Density at xxx nm wavelength 
OM   Outer Membrane 
OMP   Outer Membrane Permeabilizer 
ORF   Open Reading Frame 
PBS   Phosphate Buffered Saline 
PCR   Polymerase Chain Reaction 
PG   Peptidoglycan 
PGH   Peptidoglycan Hydrolases 
SDS-PAGE   Sodium Dodecyl Sulfate Polyacrylamide Gel Electrophoresis 
ss   Single-Stranded 
Tm   Melting temperature 
Tris    Tris(hydroxymethyl)aminomethane 
wt   Wild-Type 
xviii  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
xix  
                                                  List of figures and tables 
 
 
List of figures  
 
Figure 1.1. Lytic life cycle found in most double-stranded nucleic acid phages ........ 6 
Figure 1.2. Schematic representation of how phage endolysins gain access to the 
peptidoglycan at the end of the phage lytic cycle through a holin dependent and 
independent manner .................................................................................................. 9 
Figure 1.3. Schematic representation of the main peptidoglycan differences (in bold) 
between a Gram-positive and Gram-negative bacteria and endolysin mode of action 
according to their murein activity ............................................................................... 13 
Figure 1.4. Schematic representation of a typical Gram-negative cell envelope ....... 24 
Figure 1.5. Detailed view of the inner core oligosaccharide and Lipid A components of S. 
Typhimurium ............................................................................................................... 26 
Figure 1.6. Simplified view of the Gram-negative bilayer with an overview of its 
destabilization by using different membrane active agents (EDTA, organic acid and 
antimicrobial peptide)  ................................................................................................ 30 
Figure 3.1. Diversity of enzymatic catalytic domains/cell binding domains found at the 
N- and C-terminus of the four major endolysin classes centrally located (from all 723 
putative endolysins) .................................................................................................... 49 
Figure 3.2. Nature and repartition of peptidoglycan hydrolase domains encoded by 
derived from 727 endolysins. ..................................................................................... 52 
Figure 3.3. Radial cladogram of endolysins of all characterized phages. ................... 53 
Figure 4.1. Visualization of the Lys68 lytic activity on chloroform S. Typhimurium LT2 
permeabilized lawn. .................................................................................................... 78 
xx  
Figure 4.2. Muralytic activity of Lys68. ....................................................................... 79 
Figure 4.3. Circular dichroism spectra of Lys68 as a function of pH using a universal 
buffer with adjusted pH (3.0-10.0)... ........................................................................... 80 
Figure 4.4. Lys68 muralytic activity after thermal stress.. .......................................... 81 
Figure 4.5. Melting curves for Lys68, measured by monitoring the absorbance at 222 nm 
against increasing (denaturation) and decreasing temperatures (renaturation) at pH 
7.0... ............................................................................................................................. 82 
Figure 4.6. Circular dichroism spectra of Lys68 after thermal stress... ...................... 84 
Figure 4.7. Epifluorescence microscopy of the S. Typhimurium LT2 cells permeabilized 
with citric acid... .......................................................................................................... 89 
Figure 4.8. Muralytic activity and secondary structure comparisons between Lys68 wild-
type and mutant variants... ......................................................................................... 90 
Figure 4.9. Proposed Lys68 mechanism of action... ................................................... 91 
Figure 5.1. Far-UV Circular dichroism spectra of ABgp46 under different pH values (4.0-
8.0) .............................................................................................................................. 107 
Figure 5.2. Correlation between ﬂuorescence spectra and conformational changes 
deduced by plotting Parameter A as a function of temperature ................................ 109 
Figure 6.1. Turbidity measurements of Lys68 and its variants against L. monocytogenes 
CECT 5725... ................................................................................................................. 134 
Figure S4.1. Circular dichroism spectrum of HEWL at basic (7.0) and acid pH (4.0)... 163 
Figure S5.1. BlastP multiple alignment of ABgp46 with top five close-related 
sequences... ................................................................................................................. 164 
Figure S5.2. Amino acid sequence of ABgp42... .......................................................... 165 
 
xxi  
List of tables 
 
Table 1.1. Endolysins that have been tested in animal models and food samples since 
2000 ............................................................................................................................ 22 
Table 3.1. Identified putative endolysin catalytic and binding domains .................... 43 
Table 4.1. Overview of bacterial pathogens strains, references and sources used in 
chapter 4 ..................................................................................................................... 64 
Table 4.2. Genotypes of E. coli cloning and expression strains used in chapter 4 ..... 65 
Table 4.3. Lytic activity of Lys68 against Gram-negative or Gram-positive strains. ... 77 
Table 4.4. Apparent melting temperatures (Tm) of Lys68 as a function of pH (3.0-10.0) as 
determined by circular dichroism signal at 222 nm in thermal denaturation and 
renaturation experiments. .......................................................................................... 83 
Table 4.5. Combinatorial antibacterial activity of outer membrane permeabilizers with 
(A and B) or without (c) HEWL/Lys68 on Gram-negative bacterial pathogens. ......... 85 
Table 4.6. Influence of different S. Typhimurium LT2 physiological states 
(planktonic/biofilm) on the combinatorial effect of Lys68 and outer membrane 
permeabilizers (citric and malic acid). ........................................................................ 87 
Table 4.7. S. Typhimurium LT2 log reduction units after incubation with enzymes and 
acids. ........................................................................................................................... 88 
Table 5.1. Overview of bacterial pathogens strains, references and sources used in 
chapter 5.. ................................................................................................................... 100 
Table 5.2. Genotypes of E. coli cloning and expression strains used in chapter 5.. ... 101 
Table 5.3. Apparent melting temperatures (Tm) of ABgp46 as a function of pH (4.0-8.0) 
and temperature monitored by Circular dichroism intensity at 222 nm. .................. 107 
Table 5.4. Antibacterial activity of ABgp46 against several Gram-negative bacterial 
pathogens. .................................................................................................................. 109 
xxii  
Table 5.5. Combinatorial antibacterial activity of ABgp46 with outer membrane 
permeabilizers under different concentrations against E. coli O157:H7. ................... 111 
Table 5.6. Combinatorial antibacterial activity of the best ABgp46/outer membrane 
permeabilizers (EDTA, citric and malic acid) formula against broad range of planktonic 
Gram-negative pathogens. .......................................................................................... 112 
Table 5.7. Combinatorial antibacterial activity of the best outer membrane 
permeabilizers in absence (A) and presence (B) of ABgp46 against A. baumannii 2 and P. 
aeruginosa PAOI biofilms.. .......................................................................................... 113 
Table 6.1. List of selected LPS-destabilizing/Cell binding domain fusion peptides. ... 122 
Table 6.2. Overview of bacterial pathogens strains, references and sources used in 
chapter 6.  ................................................................................................................... 124 
Table 6.3. Genotypes of E. coli cloning and expression strains used in chapter 6. .... 125 
Table 6.4. Overview of cloning and expression vectors used in chapter 6. ................ 125 
Table 6.5. Overview of all expression constructs used in chapter 6. .......................... 127 
Table 6.6. Recombinant purification yields of Lys68 and PVP-SE1 wild-type proteins and 
their C-or N-terminal modified variants. ..................................................................... 130 
Table 6.7. Antibacterial activity of PVP-SE1gp146 (wild-type and variants) against P. 
aeruginosa PAO1, S. Typhimurium LT2 and E. coli XL1-Blue MRF´ in absence (A) and 
presence (B) of EDTA. .................................................................................................. 131 
Table 6.8. Endolysins relative lysis activity. ................................................................ 133 
Table S4.1. Combinatorial effect of Lys68 (2 µM) with EDTA (5 mM) against different 
Enterobacteriaceae species. ........................................................................................ 163 
 
Chapter 6 
 
 
 
 
Chapter 1 
 
 
 
 
 
 
 
 
 
 
This chapter is adapted from the following paper: Oliveira H; Azeredo J; Lavigne 
R; Kluskens LD (2012). Bacteriophage endolysins as a response to emerging 
foodborne pathogens. Trends in Food Science & Technology 28:103-115. 
 
        Introduction and Background 
Chapter 1 
2   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Introduction and Background 
 
3  
1.1 General introduction  
Bacterial infections have always been a threat to human health. Gram-negative (G-) 
bacterial pathogens in particular prevail in various surroundings, from food to 
clinical settings. A possible way to prevent or control such pathogens is by using 
bacteriophage (phages) lytic enzymes, called endolysins, evolved to destroy the 
peptidoglycan (PG), the structural component of the bacterial cell wall. However, 
part of the G- bacterial resilience originates from the presence of a protective 
outer membrane (OM) that prevents toxic substances, such as endolysins, from 
entering the cell. This literature review starts by addressing the G- bacterial 
infection problems, and gives a detailed overview of a possible solution involving 
endolysins to control these pathogens. Subsequently, the natural diffusion barrier 
of G- bacterial OM for external endolysins is discussed as well as possible 
strategies to cross and overcome it.  
 
1.1.1 The problem - Gram-negative bacterial infections 
Foodborne contaminations that are dominated by G- bacteria, represent a global 
incidence, causing 9.4 million acquired illnesses on a yearly basis in the United 
States alone (Scallan et al, 2011). With an estimated cost of $6 billion dollars each 
year in medical expenses and lost productivity, according to the United States 
Department of Agriculture’s Economic Research Service (USDA-ERS, 2011), control 
of foodborne outbreaks has become a vital issue in the last decade. The actual 
figure is higher since this estimate reflects illnesses caused only by the major 
foodborne pathogens like Salmonella, Escherichia coli O157:H7, Shigella sonnei 
and Campylobacter. According to several food regulatory entities, there are other 
less common G- foodborne infectious species like Cronobacter sakazakii, Pantoea 
agglomerans and Pseudomonas fluorescens that contribute to yearly costs related 
to foodborne outbreaks (EFSA, 2009; CDC, 2011) . 
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In clinical settings, hospital-acquired infections represent one of the most 
important leading causes of death worldwide, often associated with mechanical 
ventilation, invasive medical devices, or surgical procedures. With total of 1.7 
million episodes and almost 99,000 deaths annually (Klevens et al, 2007; Kung et 
al, 2008), hospital-acquired infections lead to an estimated United States health 
care budget of more than $5 billion every year (Chopra et al, 2008). G- bacteria 
represent more than 30% of hospital-acquired infections, and these bacteria 
predominate in cases of ventilator-associated pneumonia (47%) and urinary tract 
infections (45%). Pseudomonas aeruginosa, Acinetobacter baumannii, Klebsiella 
oxycota and Proteus mirabilis species are the most important G- nosocomial 
infections reported. 
Today, several antimicrobial agents are used to prevent food spoilage (chemical 
preservatives such as benzoates, nitrites, sulphites) or to treat infectious diseases 
(naturally produced antibiotics or synthetic chemotherapeutic agents). However, 
the beneficial, efficient and safety aspects of many applied antimicrobials are one 
of the hottest topics of debate among researchers specialized in food and medical 
science. For instance, sodium nitrite and nitrate are synthetic food preservatives 
that have been associated to cause chest tightness, elevated pulse rate and 
cancer among other adverse health effects (US EPA, 2006). The alarming 
emergence of bacteria resistant to antibiotics (P. aeruginosa, A. baumannii and E. 
coli are prevalent examples), acquired from foodborne or nosocomial infections, is 
considered one of the greatest threats to human health of the new millennium, as 
considered by the Infectious Diseases Society of America and the European 
Society of Clinical Microbiology and Infectious Diseases, hampering the 
effectiveness of everyday applied antibiotics (El-Tahawy, 2004; Gandhi et al, 
2010). 
Thus, despite the vast number of preservation methodologies adopted by the 
food industry and hospitals, contaminations by pathogens still occur, leading to 
serious economic consequences and threats associated with outbreaks. One 
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promising approach to prevent or destroy pathogenic bacteria is the use of PG-
degrading enzymes of phage origin as alternative bacteriolytic agents to currently 
applied antimicrobials. This topic will be discussed in detail in the next section. 
 
1.1.2 A “possible” solution - Bacteriophage lytic proteins 
Phages are viruses that specifically infect bacteria and are harmless to humans, 
animals and plants. They are the most abundant living entities on Earth, 
outnumbering bacteria by an estimated tenfold, and accounting for a total 
population size of 1031 phage particles able to infect 108 bacterial species 
(Brussow & Hendrix, 2002; Rohwer, 2003). Since their discovery, first by Hankin in 
1896 and later rediscovered by Twort (1915) and d`Herelle (1917) (Summers, 
2004), phage research has contributed to some of most important scientific 
breakthroughs in history of biological science, from molecular biology to genetic 
regulation. 
The morphology of phage particles and the type of nucleic acids form the basis of 
their classification, a responsibility attributed to the International Committee on 
the Taxonomy of Viruses. The major order of phages is the Caudovirales, with 96% 
of all reported phages (Ackermann, 2003). Caudovirales virions possess double-
stranded (ds) DNA genomes enclosed in heads with icosahedral symmetry, and 
with tails that vary in length. These tailed phages are subdivided in three families: 
Siphoviridae (61%) with long, flexible and noncontractile tails; Myoviridae (25%) 
having long, rigid and contractile tails; and Podoviridae (14%) with short and 
noncontractile tails. The remaining non-tailed phages belong to a small and highly 
variable group, with single-stranded (ss) DNA, ssRNA, or dsRNA (Ackermann, 
2007).  
In terms of reproduction cycle, being obligatory parasites, upon bacterial 
infection, phages can either cause cell lysis to release the newly formed virus 
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particles (lytic pathway) or lead to integration of the genetic information into the 
bacterial chromosome without cell death (lysogenic pathway). The lytic life cycle, 
illustrated in Figure 1.1, is predominantly found in all double-stranded nucleic acid 
(dsNA) phages.  
 
 
 
Figure 1.1. Lytic life cycle found in most double-stranded nucleic acid phages. Phages attach to 
cells (absorption), inject their DNA and hijack the host protein machinery (infection), to produce 
new phage particles (replication), causing bacterial disruption and subsequent release of their 
progeny (lysis) to initiate a new life cycle. The schematic drawing was kindly provided by Dr. Rob 
Lavigne, head of the Laboratory of Gene Technology at Katholieke Universiteit Leuven. 
 
To be able to enter the cell and replicate, phages rely on random motion to attach 
to specific receptors (e.g. lipopolysaccharides, teichoic acids, proteins) on the 
surface of bacteria that narrows the host range of bacterial infection. The 
attachment can occur by a variety of mechanisms, depending on the morphology 
of the virus, often involving tail contraction and enzymatic degradation of a small 
portion of the cell membrane, to allow genetic material injection. Intracellularly, 
the phages multiply by taking advantage of the host’s DNA replication and protein 
synthesis machinery, manufacturing and assembling new virus particles. At the 
end of the infection cycle, progeny virions are confronted with a rigid cell wall that 
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hinders their release into the environment and the opportunity to start a new 
infection cycle.  
In this last step, phage encodes lytic proteins (discussed in detail in the next 
section) responsible for the bacterial lysis and subsequent release of new phage 
particles. The regulation of the lysis event has evolved individually to optimize 
phage fitness. Consequently, a diverse lysis cassette is found in dsNA phage 
genomes, although all contain a common lytic enzyme to degrade the bacterial 
cell wall - the endolysin.  
 
1.1.2.1 Endolysin-mediated lysis 
Phage replication demands a strategy for progeny release and dispersion to 
enable infection of new hosts. Two general strategies (holin-dependent and holin-
independent export) to accomplish lysis have been described and are illustrated in 
Figure 1.2. They are exclusively reported for dsNA Caudovirales phages, as not 
much is known about lytic systems present in cassettes of phages outside this 
order.  
 
Holin-dependent export 
The holin-endolysin two-component cell lysis system, known as the lambda 
paradigm, is thought to be universal in almost all dsNA phages, with some 
exceptions (Sao-Jose et al, 2000; Kakikawa et al, 2002). In this system, soluble and 
active endolysins, lacking secretory signals, accumulate in the intracellular space 
due to the bacterial inner membrane. To gain access to the PG, small hydrophobic 
membrane-spanning proteins called holins are expressed at a genetically 
predetermined time and accumulate in clusters, producing homo-oligomeric 
pores in the inner membrane (340 nm - 1 µm diameter width) and thereby 
exposing the PG layer to the endolysins (Young, 1992; Young & Blasi, 1995). 
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Consequently, by degrading the PG, the endolysins compromise the mechanical 
strength and resistance of the cell wall that is needed to withstand the internal 
cytoplasmic turgor (osmotic) pressure, causing bacteriolysis and the subsequent 
release of the phage progeny. The lysis is then solely determined by the holin, but 
in some cases further fine-tuned by the presence of a holin inhibitor (Young & 
Blasi, 1995). This complex system illustrates the evolutionary pressure to optimize 
lysis timing, which is crucial for phage fitness. On the one hand, the vegetative 
cycle should be extended to allow sufficient accumulation and maturation of new 
phage particles. On the other hand, the vegetative cycle should be shortened, 
partially sacrificing the phage maturation period, to release early progeny viruses 
with better opportunity to infect more hosts and multiply exponentially. 
 
Holin-independent export 
Two holin-independent lytic systems are found in phages. In the first system, 
endolysins present N-terminal signal peptides that enable them to pass the 
cytoplasmic membrane and reach the PG, by making use of the host Sec system. 
Examples are endolysins found in Bacillus cereus phage TP21-L, Oenococcus oeni 
phage fOg44 and Lactobacillus plantarum phage Øg1e (Sao-Jose et al, 2000; 
Kakikawa et al, 2002). Secreted endolysins are translocated in an inactive form, 
after which the N-terminal signal is subjected to proteolytic cleavage. Already in 
the periplasm, the endolysins are only activated after dissipation of the proton 
motive force, triggered by holins that accumulate till an allele-specific time. So, 
rather than permeabilizing the endolysins through the cytoplasmic membrane, 
holins play here an endolysin activation role to control the lysis timing event. 
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Figure 1.2. Schematic representation of how phage endolysins gain access to the peptidoglycan 
at the end of the phage lytic cycle through a holin dependent and independent manner. a) Holin-
dependent export containing canonical endolysins; b) Holin-independent export with endolysins 
containing a SP, and c) Holin-independent export with endolysin containing SAR. Abbreviations: SP, 
signal peptide; SAR, signal-arrest-release; PG, peptidoglycan; CM, cytoplasmic membrane; Cyt, 
cytosol. Adapted from (Catalao et al, 2012).  
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The signal-arrest-release sequence is the second system found that uses the host 
Sec system for the secretion of endolysins. However in this case, the endolysin 
possesses a noncleavable N-terminal type II signal anchor that remains part of the 
mature endolysin and stays embedded in the inner cell membrane in an inactive 
form (Xu et al, 2004; Briers et al, 2011a). Consequently, these endolysins require 
pinholins to cause a membrane depolarization to release the SAR anchor, 
triggering endolysin activation and its access to the cell wall (Park et al, 2007; 
Pang et al, 2009). Pinholins are here distinguished from holins for their role of 
only promoting lesions (small pores < 2 nm) large enough to depolarize de 
cytoplasmic membrane in order to control the timing of lysis. 
More recently, a new model of holin-independent endolysin export was found in 
Mycobacteriophage Ms6 (Catalao et al, 2012). Although not yet completely 
understood, evidence shows that Ms6 endolysins, lacking any predicted Sec-type 
or signal-arrest-release sequence, are assisted in their export by a chaperone-like 
protein (gp1). Endolysin regulation and activation is assumed to be a combined 
effort between two genes (gp4 and gp5), suggested to encode a holin and holin-
inhibitor proteins. 
Overall, lysis is accomplished by two steps: the holin permeabilization of the 
cytoplasmic membrane or signal-arrest-release endolysin activation (first step), 
followed by PG degradation by endolysins (second step). Additionally, G- infecting 
dsNA phages have also acquired accessory proteins (spanins and LysB) in what can 
be considered a third step of host lysis - degradation of the OM (last barrier for 
progeny phage egress) (Catalao et al, 2012). Spanins (Rz/Rz1), first discovered in 
lambda phage, are proteins involved in the fusion of both inner/outer 
membranes. As for LysB, it has only been observed in Mycobacteriophages and 
their role is to digest bonds between the mycolic acids and the arabinogalactan, a 
particular content of Mycobacterium OM.  
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1.2 Endolysins as murein hydrolases  
The rigid PG layer, also known as murein, is responsible for the physical integrity 
and shape of bacteria. It is composed of several chains of alternating residues of 
N-acetylmuramic acid (MurNAc) and N-acetylglucosamine (GlcNAc), connected by 
β-1,4 glycosidic bonds, linked to a short stem tetrapeptide. Whereas the 
carbohydrate backbone is conserved in all bacteria, the peptide moiety made of L- 
and D-amino acids is only conserved in G- organisms (Vollmer & Born, 2009). In 
Gram-positives (G+), it is considerably more diverse in terms of length and 
composition. 
The amino acid residue in position 3 defines two types of PG: a meso-2,6-
diaminopimelic acid type (mDAP-type) in G- and some G+  species (i.e. Bacillus and 
Listeria spp.) and an L-lysine type (Lys-type) typical for G+ organisms. In the mDAP-
type the peptide stem is usually directly linked via an amide bond, while in the 
Lys-type they are connected through an interpeptide bridge, such as in 
pentaglycine (Staphylococcus aureus) or dialanine (Streptococcus pyogenes). 
This complexity and variety of more than 100 different reported eubacterial PG 
chemotypes has resulted in an evolutionary pressure on phages to reﬁne their 
lytic cassette in order to compromise the host cell wall (Schleifer & Kandler, 
1972). Toward this end, phages have acquired a huge diversity endolysins, varying 
in structure, type of domain and number, all discussed in detail in the next 
sections. 
 
1.2.1 Endolysin structure organization 
Depending on their origin, endolysins can vary in their molecular structure. 
Endolysins can either be globular proteins, with an enzymatic catalytic domain 
(ECD) alone responsible for the PG bonds cleavage, or modular proteins with an 
extra cell wall (or PG) binding domain (CBD) to help with substrate recognition.  
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Endolysins from G+ infecting phages possess a typical, well-defined modular 
architecture, with an N-terminal ECD and a C-terminal CBD, separated by a short 
linker. In some cases, endolysins can also contain more than one ECD or CBDs. A 
unique example is the streptococcal C1 phage endolysin (PlyC). While in general 
endolysins have a molecular mass of 25 to 40 kDa (Fischetti, 2008), this peculiar 
endolysin weighs 114 kDa. PlyC is a multimeric protein that consists of one heavy 
chain representing the catalytic site (PlyCA), and eight PlyCB chains that bind to 
the cell wall (Nelson et al, 2006). In contrast to their G+ counterparts, endolysins 
active against G- generally display a globular structure (i.e. only contain the ECD) 
and rarely show a modular organization. Few examples of modular structure are 
reported to have inverted molecular orientations compared to G+ endolysins, with 
the ECD at the C-terminal and the CBD at the N-terminal side (e.g. KZ144 of phiKZ) 
(Briers et al, 2007b). 
 
1.2.1.1  Enzymatic catalytic domain 
Depending on their ECD and the bonds that they hydrolyse, endolysins can be 
divided into different classes (Figure 1.3). Glycosidases cleave the glycan 
component at the reducing end of GlcNAc (Fig. 1.3, target 1), as shown for the 
streptococcal LambdaSa2 endolysin (Pritchard et al, 2007), or at the reducing end 
of MurNAc (Fig. 1.3, target 2), as described for the streptococcal B30 endolysin 
(Pritchard et al, 2004). The N-acetyl-β-D-muramidases (often called lysozymes or 
muramidases) share the same glycan target as the lytic transglycosidases (Fig. 1.3, 
target 3), however both deliver different end products: transglycosidases do not 
work as genuine hydrolases since no water is involved in the cleavage of the 
glycoside bond, and a 1,6-anhydro bond is formed instead in the muramic acid 
residue (Vollmer et al, 2008). This is an uncommon class among the phage 
endolysins  with  the  P.  aeruginosa  phage  phiKZ  gp144 endolysin as an example  
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Figure 1.3. Schematic representation of the main peptidoglycan differences (in bold) between a 
Gram-positive and Gram-negative bacteria and endolysin mode of action according to their 
murein activity. Legend: 1) N-acetyl-β-D-glucosaminidase; 2) N-acetyl-β-D-muramidase; 3) lytic 
transglycosylase; 4) N-acetylmuramoyl-L-alanine amidase; 5) L-alanoyl-D-glutamate 
endopeptidase; 6) D-alanyl-glycyl endopeptidase. Abbreviations: GlcNAc, N-acetyl glucosamine; 
MurNAc, N-acetyl muramic acid. 
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(Fokine et al, 2008). Distinct classes of amidases catalyze the hydrolysis of the 
critical amide bond between MurNAc and the L-alanine (Fig 1.3, target 4), 
separating the glycan strand from the stem peptide. Therefore, amidases are 
predicted to cause the strongest destabilization effect in the PG. In addition, 
distinct classes of endopeptidases and carboxypeptidases attack the LD- and DD-
bonds in the stem peptides, as has been demonstrated for Listeria Ply500 and the 
Ply118 L-alanyl-D-glutamate endopeptidases (Loessner et al, 1995) (Fig. 1.3, 
target 5). Other endopeptidases, like the staphylococcal phi11 D-alanyl-glycyl 
endopeptidase, also cleave within peptides that crosslink the cell wall (Navarre et 
al, 1999) (Fig. 1.3, target 6). 
Related with the possibility to cleave more than one PG bond, some endolysins 
have even acquired more than one ECD, such as the endopeptidase/muramidase 
from the Streptococcus agalactiae phage B30 (Pritchard et al, 2004), the 
muramidase/endopeptidase of a pneumococcal phage Cpl-1 lytic enzyme 
(Hermoso et al, 2003), the endopeptidase/amidase of the phage phi11 endolysin 
(Navarre et al, 1999) and the endopeptidase/glucosaminidase of a streptococcal 
LambdaSa2 endolysin (Donovan & Foster-Frey, 2008). However, the presence of 
two ECDs does not necessarily mean that they are equally active. For instance, the 
D-glutaminyl-L-lysine endopeptidase of the streptococcal lambdaSa2 was found to 
be responsible for almost the entire hydrolytic activity of the protein (Donovan & 
Foster-Frey, 2008).  
 
1.2.1.2  Cell binding domain 
Endolysin modularity is represented when ECDs are accompanied by a CBD to 
target different receptors (e.g. PG subunits, saccharides, proteins, lipoteichoic 
acid, choline, and PG itself). The pneumococcal phage endolysin Cpl-1 CBD 
recognizes choline decorations on teichoic acids, resulting in a very narrow activity 
spectrum (Fernandez-Tornero et al, 2005). The CBDs of the Listeria 
Introduction and Background 
 
15  
monocytogenes phage endolysins Ply118 and Ply500 can bind to different Listeria 
serovars, with an extremely high, nanomolar range affinity, comparable with 
levels of affinity-matured antibodies (Loessner et al, 2002). Another example is 
the action of an endolysin against Streptococcus group A that binds to 
polyrhamnose, which is a molecule indispensable for the growth of these bacteria 
(Fischetti, 2003). In the case of PlyC, the total CBD consists of 8 monomeric 
subunits which are able to specifically bind certain group A (S. pyogenes) and C (S. 
equi, S. dysgalactiae) streptococci with high affinity using an unknown cell wall 
epitope (McGowan et al, 2012). Notably, CBDs are mostly present in endolysins 
from G+-infecting phages and are often found in double motifs. While it is shown 
that, generally, CBDs of endolysins targeting G+ are highly specific, those found in 
G-, like the endolysins KZ144 and EL188, show a broad binding spectrum (Briers et 
al, 2007b). 
 
1.2.1.3 Domain swapping, truncation and addition 
The urge to develop endolysins with desired or enhanced properties for several 
biotechnological applications has led to the creation of tailor-made enzymes. In 
this approach, the emphasis is laid on adding, truncating or swapping endolysin 
domains to obtain enzymes with optimized applications. Domain swapping can be 
done to enhance the endolysin`s lytic activity, overcome insolubility problems or 
for labelling purposes. Exchanging catalytic domains of a Streptococcus 
pneumoniae phage endolysins resulted in enzymes with the same binding 
characteristics but with multiple PG targets (Garcia et al, 1990). In the case of the 
staphyloccocal P16 endolysin, a similar modification was made with the intention 
to overcome solubility problems (Manoharadas et al, 2009). Probably, the most 
representative case of domain swapping studies lies in exchanging the ECD for a 
fluorescent protein (e.g. GFP). By exploiting the high affinity and specificity of the 
CBDs, these CBD-GFP proteins are used to label and capture different bacterial 
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cells, e.g. Listeria and Bacillus cells (Low et al, 2005; Kretzer et al, 2007). In case of 
endolysins from G- phages, their CBDs (that bind to G- PG unspecifically) fused 
with GFPs are also applied, but now as biomarkers, to assess the G
-
 OM 
permeability (Briers et al, 2009).  
Domain truncations of both the ECD and the CBD have been carried out. CBD 
truncations have resulted in mixed successes. For instance, CBD truncation of the 
Listeria phage Ply118 and Ply500 endolysins (Loessner et al, 2002) or the 
Clostridium perfringens phage phi3626 endolysin (Zimmer et al, 2002) abolished 
its antibacterial activity, while for the Mur endolysin lytic activity remained 
unaltered (Vasala et al, 1995). In some cases, the truncation of the endolysin`s 
CBD resulted in a decrease of muralytic activity (Walmagh et al, 2012). For other 
studies, a higher bacteriolytic activity was achieved (Loessner et al, 1998; Loessner 
et al, 1999; Gaeng et al, 2000; Low et al, 2005) and in the case of the CBD-
truncated LysK and PlyGBS endolysins, a 2-fold and approximately 25-fold increase 
in muralytic activity was attained, respectively (Cheng & Fischetti, 2007; Horgan et 
al, 2009). Interestingly, despite that CBDs are responsible for targeting the 
bacterial cell wall, they do not always seem to be essential for endolysin 
antibacterial activity. 
Finally, constructs containing extra repetitive CBDs to increase affinity have also 
been made. This was the case for Listeria endolysins where duplicating the 
CBD500 increased the equilibrium cell wall binding affinity by approximately 50-
fold (Schmelcher et al, 2011). 
 
1.2.2 Endolysin biotechnological characteristics 
Before considering the application of endolysins as a means to control foodborne 
and clinical diseases (see compilation of biotechnological applications in Table 
1.1), an analysis of their physiochemical properties should be considered, 
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alongside other aspects concerning antimicrobial efficiency and safety. The 
following section debates relevant endolysin biotechnology features, giving 
examples of their positive impact in food and clinical in situ applications. 
 
1.2.2.1 Host specificity 
Endolysins only cleave PG linkages that are exclusively present in bacteria; 
however by displaying dissimilar lytic spectra they can be exploited differently. 
When a wide range of bacteria has to be controlled, endolysins with a broad host 
range will be required. For instance, in agriculture, endolysins targeting different 
bacterial species could play an important role as biopesticides, preventing tomato 
scabs, wilts and spots caused by Streptomyces scabies, Clavibacter michiganensis 
and Xanthomonas campestris, respectively. In health care units, endolysins could 
act as sanitizers targeting etilological agents of hospital-acquired infections (e.g. S. 
aureus or P. aeruginosa).  
Endolysins with a narrower range of action, targeting a specific species or at least 
closely related bacterial species or genus, could prove useful for the elimination or 
control of specific pathogens or spoilage organisms. In livestock, endolysin - 
prebiotic - products could be administered to control enteric diseases in the cattle 
and poultry gastro-intestinal tract (e.g. with C. perfringens Ply2626 endolysin on 
poultry), while leaving the gut microflora unaltered (Zimmer et al, 2002). 
Alternatively, endolysins can control mastitis-causing bacteria in mammary glands 
of dairy cattle (e.g. with Streptococcus uberis Ply700 and S. aureus LysH5 
endolysins) (Celia et al, 2008; Obeso et al, 2008), preventing cross-contamination 
of dairy products and animal carcasses during milking and slaughtering 
procedures, respectively. In industrial fermentations, endolysins like Ply511 could 
be secreted in situ in modified starter cultures, to control L. monocytogenes 
spoilage in milk (Gaeng et al, 2000), or used as a food additive, like the clostridial-
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specific CTP1 endolysin preventing cheese spoilage and blowing (Mayer et al, 
2010). 
 
1.2.2.2 Temperature 
The effect of thermal stress on endolysins can be variable. It is important to 
determine their antimicrobial activity under different temperatures (e.g. chilled 
food of approximately 4°C), to allow for efficient biocontrol. Surprisingly, 
endolysins have been shown to be active at a wide temperature range. While the 
T4 lysozyme retains only a minor fraction of its activity after a 5 min treatment at 
65°C (Nakagawa et al, 1985), KZ144 and EL188 endolysin activities remain high 
even when exposed for 10 min to 50°C (Briers et al, 2007b). Others are shown to 
be stable for 30 min at 45°C (Loeffler et al, 2003), or exhibit only a 30% decrease 
in activity when exposed for 30 min to 90°C (Schmelcher et al, 2012b). Even higher 
thermostability has been described for the lysozyme domain of gp36 from a P. 
aeruginosa phage phiKMV, which is resistant to temperatures up to 100°C 
(Lavigne et al, 2004). However, it is likely that phages isolated from more 
thermostable bacteria will contain endolysins that are even more thermostable. 
Good examples of sources of potentially thermostable endolysins are Bacillus 
phage W1 and Geobacillus phage E1, isolated from deep-sea thermophilic 
bacteria, or the phage phiTMA isolated from the extreme thermophile Thermus 
thermophilus, originating from hot springs (Liu et al, 2006; Tamakoshi et al, 2011). 
Endorsing this hypothesis is the characterized Thermus aquaticus phage phiIN93 
endolysin with an optimal activity between 60 and 120°C (Matsushita & Yanase, 
2008).  
Some bacteria, such as Listeria spp., are able to multiply even in refrigerated 
conditions. However, little is known about endolysin activity on this side of the 
temperature spectrum. Recently, an endolysin LysZ5 report showed the ability to 
reduce Listeria contamination at 4°C on soya milk (Zhang et al, 2012). It is 
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therefore estimated that with the characterization of more phages, novel thermo- 
and cryo-resistant endolysins will be identified and new potential biotechnology 
applications that require cryo/thermal processing will be established. 
 
1.2.2.3 pH tolerance 
Phage endolysin studies have indicated that their optimum pH can vary, ranging 
from acidic to basic. While some have an optimal pH within 4.0-6.0 (Borysowski et 
al, 2006), other have a better antibacterial activity at pH 7.0 (Walmagh et al, 2012) 
and even between pH 8.0-9.0 (Schmelcher et al, 2012b). In addition, the endolysin 
PlyPH, with a specific activity against Bacillus cereus and B. anthracis, remains 
active over an unusually broad pH range of 4.0 to 10.5 (Yoong et al, 2006). 
 
1.2.2.4 Long-term storage (shelf life) 
A good food antimicrobial extends the shelf-life of food products. Several 
endolysins demonstrate an extraordinarily long-term stability, such as Cpl-1, 
which showed no loss in activity over 6 months at 4°C and 3 weeks at 37°C 
(Loeffler et al, 2003). Other examples of endolysins with a long-term stability are 
KZ144 and EL188, which can be stored for 4 months at 4°C without loss of activity 
(Briers et al, 2007b).  
 
1.2.2.5 Antimicrobial efficiency 
Nanogram quantities of endolysin are able to eliminate bacteria from suspensions 
in seconds (Loeffler et al, 2001). To date, no other known biological compound 
has been found to kill microorganisms so quickly. In addition, affinity detection 
methods using nanomolar amounts of CBDs have been described (Loessner et al, 
2002).  
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The possibility to eradicate antibiotic-resistant bacteria makes endolysins 
attractive antimicrobials. This has been shown, for example, on methicillin-
resistant and multidrug-resistant S. aureus (endolysins LysK and MV-L, 
respectively) (O'Flaherty et al, 2005; Rashel et al, 2007), on vancomycin-resistant 
E. faecalis and E. faecium (endolysin PlyV12) (Yoong et al, 2004) and against multi-
resistant P. aeruginosa strains (endolysin OBPgp279) (Walmagh et al, 2012). To 
further improve the antimicrobial efficacy, an endolysin cocktail or a combination 
with antibiotics could be employed to eliminate less accessible bacteria. 
Consistent with this, antibiotic-resistant S. pneumoniae strains have been targeted 
using Cpl-1 and Pal endolysins with the same target specificity, but different 
catalytic activities in vitro (Loeffler & Fischetti, 2003) and in vivo (Jado et al, 2003). 
Also, synergistic effects have also been demonstrated with the Cpl-1 endolysin 
and penicillin or gentamicin antibiotics against S. pneumoniae strains with 
different levels of susceptibilities to penicillin (Djurkovic et al, 2005). 
Still regarding to antimicrobial efficiency, endolysins can also eliminate bacterial 
biofilms, which are often associated with potential problems in food and clinical 
processing units. Despite the higher resistance of biofilms to antimicrobials, 
compared to planktonic cells, three staphylococcal (phi11, phi12 and SAL-2) and 
one streptococcal phage endolysin (PlyC) were shown to successfully remove 
biofilms (Sass & Bierbaum, 2007; Son et al, 2010; Shen et al, 2013). In addition, 
endolysin activity has been shown in the presence of nonionic detergents (i.e. 
hard water and organic compounds), as well as its enzymatic disinfectant 
capacities on surfaces (Hoopes et al, 2009), potentiating even more the endolysins 
antimicrobial efficiency. 
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1.2.2.6 Safety 
Several successful preclinical treatments with endolysins have been carried out in 
animal models and thus far no potential toxicity was observed (Loeffler et al, 
2003; McCullers et al, 2007). Moreover, since phages are daily ingested via water 
and food without any associated health problems, endolysins may be regarded as 
safe to humans and animals. Additionally, in contrast to the several antiviral 
mechanisms of bacteria described against phages (Labrie et al, 2010), to date, 
resistance to endolysins has not yet been reported. Repetitive exposure of 
bacteria grown on agar plates to low concentrations of endolysin did not lead to 
the recovery of resistant strains; neither did bacterial resistance occur after 
several cycles of exposure to low concentrations of enzyme in liquid conditions 
(Loeffler et al, 2001; Rodriguez-Rubio et al, 2013). It has been postulated that the 
lack of bacterial resistance towards endolysins is due to their unique mode of 
action on targeting essential molecules that are difficult to be altered by bacteria 
(Loeffler et al, 2001; Fischetti, 2005). 
Since their discovery, phage-encoded endolysins have been exploited in many 
fields. Table 1.1 shows, however, an overwhelming application of endolysins in 
combating G+ pathogens. The absence of their use against G- bacteria is explained 
by the presence of an impermeable OM that hinders the action of external 
endolysins. Because G- bacteria are also an important group of foodborne and 
hospital related infections, the next sections introduce the bacterial OM 
composition and diversity, which acts as a natural barrier for external endolysins. 
Furthermore, a set of different strategies are discussed to show how to 
permeabilize the bacterial membrane to endolysins. 
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Table 1.1. Endolysins that have been tested in animal models and food samples since 2000. 
Gram 
-type 
Bacterial 
pathogen 
Endolysin  
or CBD 
Animal model  
or Food Sample  
Reference 
G+ Listeria  
monocytogenes 
Ply511 Food Sample 
(milk fermentation) 
(Gaeng et al, 2000) 
G+ Streptococcus  
pneumoniae 
Cpl-1 Animal model 
(mouse model induced bacteremia) 
(Loeffler et al, 2003) 
G+ Streptococcus  
pyogenes 
Pal Animal model 
(mouse model of pharyngitis) 
(Nelson et al, 2001) 
G+ Bacillus 
anthracis 
PlyG Animal model 
(mouse model of nasopharyngeal carriage) 
(Schuch et al, 2002) 
G+ Clostridium  
perfringens 
Phi3626 Food Sample 
(poultry intestines) 
(Zimmer et al, 2002) 
G+ Streptococcus  
pneumoniae 
Pal Animal model 
(murine sepsis) 
(Jado et al, 2003) 
G- Erwinia  
amylovora 
phiEalh  Food Sample 
(Pears surface) 
(Kim et al, 2004) 
G+ Group B 
streptococci 
PlyGBS Animal model 
(mouse model vagina and oropharynx) 
(Cheng et al, 2005) 
G+ Staphylococcus  
aureus 
phi11 Food Sample 
(bovine milk) 
(Donovan et al, 2006b) 
G+ Bacillus 
anthracis 
PlyPH Animal model 
(B. cereus RSVF1 model of peritonitis) 
(Yoong et al, 2006) 
G+ Staphylococcus  
aureus 
MV-L Animal model 
(mouse of systemic MRSA disease) 
(Rashel et al, 2007) 
G+ Listeria  
monocytogenes 
CBD118 
or CBD500 
Food Sample 
(meat, dairy and ready-to-eat products) 
(Kretzer et al, 2007) 
G+ Streptococcus  
uberis 
Ply700 Food Sample 
(bovine milk) 
(Celia et al, 2008) 
G+ Staphylococcus  
aureus 
LysH5 Food Sample 
(pasteurized milk) 
(Obeso et al, 2008) 
G+ Streptococcus  
equi 
PlyC  Food Sample 
(horse-related material surfaces) 
(Hoopes et al, 2009) 
G+ Clostridium  
tyrobutyricum 
phiCTP1 Food Sample 
(semi-skim milk) 
(Mayer et al, 2010) 
G+ Staphylococcus  
aureus 
LysH5 Food Sample 
(pasteurized milk) 
(Garcia et al, 2010) 
G+ Listeria  
monocytogenes 
CBDP40 Food Sample 
(milk and cheese) 
(Schmelcher et al, 2010) 
G+ Staphylococcus  
aureus 
P-27  
or HP 
Animal model 
(mouse model induced bacteremia) 
(Gupta & Prasad, 2011) 
G+ Listeria  
monocytogenes 
Lys Food Sample 
(soya milk) 
(Zhang et al, 2012) 
G+ Staphylococcus  
aureus 
λSA2 Animal model 
(mouse model of bovine mastitis) 
(Schmelcher et al, 2012a) 
G+ Staphylococcus  
aureus 
SAL-1 Animal model 
(mouse model of MRSA infection) 
(Jun et al, 2013) 
G+ Streptococcus  
Pneumonia 
Cpl-1 Animal model 
(mouse model) 
(Doehn et al, 2013) 
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1.3 Gram-negative outer membrane barrier for external endolysins 
Although G- bacteria class is represented by a variety of genera, the cell envelope 
of these bacteria has a common general architecture, comprising of a cytoplasmic 
membrane (symmetric membrane of mainly phospholipids in both leaflets) 
separated by a periplasmic space (containing the PG and some transport-
proteins), from the OM. With a few exceptions, the OM consists of an asymmetric 
membrane of phospholipids (inner leaflet), lipopolysaccharides (LPS) (outer 
leaflet) and proteins, like porins, serving as defusing channels, and lipoproteins, 
covalently bound to the PG and anchored to the inner leaflet (Figure 1.4 a).  
The LPS is the major component of the OM and represents the major virulence 
factor, providing the bacterium a permeability barrier for many external agents, 
such as endolysins. An overview of the LPS structure typically seen in G- bacteria is 
presented, giving specific examples within the Enterobacteriaceae (Salmonella, E. 
coli) and Pseudomonadaceae (P. aeruginosa). Furthermore, OM permeabilization 
strategies to potentiate the endolysins` antibacterial activity are discussed. 
 
 
1.3.1 LPS structure and diversity 
The LPS is an extremely diverse structure that can be modified in response to 
prevailing environmental conditions (Nikaido, 2003). Three different regions can 
be distinguished according to their chemical structure, biosynthesis, genetics and 
function: i) the lipid A component, ii) the core region and iii) the O-antigen, also 
known as O-specific polysaccharides or O-side chains, illustrated in Figure 1.4 b. 
The LPS may be presented in a rough (R-type, without O-antigen), smooth (S-type, 
with O-antigen) or a mixture (SR-type).  
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Figure 1.4. Schematic representation of a typical Gram-negative cell envelope. a) Illustration of 
the main cell envelope components (cytoplasmic membrane, the periplasmic space and the outer 
membrane). b) A zoomed image of a typical E. coli and S. Typhimurium LPS chemical structure is 
illustrated. Two different sub-regions (inner and outer) are found in core oligosaccharide based on 
their chemical composition. Small black dots represents divalent cations (Mg
2+
, Ca
2+
) that bridge 
LPS molecules via ionic linkages to form a network. Abbreviation: KDO, 2-keto-3-deoxy-octonic 
acid. Adapted from (Vaara, 1999). 
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1.3.1.1 O-polysaccharide or O-antigen 
The O-antigen, the major component of the LPS surface, is a highly antigenic 
structure consisting of a linear chain of oligosaccharide units, attached to the lipid 
A-core molecules by a ligase (Figure 1.4 b). The O-antigen is a highly diverse 
structure that provides the bacterium with an extra shelter against external 
factors. Contributing to this diversity are the chain length (up to 50 mono- or 
oligosaccharides), the sugar composition (containing 2-8 monosaccharide residues 
of which D-glucose and D-galactose are more common), their modifications (O-
acetylation, epimerization, glycosylation and amidation) and the glycosyl linkages 
between the repeating units (i.e. by α-(1→2)-, α-(1→3)- or β-(1→3)). This is 
reflected by the polymorphisms presented in the genes responsible for the 
biosynthesis of these structures (Knirel, 2009). 
 
1.3.1.2 Core oligosaccharide 
The core oligosaccharide is a short chain of oligosaccharides of ≈15 sugars. Being 
chemically diverse (although to a lesser extent than the O-antigen), the core 
region can be divided into an inner and outer core. The basis of the inner core 
consists of keto-deoxyoctanoate, also known as 3-deoxy-D-manno-2-octulosonic 
acid (Kdo) and L-glycero-D-manno-heptose (Hep) residues. Their number, linkages 
and substituent units present (e.g. other sugars or phosphate residues, or 
sometimes by acetyl groups or amino acids) account for structural diversity of this 
core region. Common to all is the Kdo residue that covalently links the inner core 
to the Lipid A (Figure 1.5) (Holst & Molinaro, 2009). The outer core is made of 
hexose residues attaching the O-antigen to the last heptose of the inner core. 
Common sugar residues found here are D-glucose, D-mannose and D-galactose. In 
particular, the P. aeruginosa inner core contains a higher amount of Kdo and 
phosphate residues, which gives an average of 6.5 formal negative charges per 
LPS molecule, compared to the 5.5 formal negative charges of the E. coli Lipid A. 
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This indicates that ionic interactions in the P. aeruginosa Lipid A with surrounding 
divalent cations have a stronger contribution for the stabilization of LPS molecules 
(Nikaido, 2003; Pier, 2007). 
 
 
 
Figure 1.5. Detailed view of the inner core oligosaccharide and Lipid A components of S. 
Typhimurium. Dotted lines represent incomplete substitutions. Abbreviations: Glc, D-glucose; Gal, 
D-galactose, GlcN, D-glucosamine; P, phosphate; Hep, L-glycero-D-mannoheptose; EtN, 2-
aminoethanol; Ara4N, 4-amino-4-deoxy-L-arabinose; KDO, 2-keto-3-deoxy-octonic acid; GlcN, D-
glucosamine; GlcNAc, N-acetyl-D-glucosamine. Retrieved from (Vaara, 1999). 
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1.3.1.3 Lipid A 
Lipid A is the innermost of the three regions of the LPS that anchors the whole 
molecule to the OM. It represents the endotoxic centre of the LPS, which is 
responsible for the pyrogenicity of LPS. Lipid A is known to possess a rather 
conservative structure which is characterized by a β (1’,6) linked disaccharide of 
D-glucosamine backbone, phosphorylated (at C1 and C4’) and acetylated on 
different positions (C2, C3, C2’ and C3’) by primary hydroxy and non-hydroxy acyl 
groups (Figure 1.5). Heterogeneity found in lipid A can arise from the type of 
sugar present, the degree of phosphorylation, the presence of phosphate 
substitutes, ethanolamine or other groups, and nature, chain length, number, and 
position of the acyl groups (Raetz & Whitfield, 2002; Holst & Molinaro, 2009) 
(Figure 1.5). Particularly, lateral interaction between the neighbouring Lipid A 
moieties is responsible for the LPS stability and subsequent permeabilizing 
efficiency. First, the negatively charged phosphate groups presented throughout 
the Lipid A (and also the core oligosaccharide) are important for strengthening the 
LPS monolayer by linking molecules via ionic bridges with divalent cations (Vaara, 
1999). However, Lipid A phosphate group substitutes can occur, lowering the 
overall negative charge of the LPS. Second, the presence of a higher number and 
length of acyl chains (fatty acids) in lipid A increases intermolecular hydrophobic 
stacking, also contributing to a more stabilized OM (Nikaido, 2003). A higher 
acylated lipid A is found in E. coli and Salmonella (composed of hexa- or hepta-
acylations, with a minimum of 14 carbon atoms long), compared to the less 
acylated Lipid A of P. aeruginosa (composed of penta-acylations, with a 12 carbon 
atoms long), favouring the E. coli and Salmonella for a more stabilized LPS 
structure (Nikaido, 2003). 
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1.4 Strategies to overcome the outer membrane 
In view of the conserved G- bacterial PG structure, the application of endolysins 
on these bacteria is considered to be the ”holy grail” in endolysin-based microbial 
control (Schleifer & Kandler, 1972). As mentioned before, two main OM-stabilizing 
forces, the LPS cation-binding sites (ionic interactions) and the dense hydrophobic 
stacking of the Lipid A acyl chain groups (hydrophobic interactions), are present. 
Possible strategies to weaken the OM are: i) the use of outer membrane 
permeabilizing (OMP) compounds (such as EDTA and organic acids) or ii) covalent 
modification of endolysins by inserting LPS-destabilizing peptides (like 
antimicrobial peptides. Their OMP mechanisms are illustrated in Figure 1.6. 
Liposome delivery, OM vesicle-delivery and pressure-promoted permeabilization 
are other possible OMP techniques that are not discussed here, as they are 
beyond the scope of this research.  
 
1.4.1 Outer membrane permeabilizer agents  
The G- bacteria OM functions as a natural barrier against external harmful agents. 
Its integrity can be challenged by targeting the aforementioned stabilizing divalent 
cations interactions with the ionic LPS structure. Polycations, chelators and 
organic acids form three distinct groups of OMPs interacting with the OM in a 
different way. 
Polycations (mostly represented by polymyxin B and their derivatives, lysine 
polymers and aminoglycosides) compete with the stabilizing cations to bind to the 
ionic sites of the LPS. This results in displacement of the divalent cations and 
destabilization and/or permeation of the OM (Vaara, 1992). Among polymyxin 
groups, polymyxin B (four net positive charges) is the strongest OMP because it 
not only weakens the OM by cation-binding competition in range of 0.3-1 µg/mL 
(sublethal effect) but also can cause leakage of cytoplasmic components (lethal 
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effect) with a minimal inhibitory concentration of 1 µg/mL in E. coli and S. 
Typhimurium (Vaara & Vaara, 1983). As for lysine polymers, lysine20 (20 lysine 
residues) has the strongest permeabilizing effect in the range of 0.3 to 3 µL/mL 
(Vaara & Vaara, 1983). In case of aminoglycosides (three to six net positive 
charges), they are weaker permeabilizers, strongly dependent on the ionic 
strength (Vaara, 1992).  
Chelators (mostly represented by EDTA) remove the stabilizing Mg2+ and Ca2+ 
cations from the LPS (Figure 1.6). Consequently, LPS components are released to 
the extracellular environment (Leive et al, 1968) and this results in an uptake of 
phospholipids that migrate from the inner layers, creating patches that facilitate 
transport of hydrophobic/lipophilic agents (Nikaido & Vaara, 1985). Like most 
chelators, EDTA has a weak bactericidal effect, able to, for example, sensitize G- 
bacteria to several hydrophobic antibiotics (e.g. erythromycin, rifampin, 
cloxacillin) (Scudamore et al, 1979). To date, EDTA is the only OMP agent 
described to act synergistically with endolysins, permeabilizing the OM of P. 
aeruginosa to these enzymes (Briers et al, 2007b). 
Recently, weak organic acids (e.g. citric, malic, benzoic and lactic acid) have been 
considered as another group of OMPs. Although some agents, such as citric acid, 
have, to a lesser extent, chelating properties, additional acidity can contribute to 
OM disruption (Alakomi et al, 2000; Theron & Lues, 2011) (Figure 1.6). It has been 
proposed that the LPS disintegration is accomplished by the ability of 
undissociated acid groups to interact/pass through the negatively charged LPS 
(where negatively charged acid forms are repulsed) and migrate inside the cells to 
cause sublethal injuries. Intracellularly, the organic acid meets a higher internal 
pH (7.2) and dissociates to produce protons (that can exit through specific proton 
channels) and anions (Breidt et al, 2004). The persistent presence of the higher 
concentration of protons increases the cytoplasmic acidity, compromising some 
enzymatic functions (e.g. inactivation of acid-sensitive enzymes) (Roe et al, 2002; 
Hirshfield et al, 2003). The presence of anion parts that cannot exit also 
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contributes to the inhibition of several metabolic reactions (e.g. increase of turgor 
pressure) (Roe et al, 1998; Kirkpatrick et al, 2001). Citric, malic and lactic acid are 
examples of weak organic acids reported to possess OM-disrupting activity against 
P. aeruginosa, S. Typhimurium and E. coli O157 (Alakomi et al, 2000; Kim & Rhee, 
2013). They can become active antimicrobial agents against G- bacteria at higher 
concentrations or when combined with fatty acids (In et al, 2013; Kim & Rhee, 
2013). 
 
 
 
Figure 1.6. Simplified view of the Gram-negative bilayer with an overview of its destabilization 
by using different membrane active agents (EDTA, organic acid and antimicrobial peptide). EDTA 
chelates outer membrane-bound stabilizing divalent cations, causing dispersion of LPS molecules 
from the cells. Organic acids can diffuse freely into intracellular spaces in their undissosiated form 
(oppositely, dissociated acids are limited to secondary transport). Increase of anion as well as 
proton concentrations affects several metabolic processes (e.g. enzyme inhibitions, amino acid 
decarboxylation, membrane disruption). Antimicrobial peptides have a binary mode of action. 
They can either lyse the cell by disruption of cytoplasmic membrane (pore formation) or 
translocate inside the cells (direct penetration) to lethally interfere with several cellular processes 
(e.g. DNA, RNA synthesis). Abbreviations: RCOOH, undissociated acid; H
+
 RCOO
-
, dissociated acid; 
pHi, intracellular pH; pKa, acid dissociation constant; OM, outer membrane. 
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1.4.2 Covalent modification - inserting LPS-destabilizing peptides  
Covalent modification by the addition of (LPS-destabilizing) peptides with a 
polycationic, hydrophobic or amphipathic nature can allow the passage of 
external proteins through the bacterial OM barrier. Antimicrobial peptides (AMPs) 
are short peptides with such characteristics that could be fused to endolysins. The 
OM-AMP interaction is not completely understood and several mechanisms have 
been proposed. Generally, two different AMP modes of action have been 
described: they can make OM pores and lyse the cells upon contact; or penetrate 
through the OM, exerting its antimicrobial effect intracellularly by inhibition of 
various vital cellular processes (Splith & Neundorf, 2011). Figure 1.6 illustrates all 
membrane active agents (EDTA, organic acid and AMPs, representing sources of 
LPS-destabilizing peptides) used in this study to permeabilize the G- OM for 
endolysins. Polycatonic peptides (such as polymyxin B or poly-L-lysine) 
compromise the OM integrity by displacement of the divalent cations responsible 
for the normal packing between phosphate groups of phospholipids and LPS 
(Vaara, 1992). A similar peptide with positively charged amino acids has been 
found in the Bacillus amyloliquefaciens phage IAM1521 endolysin C-terminal side, 
thought to be responsible for its spontaneous antibacterial activity against G- cells 
(Morita et al, 2001). Hydrophobic peptides are able to intercalate and disorder the 
lipid A acyl chain-phospholipid moieties of the OM. This leads to a reduced 
hydrophobic stacking and subsequent OM destabilization, no longer acting as an 
efficient diffusion barrier (Nikaido, 2003). In the past, several modifications of the 
hen egg white lysozyme (HEWL) with increased hydrophobic content expanded its 
activity to G- bacteria. The addition of a hydrophobic Phe-Phe-Val-Ala-Pro 
pentapeptide, which was shown to adopt β-strand conformation and interact with 
the bacterial OMs, is an example of enhanced HEWL bactericidal effect, reducing 
85% of E. coli cells (Ibrahim et al, 1994). Amphipathic peptides are α-helical 
structures that contain both cationic and hydrophobic amino acids on opposite 
sides of the helical axis, thereby exerting a powerful permeabilization effect on 
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the bacterial membranes (Oren & Shai, 1998). An example is found within the C-
terminal sequence of the T4 lysozyme. The 13-mer peptide located between the 
amino acids 143-155, corresponds to a typical positively charged amphipathic α-
helix (named α4), enabling the enzyme to interact with the negatively charged LPS 
groups of G- bacteria. Synthetic α4, is highly active on different biological 
membranes, and its antibacterial properties is apparently more important that 
the enzymatic PG degradation (During et al, 1999). 
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G- pathogenic bacteria are a global human health concern as they are common 
causes of foodborne, environmental and zoonotic infectious diseases. This 
problem is exacerbated by their ability to display intrinsic (natural) or acquired 
antibiotic resistant mechanisms. Therefore there is an urgent need to develop 
efficient mechanisms to combat harmful G- bacteria. The work developed in the 
scope of this thesis aimed at developing innovative methods of G- control, based 
on phage endolysins. The scientific challenge behind this approach is to make 
endolysins accessible to the bacterial OM that naturally acts as protective barrier 
for external agents.  
This thesis comprises 7 different chapters grouped in 5 main parts, each 
presenting:  
1- An extensive literature review on phage endolysin functions and their 
biotechnological interest to fight the problematic G- bacterial infections. A 
detailed discussion was given on the structure and composition of the 
protective G- OM, introducing several strategies to permeabilize it for 
endolysins and facilitate access to the PG (chapter 1).  
2- A deep in silico analysis of all available endolysins genes covering the 
endolysins distribution in phages/infecting hosts and their molecular 
differences, particularly those from a G- background, aiming at indicating 
the best endolysin candidates to prevent or destroy pathogenic bacteria 
(chapter 3). 
3- The characterization of two novel phage-encoded endolysins (Lys68 and 
ABgp46) to expand the knowledge on the few endolysins described from 
G- background. Their antibacterial effect in combination with different kind 
of OMPs (chelators and organic acids) was evaluated against a broad range 
of G- pathogens in planktonic and biofilm cultures (chapter 4 and 5). 
4- A description of an engineered class of endolysins (PVP-SE1gp146 and 
Lys68) fused with a set of different tags (LPS-destabilizing peptides and 
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CBDs), to enhance the endolysin`s antibacterial properties. Modified 
PVPSE1-gp146 with different LPS-destabilizing peptides was tested against 
G- pathogens. With a different objective, Lys68 variants possessing 
different PG-binding peptides, derived from listerial phage endolysin CBDs, 
were used to direct and amplify their activity against L. monocytogenes, 
illustrating an additional usage of G--like endolysins (chapter 6). 
5- Major conclusions of the work, addressing the main advantages and 
limitations of the developed endolysin strategies to kill G- bacterial 
pathogens, suggesting important issues that should be clarified in future 
works (chapter 7).  
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3.1 Introduction 
Phages are the most abundant living entities on Earth and can be found in every 
conceivable habitat (Rohwer, 2003). Regarding their diversity, phages can exist 
with different morphotype (e.g. Myoviridae, Siphoviridae and Podoviridae with 
different tail types), nucleic acid (double- or single-stranded DNA), genome size 
and type of replication mechanisms (lytic or lysogenic pathway). Tremendously 
diversified, they constitute a reservoir of great genetic diversity, which is 
supported by the high frequency of novel genes found in newly characterized 
phage genomes. This high diversification in phage population can be attributed to 
the high number of different bacterial hosts available for phage infection and the 
ability of phages to rapidly evolve in order to circumvent bacterial resistance 
mechanisms (Sturino & Klaenhammer, 2006; Labrie et al, 2010). Therefore, among 
other proteins, phages potentially encoded a diverse group of PG hydrolases 
(PGHs) - endolysins - worth of exploring. 
This chapter presents a deep in silico study of all known endolysins encoded by 
double-stranded nucleic acid (dsNA) completely sequenced phage genomes. 
There domains (ECDs/CBDs), structure (globular and modular design), as well as 
their distribution through phage families and bacterial hosts was assessed. With 
this analysis it was intended not only to resolve previous misconception regarding 
endolysins nomenclature (simply calling all endolysins lysozymes as a generic term 
for PGHs) but also to better understand the phage-endolysin-host ecology. This 
will allow in the future the study of novel uncharacterized endolysins and 
selection of the best endolysin candidates to fight specific bacterial pathogens. 
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3.2 Materials and methods 
3.2.1 Endolysin search and database  
To identify endolysin genes and create a database, a comprehensive list of all 
endolysins from 890 retrieved dsNA phages with completed genome sequences 
deposited in the NCBI database was gathered. An in silico analysis of all putative 
endolysin sequences were screened by the HHpred webserver (URL 
http://toolkit.tuebingen.mpg.de/hhpred) using Pfam, InterProScan and COG; with 
an E-value cut-off of 1x10-5 and at least 80% of query coverage. The MSA 
generation method used was HHblits (Remmert et al, 2012). To indicate a given 
ORF as a probable endolysin, two criteria were followed: (i) the presence of a 
putative ECD and (ii) the absence of additional domains with extraneous function. 
The latter allowed distinguishing endolysins involved in programmed lysis from a 
second phage-associated muralytic activity often found to be involved in DNA-
injection (structural lysins, also known as exolysins). For each putative encoded 
endolysin found, the following information was gathered: (i) presence and 
position of ECD/CBD; (ii) phage family type; (iii) Gram reaction corresponding 
host; and (iv) host genus.  
 
3.2.2 Cladogram of bacteriophage-endolysin-host 
Phage-endolysin-host cladogram was constructed using putative endolysin 
sequences of only completely sequenced dsNA phage genomes. All these protein 
sequences were retrieved from our database in FASTA format, aligned using 
Clustal Omega (beta version for proteins only, v1.1.0) with the -o output.aln -
MAC-RAM=30000 –v –v parameters. The conversion to the PHYLIP format was 
done using ClustalX multiple alignment software (version 2.0). The phylogenetic 
construction was obtained using the Phylogeny Inference Package (PHYLIP v3.68). 
The phylogenic analysis was performed using the following algorithms: Maximum 
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Likelihood, Neighbor-Joining and Parsimony. These methods were applied to the 
PHYLIP sequences base using PROML, PROTDIST+NEIGHBOR and PROTPARS, with 
SEQBOOT programmed to 100 replicates to bootstrap and number seed variation 
(the trees were compared to address similarity). Bootstrap values were calculated 
using CONSENSE. In all methods, the jumble number used was 10 and the 
bootstrap values were all above 80%. Although more than one method was used 
to construct the trees, the Maximum Likelihood method was selected since it 
chooses those trees that maximize the probability of observing the data. 
Phylogenetic trees obtained from PHYLIP were represented and arranged, without 
being altered, using the FigTree software (version 1.3.1). 
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3.3 Results 
3.3.1 Outline - Endolysins structure diversity and distribution 
With an in silico analysis of a total of 890 complete phage sequences found in the 
NCBI, 723 putative endolysins were identified, from phages infecting 64 different 
bacterial genera. The endolysins were identified in 136 Myoviridae, 378 
Siphoviridae, 97 Podoviridae, and nine Tectiviridae (all dsDNA), four Cystoviridae 
(dsRNA) and 99 unclassified phages. Despite their conserved biological function, 
phage endolysins are enzymatically and architecturally tremendously diverse and 
vary hugely in length and size. With a remarkable number of 24 different ECDs 
and 13 CBD types (Table 3.1), these specialized enzymes comprehend 89 different 
types of architectural organizations (Figure 3.1) ranging from 72 to 578 amino 
acids residues (on average around 177 and 390 amino acids for endolysins from a 
G- and G+ background, respectively). All the information mentioned above was 
gathered in a database available at http://dx.doi.org/10.1128/JVI.03277-12. 
For a systematic analysis, predicted similar domains found in different databases 
(CHW and LYSM from both Pfam and SMART databases) were referred to as the 
same domain. It is important to note that, despite AMI-5 being a domain similar 
to other amidases, this bioinformatic analysis showed a similarity with the 
peptidase NLPC-P60 domain (E-values differ at most 5 log). Additionally, in vitro 
studies with AMI-5-endolysin from streptococcal phage Dp-1 indicate a peptidase 
activity (Sheehan et al, 1997). Since the 16 Ami-5 domains found were all from 
Streptococcus spp., they were further considered as NLPC-P60. 
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Table 3.1. Identified putative endolysin catalytic and binding domains.  
PREDICTED CATALYTIC 
DOMAIN 
CONSERVED DOMAINS PHAGE EXAMPLE 
HHpred 
probability/E-value 
Phage_lysozyme (LYSO) PF00959 / IPR002196 Burkholderia phage Bcep176 100.0 / 3.1E-34 
Muramidase (MURA) COG4678 Enterobacteria phage lambda 100.0 / 6.2E-52 
Glyco_hydro_19 (GH19) PF00182 / IPR000726 Pseudomonas phage F10 100.0 / 6.8E-42 
Glyco_hydro_25 (GH25) PF01183 / IPR002053 Clostridium phage phiCTP1 100.0 / 4.9E-48 
Glyco_hydro_108 (GH108) PF05838 / IPR008565 Vibrio phage VP882 100.0 / 1.5E-37 
SLT (SLT) PF01464 / IPR008258 Pseudomonas phage B3 99.9 / 2.9E-23 
Transglycosylase (TRANG) PF06737 / IPR010618 Mycobacterium phage Blue7 100.0 / 8.3E-31 
Glucosaminidase (GLUCO) PF01832 / IPR002901 Bacillus phage Bam35c 100.0 / 6.8E-32 
Amidase02_C (AMI02-C) PF12123/ IPR021976 Clostridium phage phiCD38-2 98.2 / 1.2E-06 
Amidase_5 (AMI-5) PF05382 / IPR008044 Streptococcus phage 858 99.9 / 3.0E-26 
Amidase_3 (AMI-3) PF01520 / IPR002508 Listeria phage 2389 100.0 / 6.4E-44 
Amidase_2 (AMI-2) PF01510 / IPR002502 Gordonia phage GTE7 100.0 / 2.4E-29 
NlpD (NLPD) COG0739 Mycobacterium phage Timshel 97.8 / 2E-05 
VanY (VANY) PF02557 / IPR003709 Yersinia phage PY100 99.9 / 1.2E-24 
Peptidase_U40 (PET-U40) PF10464 / IPR19505 Pseudomonas phage phi-6  100.0 / 2E-138 
Peptidase_M15_3 (PET-15-3) PF08291 / IPR013230 Bacteroides phage B40-8 100.0 / 1.1E-38 
Peptidase_M15_4 (PET-15-4) PF13539  Salmonella phage ST64T 99.7 / 8.2E-17 
Peptidase_M23 (PET-M23) PF01551 / IPR016047 Thermus phage P23-45 100.0 / 2E-28 
YkuD (YKUD) PF03734 / IPR005490 Synechococcus phage S-CBS4 99.7 / 7.1E-18 
NLPC_P60 (NLPC-P60) PF00877 / IPR000064 Mycobacterium phage Dori 99.8 / 2.9E-19 
Peptidase_C39_2 (PET-C39-2) PF13529 Rhodococcus phage REQ3 99.8 / 1.8E-17 
CHAP (CHAP) PF05257 / IPR007921 Staphylococcus phage phi13 99.8 / 9.4E-22 
DUF3597 (DUF) PF12200 / IPR022016 Listeria phage A188 99.5 / 7.6E-15 
    
PREDICTED BINDING DOMAIN    
PG_binding_3 (PG-3) PF09374 / IPR018537 Vibrio phage VP882 99.9 / 7.9E-25 
LysM (LYSM) PF01476/ IPR018392  Enterococcus phage phiEf11 99.0 / 1.4E-10 
LysM (LYSM) smart00257 Lactobacillus phage Lb338-1 99.5 / 5.0E-14 
SH3_3 (SH3-3) PF08239/ IPR013247 Lactobacillus phage Lv-1 97.6 / 5.3E-05 
SH3_5 (SH3-5) PF08460 / IPR013667 Staphylococcus phage phi2958PVL 99.5 / 1.5E-14 
PG_binding_1 (PG-1) PF01471 / IPR002477 Mycobacterium phage Hertubise 99.5 / 8.7E-14 
ChW (CHW) smart00728  Lactobacillus phage A2 99.3 / 2.3E-12 
ChW (CHW) PF07538 / IPR006637 Lactococcus phage 949 99.2 / 7.1E-12 
Cpl-7 (CPL7) PF08230/ IPR013168 Streptococcus phage SMP 99.5 / 2.4E-14 
LGFP (LGFP) PF08310/ IPR013207 Nocardia phage NBR1 99.7 / 1.6E-17 
SH3-related (SH3-r) SUPFAM0051050 Listeria phage A500 100.0 / 4.4E-54 
FOG (FOG) COG5263  Listeria phage B054 99.8 / 4.0E-19 
SH3b (SH3b) smart00287  Lactococcus phage P087 97.5 / 4.4E-05 
SPOR (SPOR) PF05036/ IPR007730 Bacillus phage AP50 99.1 / 1.8E-10 
SLAP (SLAP) PF03217/ IPR004903 Bacillus phage 0305phi8-36 98.9 / 3.0E-08 
 
The acronyms used in all ECDs and CBDs are illustrated in parentheses. Domain abbreviations: Glyco_hydro, 
Glycoside hydrolase; SLT, Soluble Lytic Transglycosylase; CHAP, Cysteine, Histidine-dependent 
Amidohydrolases/Peptidases; DUF, Domain of Unknown Function; LYSM, Lysin motif; CHW, Clostridial 
hydrophobic with conserved W (Trp); SPOR, Sporulation related domain; SLAP, bacterial Surface LAyer 
Protein. Databases: PF, Pfam; COG, Clusters of Orthologous Groups of proteins; IPR, InterProScan; Smart, 
Simple Modular Architecture Research Tool. AMI-5 is further considered as NLPC-P60. 
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3.3.2 Enzymatic catalytic domains 
3.3.2.1 Phage glycosidase PGHs 
This group of enzymes belongs to the lysozyme-like superfamily that catalyzes the 
glycolytic cleavage of the O-glycosidic bond of the bacterial PG. The PGHs are very 
diverse and can be defined by sequence similarity according to the Carbohydrate-
Active Enzymes database (Cantarel et al, 2009). GH24, GH25 and GH108 (EC 
3.2.1.17) are a structurally diverse set of phage endolysin members with the same 
lysozyme activity cleaving the MurNAc-N-GlcNAc bond of the carbohydrate 
backbone. GH24 are the most predominant PGHs, generally containing globular 
MURA or LYSO domains that are only present in lytic cassettes of phages infecting 
G- bacteria. GH25 endolysins, on the other hand, are acquired by Siphoviridae 
viruses targeting G+ organisms, mostly belonging to the Firmicutes family (e.g. 
Bacillus spp., Staphylococcus spp., Streptococcus spp.) that can be linked to 
several distinct C-terminal CBDs (SLAP, CPL-7, LYSM, SH3 and FOG). The GH108 
class contains just nine endolysins with an enzymatic activity restricted to phages 
infecting only seven G- genera and have never been characterized in vitro. Other 
SLT and TRANG domains belong to the lytic transglycosylase group of enzymes. 
Although degrading the same PG covalent bond as the previous group, they are 
not hydrolases. SLT-encoding endolysins are globular and acquired by phages to 
target G- PG (found in Burkholderia, Campylobacter, Escherichia and Pseudomonas 
phage endolysins), while the TRANG-type enzymes are modular and specialized in 
G+ PG degradation (only found in Mycobacteriophages Gladiator, Da Vinci, 
Hammer, Trixie, Jeffabunny, Blue7 and Turbido). P. aeruginosa phage phiKZ 
endolysin is an example of a (SLT) lytic transglycosylase for which activity has been 
biochemically confirmed (Paradis-Bleau et al, 2007). GH19 (EC 3.2.1.14) is a 
distinct class cleaving the glycosidic β-1,4 linkages of unbranched chains of N-
acetylglucosamine polymers. This structure is uncommon in bacterial cell walls; 
therefore one can speculate that GH19-identified endolysins can have glycosidase 
activity, acting either as N-acetylglucosaminidase or as N-acetylmuramidase. They 
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are mainly found in phages infecting Mycobacterium spp., Gordonia spp. and 
Corynebacterium spp. and have been recently characterized in the P. fluorescens 
OBP and S. Enteritidis phage PVP-SE1 (Lai et al, 2011; Walmagh et al, 2012). 
Finally, glucosaminidases (GLUCO) (EC.3.2.1.52) are core-specific lysosomal 
enzymes cleaving the GlcNAc-(β-1,4)-MurNAc bond. In phage endolysins, this 
domain is repeatedly found in Siphoviridae phage lytic cassettes that mostly target 
hosts within the Firmicutes family. Although this catalytic class is frequently 
present in Staphylococcus infecting phages containing three domains in a 
CHAP/AMI-2/GLUCO module, only the Streptococcus agalactiae prophage 
LambdaSa2 was shown to display β-D-N-acetylglucosaminidase activity (Pritchard 
et al, 2007). 
 
3.3.2.2 Phage amidase PGHs  
N-acetylmuramoyl-L-alanine amidases (EC 3.5.1.28) are endolysins composed of 
domains of the AMI-2, AMI-3, AMI-5 and AMI02-C type, cleaving the same PG 
bond between the N-acetylmuramoyl residues and L-amino acid residues. AMI-2, 
the most predominant domain (representing 28.22%), found in Mycobacterium-
like and Staphylococcus-like endolysins, is usually located as a central domain. 
Escherichia phage T7 and Staphylococcus phage Twort endolysins are well studied 
enzymes (Cheng et al, 1994; Loessner et al, 1998). AMI-3 domains are 
predominantly found in G+-like endolysins. It is important to highlight that all 
staphylococcal phage endolysins bearing AMI-3 have a CHAP/AMI-3/SH3-5 
structure. Finally, AMI02-C is located at the C-terminal side and is merely present 
in some Bacillus and Clostridium-like endolysins. To our knowledge, no in vitro 
studies have yet been performed to confirm lytic activity of this domain. 
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3.3.2.3 Phage carboxy/endopeptidases 
Phage carboxy/endopeptidase PGHs form the larger group of ECDs that cleave 
short peptides that link the sugar polymers of the PG. A total of nine different 
peptidases were found: endopeptidase domains PET-M23, NLPC-P60, NLPD, PET-
U40 and PET-C39-2; and the carboxypeptidase domains VANY, PET-M15-4, PET-
M15-3 and YKUD. PET-M23 is found in phage endolysins from several genera. It 
has been reported that the Bacillus subtilis prophage Sp-β endolysin (named CwlP) 
contains a related domain that has been shown to function as a DD-
endopeptidase cleaving 4R3 D-Ala–m-DAP interpeptide linkages (Sudiarta et al, 
2010). The NLPC-P60 domain is described as a superfamily with a very different 
range of activities. Only found in G+-like endolysins, they can cleave N-
acetylmuramate-L-alanine linkages, as was shown for the Streptococcus phage Dp-
1 and Lactococcus lactis phage BK5-T endolysins (Boyce et al, 1995; Sheehan et al, 
1997). More recently, NLPC-P60, found in some Mycobacteriophage endolysins, 
was described as a cysteine proteinase cleaving the 4→3 linkage between D-Glu 
and m-DAP residues (Payne & Hatfull, 2012). PET-C39-2 was first identified in Lysin 
A proteins (Mycobacteriophage cell wall hydrolytic enzymes), cleaving the D-Glu-
m-DAP linkages (Payne & Hatfull, 2012). This peptidase is also a cysteine 
proteinase and is mainly present in Mycobacteriophages. VANY is described in the 
Pfam database as a D-alanyl-D-alanine carboxypeptidase, possibly due to the 
Enterococcus faecium vancomycin resistance protein VanY (Wright et al, 1992). 
Concerning its phage origin, this domain was identified both in G+ and G--like 
endolysins, particularly in phages infecting Listeria, Bacillus and Escherichia 
organisms. In opposition to what is described by Pfam, the Listeria phage 
endolysins Ply118 and Ply500 and the enterobacteriophage T5 endolysin classified 
as VANY carboxypeptidases act as L-alanyl-D-glutamate endopeptidases (Loessner 
et al, 1995; Mikoulinskaia et al, 2009). PET-M15-4 is a domain also described as D-
alanyl-D-alanine carboxypeptidases, however it has been predicted to display L-
Ala-D-Glu activity (Payne & Hatfull, 2012). This domain was found in several 
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Mycobacteriophages and in some phages infecting G- organisms, such as 
Salmonella. PET-M15-3 peptidase domains are metallopeptidase domains 
belonging to family M15A, found in only nine different endolysins, mainly from G- 
infecting phages. The exact cleavage site has not yet been identified, due to the 
lack of biochemical evidence. CHAP is a common domain found in phage 
endolysins identified in 87 proteins. This CHAP domain is strictly encoded in 
phages infecting G+ hosts, predominantly in phages infecting Streptococcus spp. 
and Staphylococcus spp. Of particular interest is their association with several 
other families of amidases, which suggests that they might act in a cooperative 
manner to cleave multiple PG substrates. Reports have shown that CHAP can 
serve as a peptidase or amidase, acting as D-alanyl-L-alanyl endopeptidase (in 
Streptococcus phage B30), as a D-alanyl-glycyl endopeptidase (in Staphylococcus 
phage phi11) or as an N-acetylmuramoyl-L-analine amidase (in Streptococcus 
phage C1). This latter endolysin (PlyC) is a unique multimeric protein composed of 
two separate gene products (PlyA and PlyB) (Navarre et al, 1999; Baker et al, 
2006; Nelson et al, 2006). The remaining NLPD, PET-U40 and YKUD have only been 
found in one phage endolysin each, Mycobacteriophage Timshel (PET-M15-
4/NLPD), Cystoviridae Pseudomonas phage phi-6 (PET-U40), and Synechococcus 
phage S-CBS4 (GLUCO/YKUD) endolysins, respectively. NLPD and YKUD remain 
experimentally uncharacterized. 
 
Phage endolysins with multi-catalytic activities 
Through evolution, endolysins appear to have acquired certain substrate 
specificities by obtaining multiple ECDs found in phages infecting a range of 11 
different genera, but predominantly present in Staphylococcus and 
Mycobacterium-like phages. The latter have 26 different types of structures, 14 of 
which combine two ECDs. The most prevalent ones contain an N-terminal 
predicted peptidase, a centrally located AMI-2, MURA, and TRANG, and a C-
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terminal PG-1. Less frequently, staphylococcal-like endolysins with multiple ECDs 
can contain up to three ECDs with alternating CHAP/AMI-3/SH3-5, CHAP/AMI-
2/SH3-5 or CHAP/AMI-2/GLUCO modules. An unusual double amidase activity was 
found with an AMI-2/AMI-2C and an AMI-3/AMI-2C structure in six Bacillus 
phages and two Clostridium phages, respectively. In G--like endolysins, the few 
multi-ECDs found belong to the Prochlorococcus marinus phage PSS2 and 4 
Synechococcus phages with an N-terminal GH activity (MURA or GLUCO) and an 
additional peptidase activity (PET-C39-2, YKUD or PET-M15-3). Another notable 
detail is that 150 (77%) of the 196 annotated multi-ECDs phage endolysins belong 
to Siphoviridae viruses, mostly infecting G+ hosts. Studied examples including 
plural active lytic domains are the staphylococcal phi11 (Navarre et al, 1999), the 
Group B streptococcal endolysin B30 (Pritchard et al, 2004) and the streptococcal 
lSa2 phage endolysin (Pritchard et al, 2007). 
 
3.3.3 Cell binding domains 
Endolysin modularity can also associate ECDs with a selected CBD (Table 3.1). 
Notably, CBDs are predominantly present in Bacillus, Lactobacillus, Lactococcus, 
Mycobacterium, Staphylococcus and Streptococcus phage endolysins (Figure 3.1). 
Among the great variety of CBD motifs found, only PG-1, SH3, LYSM and CPL-7 
have been characterized in vitro (Loessner et al, 2002; Hu et al, 2010; Walmagh et 
al, 2012). PG-1 is almost only restricted to phages infecting G+ genera with few 
exceptions detected in G--like endolysins (Salmonella phage PVP-SE1 and 
Pseudomonas phages phiKZ, EL, 201phi21 and OBP), where they occur in a unique 
inverse rearrangement (one or more PG-1 CBDs at the N-termini). PG-3 type has 
been acquired from phages with a rare modular arrangement (GH108/PG-3), 
infecting G- counterparts. SH3 domains commonly found in autolysins and phage 
endolysins often belong to the SH3b, SH3-3 or SH3-5 type. This CBD, shared by 
lysostaphin (a bacteriocin from Staphylococcus  simulans  bv.  staphylolyticus) and 
Endolysins in silico analysis 
 
49  
 
Figure 3.1. Diversity of enzymatic catalytic domains/cell binding domains found at the N- and C-
terminus of the four major endolysin classes centrally located (from all 723 putative endolysins): 
N-acetylmuramidases (blue scale), N-acetylglucoaminidases (purple), N-acetylmuramoyl-L-alanine 
and carboxy/endopeptidases (green scale). CHAP (orange) can act as an amidase or peptidase. 
These four major classes have been centrally located to show all ECDs (with colours mentioned 
above) and CBDs (gray scale) found attached to their N- and C-termini. For the correct 
interpretation of the schematic representation: of all endolysins found with a CHAP domain, a 
GLUCO at their N-terminus was observed. In some proteins a GLUCO, AMI-2 and AMI-3 domain at 
the C-terminus was identified. 
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its homologue, hydrolase ALE-1, has been uncovered to recognize pentaglycine 
cross bridges in PG (Grundling & Schneewind, 2006; Lu et al, 2006). Therefore, the 
fact that most of SH3 domains are found in Staphylococcus-like endolysins is not 
surprising. The LysM domain is considered to be the CBD with the widest range of 
receptors identified in more than 4000 proteins of both prokaryotes and 
eukaryotes. It has been postulated that this domain binds to various types of PG 
and most likely recognizes the N-acetylglucosamine moiety (Buist et al, 2008). This 
is in agreement with the findings presented herein that show that LysM is always 
correlated to MurNAc-N-GlcNAc glycosidase activity (LYSO or GH25), with the 
exception of three endolysins, in which LysM is joined with an amidase domain 
(AMI-2 or AMI-3 type). Interestingly, the LysM domain is often found in double 
motifs, having a unique architecture of three motifs in the Lactobacillus phage 
Lb338-1 endolysin (GH25/LYSM/LYSM/LYSM). Endolysin modules containing the 
less abundant CPL-7 are GH25/Cpl-7/Cpl-7, NLPC-P60/GH25/Cpl-7 and NLPC-
P60/Cpl-7/GLUCO present in Clostridium phage (phiCTP1), Mycobacterium phages 
(Optimus and Baka) and in Streptococcus phages (SMP and 315.3), respectively. 
Although CBD location is usually found at the N- or C-terminus, the 
aforementioned CBDs (LYSM, CPL-7 and PG-1) can also be located as central 
domains (e.g. Mycobacteriophage Adjutor with NLPC-P60/PG-1/PG-1/GH19, 
Streptococcus phage SMP with NLPC/CPL-7/CPL-7/GLUCO and Streptococcus 
phage phi-SsUD.1 with AMI-3/LYSM/LYSM/NLPC-P60). Concerning CHW, it has 
been stated that this protein family is almost exclusively limited to the Clostridium 
acetobutylicum bacterial species (Sullivan et al, 2007). The present results reveal 
only nine CHW domains detected in three Lactococcus and six Lactobacillus phage 
endolysins. Curiously, this domain is always present in endolysins attached to an 
AMI-2 type domain and bears multi-CHW motif copies. The Lactococcus phage A2 
endolysin has an AMI-2/CHW/CHW/CHW arrangement while Lactococcus phages 
949, asccphi28 and KSY1 contain the AMI-2/CHW/CHW modules. The 
acquirement of other uncommon CBD motifs, like LGFP, SPOR, FOG and SLAP, can 
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represent alternative ways for tighter binding, by directing the catalytic cavity into 
target muropeptides or changes in species specificity. Remarkably, FOG motifs are 
characterized by having six CBD (PF01473) repeats found only in six streptococcal 
phages (Cp-1, Dp-1, EJ-1, MM1, PH10 and SM1) and one Listeria phage (B054). To 
our knowledge these CBDs have never been characterized in vitro in the big pool 
of phage PGHs.  
Altogether, the structural endolysin design (ECD and CBD), their distribution 
through phage genomes (dsDNA or dsRNA genomes) and phage infecting hosts 
(different bacterial genera) are summarized in Figure 3.2. The diverse nature and 
repartition of endolysin domains observed, is a reﬂection of the phages’ different 
strategies to infect various bacterial and assure the same biological function, i.e. 
to disrupt the PG. As mentioned before, specific patterns could be identified. For 
instance the glycoside hydrolases are heavily present in G- infecting phages. 
Another example is the predominant domain AMI-2 that is mostly found in 
Mycobacterium-like and Staphylococcus phages.  
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Figure 3.2. Nature and repartition of peptidoglycan hydrolase domains encoded by derived from 
727 endolysins. 
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3.3.4 Cladogram bacteriophage-host-endolysin relationship 
To comprehend the possible evolutionary position of phage endolysins, a 
maximum likelihood tree was constructed. By analyzing the cladogram (Figure 
3.3) we were able to perceive the great variety of endolysin domain structures, 
generally with conserved ECDs and little homology within the CBDs.  
 
Figure 3.3. Radial cladogram of endolysins of all characterized phages. The cladogram was 
constructed using PHYLIP v3.68, with Neighbor-Joining algorithm. The resulting cladogram was 
represented and arranged, without being altered, using the FigTree software (version 1.3.1). 
Highlighted areas are numbered and correspond to the more conserved clades. 1 - 
Mycobacterium/Siphoviridae/AMI-2; 2 - G
+
/GH25; 3 - Lactococcus/Siphoviridae/AMI-2; 4 - G
-
/LYSO; 
5 - G
-
/MURA; 6 - Streptococcus/Siphoviridae/NLPC-P60; 7 - G
-
/Podoviridae/AMI-2; 8 - G
-
/Myoviridae/VANY; 9 - Staphylococcus/Siphoviridae; 10 - G
-
/GH19; 11 - Escherichia/Tectiviridae 
/SLT; 12 - Mycobacterium/Siphoviridae/NLPC-P60/GH25; 13 - Mycobacterium/Siphoviridae/PET-
M15-4/PG1; 14 - Mycobacterium/Siphoviridae/PETM-15-4/GH19; 15 - Mycobacterium/ 
Siphoviridae/PET-M23/AMI-2; 16 - Mycobacterium/Siphoviridae/PET-C39-2/GH19. 
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Interestingly, there is no distinct clade organization, which shows that the tree is 
not conceived by just one factor, such as phage family, host or ECD. For tailed 
phages, the parameter that is apparently more important for the cladogram 
organization is endolysins’ domain architecture, which is visible on the highlighted 
clades - the more robust clades. Regarding non-tailed phage endolysins, 
Escherichia-like endolysins from Tectiviridae contain an SLT catalytic domain and, 
as expected, they are in the same evolutionary clade. However, it was reported 
that, despite the amount of similar Tectiviridae genomes, one of the major 
differences was observed when comparing their lytic enzymes (Saren et al, 2005). 
Oppositely, Cystoviridae Pseudomonas-like endolysins appear not to be conserved 
as they are dispersed over the tree.  
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3.4 Discussion 
3.4.1 The enzymatic catalytic domains - Evolutionary claims 
The acquirement of specific ECDs from a large pool of potential candidates may be 
influenced by three factors: 
 
(i) Specific ECD substrate may be restricted to a few bacteria  
For instance, because Staphylococcus, Streptococcus and Lactococcus have unique 
3→4 glycine pentaglycine (Gly)5, dialanine (L-Ala-L-Ala) or L-Lys-D-Asp 
interpeptide bridges within the PG, their specific phages have acquired a CHAP 
domain that exclusively cleave these links (Vollmer & Born, 2009). LYSO activity is 
dominant in phages infecting G- species. This can be explained by the ability of 
many G+ pathogens to modify their glycan strands by N-glycosylation, de-N-
acetylations and/or O-acetylations that contribute to high levels of resistance to 
lysozyme (Vollmer & Born, 2009).  
 
(ii) PG composition and length varies with growth phase and conditions  
As a result of generation of the cellular shape, its maintenance and bacterial 
adaptation, PG structure and composition is continuously changing (incorporation 
of new and removal of old material) (Glauner et al, 1988). This would drive phages 
to a careful selection of a capable endolysin that efficiently digests all PG variants 
(always with available substrate to digest). E. coli, Mycobacteria and S. 
pneumoniae are known microorganisms in which muropeptides undergo several 
changes (Pisabarro et al, 1985; Glauner et al, 1988; Lavollay et al, 2008). 
Interestingly, their infecting phages represent the niche with lytic cassettes that 
spans the greatest ECD diversity and multiplicity. Especially, Mycobacteriophage 
endolysins have an impressive number of 127 multi-functional ECD combinations 
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with preferred combinations of PEP-M13/AMI-2/PG-1, NLPC-P60/GH25 and PET-
M15-4/GH19 modules. In some cases, ECDs within the same endolysin may act 
synergistically, cooperatively or even alone.  
 
(iii) Distinct ECDs guarantee a similar biological function 
Cleavage of a speciﬁc bacterial PG is not restricted to a single ECD, but can be 
ensured by several ECDs with different cleavage sites. For instance, the MurNAc-
N-GlcNAc glycosidase activity is performed exclusively by the LYSO-containing 
endolysins in the Xanthomonas phages, whereas at least four distinct domains 
(LYSO, MURA, GH108 and SLT) are responsible for this activity in Escherichia 
phage endolysins. The amidase cleavage of the D-lactyl moieties of MurNAc and L-
alanine of the short stem peptide (NAM-amidase) is carried out by AMI-2 in Vibrio 
phage endolysins, while in Bacillus-like endolysins it is performed by distinct 
AMI02-C, AMI-2 and AMI-3 domains. In general, ECDs are not global, but are 
rather found in a restrictive number of bacterial genera. ECDs variety among 
endolysins resulted from the historical battle between phage and bacterium 
attaining a wealth of possible PGHs sequences to reach the same final outcome: 
bacteriolysis. 
 
3.4.2 The cell binding domains - Evolutionary claims 
An evolutionary relationship between S. pneumoniae autolysins and some 
streptococcal phage endolysins was originally proposed, based on their significant 
nucleotide sequence similarities (Garcia et al, 1988). It was suggested that 
modular endolysins may have evolved by the interchange of phage and bacterial 
genes encoding individual modules (Garcia et al, 1988), gaining strong support 
after the creation of functional chimeric phage-bacterial enzymes, which 
consisted of one phage- and one bacterial-derived exolysin domain (Diaz et al, 
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1990; Diaz et al, 1991). The recruitment and distribution of CBD through phages 
genomes (Figure 3.2) can be correlated by different facts: 
 
(i) Specific CBD receptors may be restricted to a few bacteria  
As the major role of endolysins is to enable progeny virions to be released from 
the host cell, to ensure the effective release of phages the CBDs may have evolved 
to target a unique and essential component of the host cell wall (Fischetti, 2003). 
This would explain the variability of this module and the highly selective lytic 
activity of endolysins. Therefore, in some cases, CBDs can confer highly specific 
ligand recognition to endolysins, resulting in a very narrow substrate spectrum of 
the full-length endolysin, often limited to the host species or strain (Perez-Dorado 
et al, 2007), or to a lesser extent, genus-speciﬁc (Loessner et al, 1997; Loessner et 
al, 2002). Well-studied examples of ligand recognition are the pneumococcal 
endolysins derived from phages Cp-1 (Cpl-1 endolysin), Dp-1 (PAL endolysin) and 
Ej-1 (Ej-1 endolysin). Their corresponding CBDs specifically bind choline, which is 
only present in teichoic acids of the pneumococcal cell wall and which is essential 
for bacterial viability (Garcia et al, 1988; Sheehan et al, 1997; Saiz et al, 2002). 
Also, the CBDs of the L. monocytogenes phage endolysins Ply118 and Ply500 can 
bind to different Listeria serovar groups as visualized by fusions with green 
fluorescent protein (GFP), showing that they are correlated with the occurrence of 
somatic antigens related to these serovars (Loessner et al, 2002).  
 
(ii) Minimal disruption of normal flora  
The reason for the presence of a CBD typically seen in G+-like endolysins, lies in 
the absence of an OM in G+ bacteria. After external bacterial lysis, CBD keeps the 
endolysin tethered to the PG, making them unavailable for degrading any 
adjacent G+ PG from forthcoming potential hosts (bacterial threshold), thereby 
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not compromising phage survival (Fischetti, 2008). The strong substrate speciﬁcity 
of L. monocytogenes phage endolysins Ply118 and Ply500 of nanomolar affinities 
is in favour of this hypothesis, suggesting that they have evolved to bind 
irreversibly to their cell wall ligand (Loessner et al, 2002). On the other hand, the 
presence of an OM in G- bacteria that impairs direct external endolysin contact 
eliminates the need for a CBD in endolysins from phages infecting these bacteria. 
In this in silico analysis, a predominant CBD distribution among G+ infecting 
phages was observed (Figure 3.2). Lactobacillus and Lactococcus together with 
Bacillus genera represent the phage niche with the most diverse CBD collection 
(PG-1, SH3-3, SH3-5, SH3b, CHW, LYSM and SPOR). Excellent examples are phage 
endolysins with 3 CBDs, only observed in Lactobacillus phage A2 (AMI-
2/CHW/CHW/CHW) and Lactobacillus phage Lb338-1 (GH25/LYSM/LYSM/LYSM), 
or endolysins containing different types of CBDs, as is the case for the 
Lactobacillus phage phiAT3 endolysin (GH25/SH3-5/LYSM). 
 
(iii) Catalytic activity regulator  
Rather than binding to the cell wall, CBD-associated domains sometimes can play 
determining roles in the enzymatic efficiency by allowing enough substrate to 
reach the catalytic site. Other carbohydrate hydrolases, such as xylanases and 
cellulases that cleave insoluble carbohydrate polymers, share a similar modular 
architecture (Khosla & Harbury, 2001) and their CBDs act by increasing enzyme-
substrate proximity (Bolam et al, 1998). Equilibrium association constants of CBDs 
of Listeria phage endolysins Ply118 and Ply500 place them in the same range as 
affinity-matured antibodies against bacterial cell surface antigens. Interestingly, 
the deletion of their CBDs rendered enzymes with no muralytic activity (Loessner 
et al, 2002). Also, the activity of a C-terminally truncated Clostridium phage 
phi3626 endolysin was entirely abolished, emphasizing the important role that 
CBDs play in the enzyme´s activity (Zimmer et al, 2002). As opposed to previous 
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observations, structural analysis of PlyL indicates that the C-terminal CBD not only 
targets the endolysin to a specific ligand, but also inhibits the catalytic activity in 
the absence of the cognate substrate. It has been hypothesized that substrate 
recognition by the CBD of PlyL disrupts interactions between the CBD and the 
ECD, relieving the inhibitory effect on the latter (Low et al, 2005). These inter-
domain interactions are absent in the C-terminal truncated variant, converting the 
catalytic domain into a constitutively active domain. Therefore, B. subtilis, which is 
lacking the cognate target, is hydrolyzed more efficiently by the truncated form 
compared to the full-length version. Consequently, the role of the CBD is variable 
and therefore each case must be examined individually.  
 
(iv) Is it possible to lose non-essential domains?  
Though a multi-domain architecture is indicative of a modular enzyme, it does not 
guarantee its functionality as a modular protein. An analogy comparison can be 
made for phage endolysins, in which the presence of a CBD does not often 
constitute a prerequisite for enzyme activity. Deletion of the CBD of L. 
monocytogenes endolysin PlyPSA only reduces the lytic activity (Korndorfer et al, 
2006). Also the C-terminal domain of Lactobacillus delbrueckii subsp. lactis phage 
LL-H endolysin can be removed without destroying the lytic activity (Vasala et al, 
1995). C-terminal deletions of S. aureus phage endolysins PlyTW and Ply187, L. 
monocytogenes phage endolysin Ply511, B. amyloliquefaciens phage endolysin 
Morita2001, B. anthracis prophage endolysin PlyL and Bacillus cereus phage 
endolysin Ply21 even increase the muralytic activity (Loessner et al, 1998; 
Loessner et al, 1999; Gaeng et al, 2000; Morita et al, 2001; Low et al, 2005). This 
pattern is also present in endolysins with dual lytic domains, where in theory both 
should be equally active. Indeed, silent ECDs (almost devoid of activity) have been 
observed in several multi-ECDs endolysins studied (streptococcal phage 
lambdaSa2 and B30 and staphylococcal phage phi11 endolysins) (Donovan et al, 
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2006a; Donovan & Foster-Frey, 2008; Horgan et al, 2009). Interestingly, in all 
these cases the N-terminal ECD encodes the active domain with the highest 
activity. 
In conclusion, the ubiquity and huge genetic diversity found in phages is 
considered to be a result of both vertical and horizontal evolution. Through these 
processes, phages have acquired different lytic systems employing PG-degrading 
enzymes to fight a diversified and changeable bacterial cell wall. Although 
modular enzymes are not common in nature, a number of multicomponent 
endolysins have been found able to digest the bacterial PG. Therefore, endolysins 
can be seen as an important result of phage evolution to permit rapid adaptation 
to new environmental conditions. With the structural and predicted mechanistic 
basis for phage endolysins now being elucidated, their utility can be further 
examined exploring novel uncharacterized domains and by tailoring modular 
endolysins to acquire new functions. 
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A highly thermostable Salmonella phage 
endolysin, Lys68, with broad anti-Gram-negative 
activity in presence of weak acids 
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4.1 Introduction 
G- bacterial pathogens are common causes of foodborne (e.g. Salmonella, 
Escherichia coli O157:H7) and hospital-acquired (e.g. Pseudomonas, 
Acinetobacter) infectious diseases (Chopra et al, 2008; Scallan et al, 2011). In an 
era in which the threat of antibiotic and multi-resistant bacteria is increasing and 
solutions are becoming scarce, it is important to search for alternative 
antimicrobials. One promising alternative approach to prevent or destroy 
pathogenic bacteria is the use of bacterial cell wall hydrolases. Among them, 
increasing interest has been given to lysozymes (e.g. hen egg white lysozyme - 
HEWL) and phage endolysins. HEWL is a marketed protein, largely studied and 
widely used in food and pharmaceutical industry products. Endolysins are 
specialized PG-degrading enzymes, part of a universal lytic cassette system 
encoded by all dsNA phages. In contrast to the obvious potential of endolysins in 
fighting G+ pathogens, strategies to overcome the OM need to be developed in 
order to extend their use to attack G- bacteria.  
This chapter describes a novel Salmonella phage endolysin (further abbreviated as 
Lys68). After an in silico analysis, its lytic spectrum, muralytic activity and stability 
under different pH values and temperatures were analyzed, enlarging the pool of 
the few characterized G- phage endolysins described so far. Its antibacterial action 
against G- pathogens was also studied and compared to HEWL, an enzyme 
comparable in size and catalytic activity, in combination with selected OMP 
agents: EDTA (at 0.5 mM), citric (at 2 mM) and malic acid (at 5 mM), 
concentrations described in literature as adequate for permeabilization (Doores, 
1993; Alakomi, 2007; Walmagh et al, 2012). Finally, the endolysin PG digestion 
and the OM permeabilizing mechanisms were discussed. As far as we know, this is 
the first study that exploits the possibilities of combining a phage-encoded 
endolysin with several weak acids as potential OMP agents, for an efficient killing 
of several G- pathogens. 
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4.2 Materials and methods 
4.2.1 Bacterial strains, bacteriophage and chemicals 
Bacterial strains used in the work described in this chapter are listed in Table 4.1 
and belong to the Centre of Biological Engineering (CEB) bacterial collection. All 
strains were grown in Lysogeny broth (LB, Liofilchem) at 37°C, 120 rpm, with the 
exception of Pseudomonas fluorescens, grown at 25°C, and Campylobacter jenuni, 
grown in Columbia Blood agar (Oxoid) in a microaerobic atmosphere (5% O2 and 
10% CO2) at 42°C and further incubated in NZCYM broth (BD Biosciences) at 55°C. 
 
Table 4.1. Overview of bacterial pathogens strains, references and sources used in chapter 4. 
Bacterial strain Reference(s) Sources  
Salmonella Typhimurium ATCC 19585 (further designated as LT2) NA 
Salmonella Enteritidis ATCC 13076 / 932* NA 
Salmonella bongori SGSC 31001 Frog 
Campylobacter jejuni 12662* / New M1* Poultry 
Cronobacter sakazakii CECT 8581 Child's throat 
Cronobacter muytjensii ATCC 51329 NA 
Pseudomonas fluorescens 7A* Dairy industry 
Pseudomonas aeruginosa ATCC 15692 (further designated as PAO1) Infected burn/wounds 
Acinetobacter baumannii 2* Infected burn/wounds 
Yersinia enterocolitica SA54291 NA 
Klebsiella oxytoca ATCC 131821 Pharyngeal tonsil 
Pantoea agglomerans SA56341 NA 
Enterobacter amnigenus CECT 48781 Soil 
Proteus mirabilis SA54451 NA 
Citrobacter freundii SA5345 NA 
Escherichia coli O157:H7 CECT 47821 Human stool  
Shigella sonnei ATCC 259311 Human faeces 
 
NA - Not available; * strains belonging to the CEB bacterial collection 
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E. coli cloning and expression strains (Invitrogen) are given in Table 4.2. 
Salmonella phage phi68 (encoding the Lys68 endolysin) was isolated from waste 
effluents and belongs to the CEB phage collection. For other chemicals used, EDTA 
was acquired from Pronalab while isopropyl-β-D-thiogalactopyranoside (IPTG), 
HEPES, citric acid and malic acid were purchased from Sigma-Aldrich. HEWL was 
obtained from Fisher Scientific. 
 
Table 4.2. Gynotypes of E. coli cloning and expression strains and vector used in chapter 4. 
Bacterial strains Genotype 
TOP10 
F
-
 mcrA Δ(mcrCB-hsdSMR-mrr) Ф80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara-
leu)7697 galU galK rpsL(Str
r
) endA1 λ
-
 
BL21(DE3) F
–
 ompT hsdSB(rB
–
  mB
–
) gal dcm (DE3) 
 
For transformation of Lys68 constructs (described in the 4.2.3.1 Cloning 
methodology section) chemically competent E. coli TOP10 and E. coli BL21 cells 
were prepared for cloning and protein recombinant expression, respectively. The 
procedure to make competent started to grow each colony overnight in 10 mL of 
LB medium and diluted (1:100) to 50 mL fresh LB medium the following day. After 
growing at 37°C and 120 rpm and reaching a OD of about 0.3, cell were pelleted 
(10 min, 4°C, 5000 rpm) and resuspended in 25 mL ice-cold 0.1 M CaCl2 and 
incubated for 30 min. Next, following a second centrifuge step, cells were 
resuspended in 1.5 mL of 0.1 M CaCl2 in the presence of 10% glycerol. Competent 
cells were stored at -80°C prior to use in 100 µL aliquots. Transformation of 
foreign DNA was accomplished by the heat shock procedure. First, ≈ 200 ng of 
plasmid was incubated with 100 µL of thawed competent cells on ice for 30 min, 
after which a heat shock of 42°C for 45 s was carried out. For a proper selection, 
cells were allowed to grow in liquid LB and plated onto LB agar plates containing 
the proper antibiotic for each transformant.  
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4.2.2 In silico analysis  
Lys68 endolysin was screened by the HHpred webserver (URL 
http://toolkit.tuebingen.mpg.de/hhpred) using Pfam, InterProScan and COG; with 
an E-value cut-off of 1x10-5 and at least 80% of query coverage. The MSA 
generation method used was HHblits (Remmert et al, 2012). 
To identify putative catalytic residues within Lys68 sequence, BlastP searches 
were conducted. Blasting the endolysin sequence, high homology residues, 
indicated as probable catalytic residues can be found. To experimentally prove 
their in silico prediction, point mutations (described in the next section) were 
made using a QuickChange II XL Site-Directed Mutagenesis Kit (Agilent 
Technologies). Mutagenic primers were designed using a web-based QuickChange 
Primer Design Program (www.agilent.com/genomics/qcpd).  
 
4.2.3 Cloning, recombinant protein expression and purification 
Primers used to clone the Lys68 endolysin were purchased from Invitrogen. The 
vector pET28a (Novagen) was used to clone and express Lys68, and has a resistant 
marker for kanamycin (50 µg/mL). Restriction enzymes were purchased from NEB. 
 
4.2.3.1 Cloning methodology  
Standard PCR 
The isolated Salmonella phage phi68 was partially sequenced showing 
resemblance to the sequenced S. Enteritidis typing phage SETP3 (data not shown). 
Based on phage SETP3 genomic sequence available at NCBI database (reference 
sequence: NC_009232.2), primers were designed to amplify the putative 
endolysin gene by PCR. Lys68 open reading frame was amplified using the 
following PCR amplification mixture and end concentrations given: KAPA HiFi 
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Buffer Fidelity (1x); 10 mM dNTP Mix (0.3 mM); forward 
(AGATATCATATGTCAAACCGAAACATTAGC) and revere primers 
(GTGGTGCTCGAGCTACTTAG) (0.3 µM each), with introduced NdeI and XhoI 
restriction sites are underlined; template Salmonella phage phi68 DNA (1 to 10 
ng); KAPA HiFi DNA Polymerase from KaPaBioSystems (1 U) (Grisp) and PCR-grade 
water up to 50 µL. The DNA thermal cycler (MJ Mini™ Gradient Thermal Cycler, 
Biorad) was programmed for a standard PCR reaction of 35 cycles, including: an 
initial DNA denaturation step (5 min at 98°C), DNA denaturation step (30 s at 
98°C), primer annealing step (30 s at a 55°C), and extension step (2 min at 72°C), 
followed by a final extension step (5 min at 72°C) to allow proper PCR product 
elongation. After PCR reaction, samples were separated on a 1% agarose gel in 
TAE electrophoresis buffer (40 mM Tris-HCl pH 7.2, 500 mM sodium acetate and 
50 mM EDTA), stained with SYBR® Safe (Invitrogen), visualized by UV illumination 
(BioRad) and cleaned (DNA Clean & ConcentratorTM-5k, Zymo Research). To clone 
the amplified Lys68 gene (insert) in the pET28 expression vector selected, both 
plasmid and insert were double-digested using the same NdeI/XhoI sticky end 
endonucleases in the following reaction: 1 µL of DNA (approx. 300 ng), 1 µL of 
both restriction enzymes (10 U), 1 µL of 10x CutSmart buffer (NEB), and PCR-grade 
water up to 10 µL. After 2 h incubation, insert/vector digested products were 
cleaned (DNA Clean & ConcentratorTM-5k, Zymo Research) and ligated 
(overnight, 16°C) using a T4 ligase (New England Biolabs) and a 3:1 (insert/vector) 
molar ratio. E. coli Top10 cells were transformed with the ligation mixture.  
 
Colony PCR 
Colony PCR was carried out to screen for the correct construct before being 
confirmed by sequencing. E. coli TOP10 transformants were transferred by 
toothpick to a 96-well microtiter plate. Colonies were grown individually in each 
well containing 100 µL of LB supplemented with antibiotic (50 µg/mL kanamycin) 
Chapter 4 
68   
for 1.5 h at 37°C and in static conditions. Next, the following PCR mixture was 
made: forward and reverse primers (insert-specific combined with vector-specific 
primers at 0.4 µM); dNTPs mix (0.2 mM each nucleotide); buffer Dream Taq (10x); 
Dream Taq polymerase (2.5 U) (Fermentas); 2.5 µL of cell culture grown in each 
well and PCR-grade water up to 25 µL total volume. Then, a PCR reaction was 
conducted: initial denaturation step of 5 min at 95°C followed by 35 cycles 
consisting of 30 s at 98°C/30 sec at 50°C/2 min at 72°C, ending with a final 
extension period of 10 min at 72°C. PCR product was loaded onto agarose gels for 
confirmation. Finally, plasmid of positive constructs was extracted and verified by 
sequencing (Macrogen). 
 
Mutagenesis 
To substitute the putative catalytic residues within the Lys68 sequence, two active 
site mutations (Glu18Ala and Thr35Ala) were introduced. Two sets of overlapping 
mutagenic primers (5'-CGCGGCATTCGCGGGGTTCCGGG, forward, 5'-
CCCGGAACCCCGCGAATGCCGCG, reverse, for Glu18Ala, and 5'-
AGAATGAGAAGTACCTTGCTATTGGCTACGGCCAC, forward 5'-
GTGGCCGTAGCCAATAGCAAGGTACTTCTCATTCT, reverse, for Thr35Ala, with 
mutation basepairs underlined), were applied using the QuickChange II XL Site-
Directed Mutagenesis Kit (Agilent Technologies), following the manufacturer’s 
instructions. Briefly, 10 ng of pET28-Lys68 template, 125 ng of the two mutagenic 
primers, a dNTP mix (1x), a reaction buffer, a Quick Solution reagent 2.5 U of 
PfuUltra HF DNA polymerase and PCR-grade water up to 50 µL (total volume) was 
added together. After the recommended mutagenic PCR reaction, the product 
was digested with DpnI for 1 h at 37°C, to allow degradation of parental 
methylated DNA. After transformation into XL10-Gold ultracompetent cells 
provided, positive transformants were grown, their plasmid extracted and sent for 
sequencing (Macrogen). 
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4.2.3.2 Protein overexpression and purification  
After sequencing, all vectors were introduced and expressed in E. coli BL21(DE3). 
Cells were grown in 200 mL LB supplemented with the specific antibiotic (50 
µg/mL of kanamycin) to an OD600nm of 0.6 (4 h, 120 rpm at 37°C), and recombinant 
protein expression was induced with IPTG to a final concentration of 0.5 mM. 
After optimization, E. coli expression temperature (16°C) and temperatures (18 h) 
were chosen to maximize soluble expression yields. The culture was then 
centrifuged (9500xg, 30 min) and cells were disrupted by resuspending the pellet 
in 1/25 volumes of lysis buffer (20 mM NaH2PO4, 0.5 M NaCl/NaOH, pH 7.4), 
followed by three cycles of freeze-thawing (-80°C to room temperature). 
Maintaining the sample on ice, cells were further disrupted by sonication (Cole-
Parmer, Ultrasonic Processors) for 8-10 cycles (30 s pulse, 30 s pause). Insoluble 
cell debris were removed by centrifugation (9500xg, 30 min, 4°C). The 
supernatant was collected and filtered (0.22 µm filters) and applied to Ni2+-NTA 
resin stacked in HisTrapTM HP 1 ml columns (GE Healthcare) for purification, using 
protein-dependent imidazole concentrations optimized for and evolving four 
steps: 
1. Equilibrium step - 10 mL of lysis buffer (65 mM imidazole concentration).  
2. Loading step - Loading of total soluble expressed E. coli extract that was 
resuspended in lysis buffer (65 mM imidazole concentration). 
3. Washing step - 10 mL of lysis buffer (65 mM imidazole concentration). 
4. Elution step - 2 mL of lysis buffer with 300 mM imidazole.  
Eluted protein fractions were then visualized by standard denaturation SDS-PAGE 
(sodium dodecyl sulfate polyacrylamide gel electrophoresis) gels using the Bio-Rad 
system under denaturation conditions. To perform the electrophoresis, a 5% of 
upper and a 12% lower stacking and separating acrylamide gels were assembled. 
From the eluted fractions, 10 µL were added to 10 µL of Laemmli buffer (2x) 
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(Sigma), boiled at 95°C for 5 min and loaded onto the gels together with a Low 
Molecular Weight ladder (GE Healthcare). Protein bands were routinely separated 
for 2 h, at 120 volts. Gels were rinsed with water and stained with 0.05% of 
Commassie brilliant blue R-250 (Sigma) solution for 2 h. Background destaining 
was performed with several washing steps with water. Only protein samples with 
purities equal to or higher than 90% were considered pure and used to perform 
additional studies. Proteins were dialyzed in 10 mM phosphate buffered saline 
(PBS) at pH 7.2 (using Maxi GeBAflex-tube Dialysis Kit - Gene Bio-Application 
L.T.D). The Protein concentrations were then determined by the BCATM Protein 
Assay Kit with bovine serum albumin as standard (Thermo Scientific).  
 
4.2.4 Biochemical characterization 
4.2.4.1 Endolysin lytic spectrum 
To determine lytic spectrum of Lys68, a range of different strains was tested 
(Table 4.1). G- and G+ overnight grown cultures were overnight grown and diluted 
1:100 diluted in the following day in fresh 5 mL LB and allowed grow until 
reaching the mid-exponential phase (OD600nm of 0.6). Cells were then plated (100 
μL) onto LB agar Petri dishes for lawn formations. After 8 h incubation, a 30-μL 
drop of 2 µM of purified Lys68 was added to visualize lysis halos. In the case of G- 
cells a step involving treatment with chloroform vapours was included to 
permeabilize the OM (Raymond Schuch, 2009). After lawn formations, in a 
chemical fume hood, 10 mL of chloroform were added to an inverted lid glass 
plate. Bacterial lawns were inverted on top of the chloroform and incubated for 1 
h to allow chloroform evaporation. Finally, a 30-μL drop of 2 µM of Lys68 protein 
was added to visualize lysis halos. In both cases, halo spots commonly appeared 
after 30 min up to 1 h after the start of the incubation period. 
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4.2.4.2 Muralytic activity 
The PG lytic (or muralytic) activity was quantified on P. aeruginosa PAO1 cells with 
the OM permeabilized (exposed PG), as a substrate (Lavigne et al, 2004). This 
substrate was prepared by growing P. aeruginosa cells to an OD600nm (optical 
density at 600 nm) of 0.6, centrifuging them (4000xg, 15 min, 4°C) and 
resuspending them in a chloroform-saturated 0.05 M Tris buffer (pH 7.7). After 
gently shaking for 45 min at room temperature, protoplasts were collected 
(4000xg, 15 min, 4°C), washed and resuspended in 80 mM phosphate buffer (pH 
7.2) at an OD600nm of 1.0. Substrate was then stored at -20°C prior to use. To 
perform the muralytic activity, 30 μL of serial dilutions of enzyme were added to 
270 μL of OM permeabilized cells (prepared substrate). The endolysin activity was 
measured over a period of 30 s or up to 30 min, through the decrease in OD600nm 
using a BIO-TEK®, Synergy HT Microplate Reader. Obtained values for the negative 
control (30 μL of PBS pH 7.2) were subtracted from the sample values. The 
muralytic activity was calculated according to a standardized calculation method 
optimized and extensively described elsewhere (Briers et al, 2007a). Enzymatic 
activity was defined as follows: Activity (units/µM) = ((slope 
(OD600nm/min)/µM))/0.001), where the activity of 1 unit is defined as the 
concentration of enzyme (in µM) necessary to create a drop in OD600nm of 0.001 
per minute. Averages ± standard deviations are given for n = 3 repeats. 
 
pH dependence 
The pH dependence on the muralytic activity was assessed using the same 30 μL 
of serial dilutions of enzyme on 270 μL of OM permeabilized cells, but now 
resuspended in a universal pH buffer (150 mM KCl, 10 mM KH2PO4, 10 mM Na-
citrate and 10 mM H3BO4) adjusted to different pH values within the range of 3.0 
and 10.0. Averages ± standard deviations are given for n = 3 repeats. 
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Cryo/Thermal stability 
For cryostability tests, the same muralytic activity described was performed with 
Lys68 samples stored during 2 months at cold temperatures (4°C and -20°C). 
Thermostability was evaluated by incubating the endolysin at several 
temperatures 40°C, 60°C, 80°C and 100°C for 30 min and in addition at 100°C 
during different time intervals (5, 10, 20, 25, 30 and 45 min) in a MJ MiniTM BIO-
RAD Thermocycler. Following a 30-min cooling step on ice, the (residual) activity 
was measured using 30 µL of 2 μM Lys68 on 270 µL of OM permeabilized cells 
resuspended in 80 mM phosphate buffer pH 7.2. The residual muralytic activity of 
each sample relative to the activity of unheated reference sample at time 0 (= 
100% activity) was determined. Averages ± standard deviations are given for n = 3 
repeats. 
 
4.2.4.3 Circular dichroism 
To analyse the Lys68 endolysin secondary structure, circular dichroism (CD) 
experiments were performed in the far- and near-UV region, using a Jasco J-815 
CD spectrometer equipped with a water-cooled Peltier unit. These experiments 
were carried out at the INL, the International Iberian Nanotechnology Laboratory 
in Portugal. The spectra were recorded in a cell width of 0.1-mm path length 
(110.QS, Hellma) from 185 to 360 nm for all proteins with 1 nm steps, scan speed 
of 20 nm/min, high sensitivity and a 16 s response time. Three consecutive scans 
from each sample and its respective buffer baseline were obtained. The averaged 
baseline spectrum was subtracted from the averaged sample spectrum measured 
under the same conditions. Secondary structure estimates were derived from the 
spectra using the CDSSTR (Compton & Johnson, 1986) and CONTINLL (Provencher 
& Glockner, 1981; van Stokkum et al, 1990) routine of the DICHROWEB (Whitmore 
& Wallace, 2004; Whitmore & Wallace, 2008) server run on the Set 4 optimized 
for a wavelength of 190-240 nm. Thermal denaturation/renaturation of the 
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proteins was measured by monitoring the change in ellipticity in a cell width of 0.1 
cm path- length at 222 nm over the range of 20°C to 75°C, in increments of 1°C. 
The experimental denaturation/renaturation profiles were analyzed by a 
nonlinear least squares fit assuming a two-state transition and used to calculate 
the melting temperature (Tm). For CD measurements, a concentration of 8 µM of 
protein was prepared in the presence of a universal buffer (10 mM KH2PO4, 10 
mM Na-citrate and 10 mM H3BO4) adjusted to different pH values within the 
range of 3 and 10 (for pH dependence tests) and in 80 mM phosphate buffer pH 
7.2 (for thermostability tests). The same conditions were used for the analysis of 
the pH and temperature on the muralytic activity described above. 
 
4.2.3.4 Fluorescence binding assay 
To visualize the OMP effect, S. Typhimurium LT2 cells were incubated with 2 mM 
citric acid and 2 µM KZ-EGFP protein. KZ-EGFP is a previously described PG binding 
domain from a Pseudomonas phage endolysin KZ144 coupled with a green 
fluorescent protein that has strong G- PG affinity (Briers et al, 2009). After 30 min 
incubation period, the sample was washed twice in 10 mM HEPES/NaOH (pH 7.2). 
Afterwards, a 30-µL drop was spotted onto a microscope slide and images were 
recorded using a confocal laser scanning microscopy (FluoView FV1000 
microscope, Olympus) in search for fluorescent Salmonella. Cells treated with 
water (instead of citric acid) and EFGP were used as negative control. 
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4.2.5 Antibacterial assays 
4.2.5.1 In vitro assays on planktonic exponential cells 
An overnight culture of G- cells was diluted (1:100) in fresh 5 mL LB and incubated 
at 37°C at 120 rpm. When reaching the mid-exponential phase with an OD600nm of 
0.6, cells were resuspended in 10 mM HEPES/NaOH (pH 7.2), and then 100-fold 
diluted to a final density of 106 colony forming units (CFU)/mL. Each culture (50 
μL) was incubated for up to 2 h at room temperature with 25 μL of Lys68 (2 μM 
final concentration) together with 25 μL of water or 25 μL of OMPs (EDTA, citric 
acid and malic acid) dissolved in water. The final concentrations used were 0.5 
mM, 2 mM and 5 mM, respectively, concentrations retrieved from literature 
(Alakomi, 2007; Briers et al, 2011b). Following the same protocol, HEWL was 
assessed at a final concentration of 2 μM to compare with the Lys68 results. As a 
negative control, 50 μL of cells were incubated with 25 μL water and 25 μL of PBS 
(pH 7.2) (culture control), with 25 μL of OMP and 25 μL of PBS (pH 7.2) (OMP 
control) or with 25 μL water and 25 μL of endolysin dialyzed in PBS (pH 7.2) 
(endolysin control). After a 30 min incubation period, cell suspensions were 
serially diluted and colonies were counted after overnight incubation at 37°C in LB 
agar plates. The antibacterial activity was quantified as the relative inactivation in 
logarithmic units (= log10 (N0/Ni) with N0 = number of untreated cells (in the 
negative control) and Ni = number of treated cells counted after incubation). 
Averages ± standard deviations are given for n = 4 repeats. 
 
4.2.5.2 In vitro assays on different bacterial physiological states 
To study the influence against different bacterial physiological states, Lys68/OMPs 
mixture was tested against planktonic S. Typhimurium LT2 under exponential and 
stationary phase and also against biofilms. S. Typhimurium LT2 cells, grown 
overnight at 37°C, were diluted 1:100 in fresh LB and grown for 3 h (planktonic 
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exponential phase), 12 h (stationary phase) and 24 h (in this case, 200 µL volume 
on 96-microplate wells - biofilm cells). In the planktonic and stationary assay, 50 
µL cells resuspended in 10 mM HEPES/NaOH (pH 7.2) to a final 106 CFU/mL were 
incubated with 25 µL Lys68 (2 µM final concentration) together with 25 µL of citric 
and malic acid (2 mM and 5 mM final concentrations, respectively) for 2 h. For 
biofilm assays, overnight cultures of S. Typhimurium cells were normalized (OD 
adjusted to 1.0 in LB medium) after which 2 μL of the cell suspension was 
transferred to 96-well polystyrene plates (Orange Scientific) containing 198 μL of 
LB. To establish mature biofilms the plate was incubated for 24 h at 37°C and 120 
rpms. Afterwards, the culture medium was removed and non-adherent cells were 
also removed by washing the biofilms twice with 200 µL of 10 mM HEPES/NaOH 
(pH 7.2). Cells were then incubated with 100 µL of HEPES together with 50 µL 
Lys68 (2 µM final concentration) and 50 µL of citric and malic acid (2 mM and 5 
mM final concentrations, respectively) for 2 h. For all experiments, cells incubated 
with water (instead of citric/malic acid) or PBS (instead of Lys68) were used as 
negative control. After incubation, the effect of the Lys68 and OMP mixtures on G- 
cells (planktonic and biofilms) was assessed by quantification of the number of 
CFUs. Again, the antibacterial activity was expressed as the relative inactivation in 
logarithmic units described above. Averages ± standard deviations are given for n 
= 4 repeats.  
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4.3 Results 
4.3.1 In silico analysis 
The 489-bps endolysin gene from Salmonella phage phi68, encoding a 162-amino 
acid protein with a deduced molecular mass of 19.6 kDa, was amplified and 
sequenced (GenBank accession number for Lys68 nucleotide sequence, 
KJ475444). Based on data from HHpred output (an E-value of 2.3x10-47 and 100% 
of query coverage) Lys68 is predicted to be a globular protein with a conserved 
domain between amino acids 1-151 and belongs to the glycoside hydrolase family 
GH24 (CAZY, 2014). This catalytic domain is predicted to degrade cell walls by 
catalyzing the hydrolysis of 1,4-linkages between N-acetylmuramic acid and N-
acetyl-D-glucosamine residues. BlastP comparison revealed high homology (>90%) 
to six other endolysin proteins from Salmonella phages, namely SETP3, ST4, SE2, 
vB_SenS-Ent1, SS3e and wksl3, that have not yet been characterized in vitro. A 
BlastP analysis also indicates conservation in both presumed catalytic residues 
Glutamic acid (Glu18) and Threonine (Thr35) for the glycosylase reaction. 
 
4.3.2 Recombinant purification and substrate specificity 
Overexpression of Lys68 in E. coli BL21(DE3) yielded a soluble protein of 14.3 
mg/L. To confirm the predicted catalytic activity and to determine the bacterial 
host spectrum, Lys68 endolysin (2 µM) drops was spotted on several OM-
permeabilized G- cell substrates and several intact G+ strain lawns (listed in Table 
4.3 and Figure 4.1) with different structural types of PG. All OM permeabilized G- 
cell substrates together with L. monocytogenes were efficiently lysed. Conversely, 
the remaining tested G+ bacteria all survived the treatment of Lys68.  
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Table 4.3. Lytic activity of Lys68 against Gram-negative or Gram-positive strains. 
Bacterial strain  Relative lysis activity 
G
-
  30 min      1 h 
Escherichia coli BL21(DE3)  Susceptible  
Escherichia coli O157:H7 CECT 4782
1
 Susceptible  
Salmonella Typhimurium LT2
1
 Intermediate              susceptible 
Salmonella Enteritidis ATCC 13076 Susceptible  
 932* Susceptible  
Salmonella bongori SGSC 3100
1
 Susceptible  
Campylobacter jejuni 12662* Susceptible  
 New M1* Susceptible  
Cronobacter sakazakii CECT 858
1
 Susceptible  
Cronobacter muytjensii ATCC 51329 Susceptible  
Pseudomonas fluorescens 7A
1
* Susceptible  
Pseudomonas aeruginosa PAO1
1
 Susceptible  
Acinetobacter Baumannii 2
1
* Susceptible  
Yersinia enterocolitica SA5429
1
 Susceptible  
Klebsiella oxytoca ATCC 13182
1
 Susceptible  
Pantoea agglomerans SA5634
1
 Intermediate                susceptible 
Enterobacter amnigenus CECT 4878
1
 Susceptible susceptible 
Proteus mirabilis SA5445
1
 Intermediate               Intermediate 
Citrobacter freundii SA5345 Intermediate               susceptible 
Shigella sonne ATCC 25931
1
 Susceptible  
G
+
    
Listeria monocytogenes CECT 5725 Intermediate             Intermediate 
Staphylococcus epidermidis 9142* Resistant                      Resistant            
Staphylococcus aureus CECT 976 Resistant               Resistant 
Paenibacillus larvae H23* Resistant                                Resistant               
 
 
1
strains tested with enzymes/OMPs;  
*strains from the CEB bacterial collection;  
  Susceptible (clear lysis halo); Intermediate (turbid lysis halo); Resistant (absence of lysis halo) 
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Figure 4.1. Visualization of the Lys68 lytic activity on chloroform S. Typhimurium LT2 
permeabilized lawn. Six 10 µL-radial endolysin (2 µM) drops resulted in lysis halos. PBS added to 
the center served as negative control (no lysis halo observed). 
 
4.3.3 Biochemical characterization 
4.3.3.1 pH dependence and muralytic activity 
Muralytic activity 
Biochemical characterization of Lys68 started exploring the muralytic activity 
under different conditions. Regarding pH dependence, Lys68 remains active over 
a pH range from 4.0 to 10.0 (maintaining 41.17%±4.81 and 46.31%±0.96 of its 
activity, respectively) (Figure 4.2 a), with a pH optimum around 7.0 (pH of the 
bacterial cytoplasm). When kept at optimal pH, Lys68 has a muralytic activity of 
400 Units/µM that decreases to 310 Units/µM (23.3% less) and 100 Units/μM 
(74.9% less) when the protein is stored for two months at 4°C and -20°C, 
respectively (Figure 4.2 b).  
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Figure 4.2. Muralytic activity of Lys68. a) pH optimum for enzymatic activity of Lys68. Relative 
muralytic activity is measured as the slope of the OD600nm/min curve, given in percentage by 
comparing to the activity at pH 7.0 (the highest measured value) (Y-axis) on OM-permeabilized P. 
aeruginosa PAO1 substrate and is shown for a pH range between 3.0 and 10.0 (X-axis). b) 
Saturation curves for Lys68 muralytic activity under optimal pH (7.2). The activity in OD600 nm/min 
(Y-axis) for incremental amounts of Lys68 (0 months - squares; 2 months at 4°C - circles; 2 months 
at -20°C - triangles) is depicted. Muralytic activity reaches saturation at 2 to 3 μM.  
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Circular dichroism analysis 
To elucidate the major structural features of Lys68, CD studies were employed 
using a universal buffer at different pH values (Figure 4.3). The Lys68 CD profile 
exhibited two negative dichroic minima at 222 nm and 208 nm and a positive 
dichroic maximum at 192 nm, which is characteristic of a protein with a high α-
helix content. 
 
 
 
 
 
 
 
 
Figure 4.3. Circular dichroism spectra of Lys68 as a function of pH using a universal buffer with 
adjusted pH (3.0-10.0). 
 
Deconvolution of the CD spectra, using a dataset as specified in materials and 
methods, allowed us to determine that 37% of Lys68 folds as α-helices, 17% as β-
sheet, and 18% as turns, while 27% was unordered. Interestingly, when the pH 
was between 4.0 and 10.0, the obtained spectra were almost identical and the 
predicted secondary structures content remained essentially unchanged. These 
data shows that the secondary structure content of Lys68, at various pH 
conditions, is highly conserved, even at pH 4.0, similar to the trend observed for 
HEWL after analysis its CD spectrum (Supplementary Figure S4.1). Conformational 
changes occurred around pH 3.0 with loss of secondary structure. 
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4.3.3.2 Thermostability 
Muralytic activity 
Thermal stress of Lys68 was investigated and is depicted in Figure 4.4. 
Thermostability tests showed no reduction on the enzymatic activity after 30 min 
incubation of the enzyme at 40°C, and only minor loss of activity was observed 
when incubated at 60 and 80°C during the same time. At 100°C, the muralytic 
activity dropped to 25.8%, 10.2% and 0.27% of the initial activity after 20, 30 and 
45 min incubation, respectively. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.4. Lys68 muralytic activity after thermal stress. a) Residual Lys68 activity (2 µM) on OM 
permeabilized P. aeruginosa PAO1 cell substrate after incubation at 40, 60 and 80°C for 30 min 
and b) after heat treatment at 100°C for 0, 5, 10, 20, 30 and 45 min, followed by a 30-min cooling 
step on ice. 
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Circular dichroism analysis 
Related to the muralytic studies, CD studies were performed to evaluate the Lys68 
thermostability by following the loss of CD signal (ellipticity) at 222 nm (dichroic 
band characteristic for α-helical proteins) when increasing the temperature of the 
sample from 20 to 75°C. Lys68 demonstrated a sigmoidal thermal denaturation 
profile, reflecting protein unfolding (Figure 4.5). 
 
 
 
 
 
 
 
 
 
 
Figure 4.5. Melting curves for Lys68, measured by monitoring the absorbance at 222 nm against 
increasing (denaturation) and decreasing temperatures (renaturation) at pH 7.0.  
 
The Tm was found to be around 44°C according to a two-state model. 
Interestingly, the renaturation experiments showed a maximum recovery of the 
native features after the protein was heated up to 75°C under the same 
experimental conditions, and a loss in ellipticity of only 1.3%. Employing the 
thermal denaturation at eight different pH values from 3.0 to 10.0, the Tm of Lys68 
increases from 38.1°C (for pH 3.0) to 44.7°C and 43.4°C (optimal pH 6.0-7.0, 
respectively), after which it decreases again to 36.1°C (for pH 10.0) (Table 4.4). 
This indicates that the protein is more stable at neutral pH and the stability 
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decreases at acidic or basic pH values, which is positively correlated with the 
observed optimal pH from the Lys68 muralytic activity. 
 
Table 4.4. Apparent melting temperatures (Tm) of Lys68 as a function of pH (3.0-10.0) as 
determined by circular dichroism signal at 222 nm in thermal denaturation and renaturation 
experiments. 
pH 
Tm 
(Denaturation cycle) 
Tm 
(Renaturation cycle) 
3 - - 
4 38.1°C 35.0°C 
5 43.0°C 40.7°C 
6 44.7°C 41.8°C 
7 43.4°C 40.8°C 
8 41.5°C 38.5°C 
9 39.4°C 34.6°C 
10 36.1°C - 
 
Afterwards, Lys68 was subjected to thermal stress under different temperatures 
(40, 60, 80 and 100°C) and protein ellipticity was monitored (Figures 4.6 a, b). It 
was observed that from 4°C to 40°C, Lys68 remained very stable and kept its 
activity for longer periods. As the incubation temperature increased from 40°C to 
60°C, 80°C and 100°C, evident changes in secondary structures occurred, with a 
continuous decrease in the ellipticity of the 208 nm and 220 nm bands. In 
accordance, CD thermal stability showed that the loss of muralytic activity upon 
thermal stress is accompanied with gradual loss of endolysin secondary structure. 
 
 
 
Chapter 4 
84   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 4.6. Circular dichroism spectra of Lys68 after thermal stress. a) Lys68 (2 µM) incubated at 
40, 60 and 80°C for 30 min followed by 30 min incubation on ice, and b) after heat treatment at 
100°C for 0, 5, 10, 20, 25 and 30 followed by 30 min incubation on ice. 
 
4.3.4 In vitro antibacterial activity 
4.3.4.1 Enzymes/OMPs effect on Gram-negative cells 
The in vitro antibacterial activity of Lys68/OMP and HEWL/OMP was investigated 
on a wide panel of G- bacteria (Table 4.5). As is depicted, a stronger antibacterial 
activity was observed against S. Typhimurium LT2, A. baumannii 2 and P. 
aeruginosa PAO1, compared to the other tested species.  
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Table 4.5. Combinatorial antibacterial activity of outer membrane permeabilizers with (A and B) 
or without (C) HEWL/Lys68 on Gram-negative bacterial pathogens. Marked in bold are significant 
log reduction units observed (≥ 1 log). 
A                               Bacterial Species HEWL/Water HEWL/EDTA HEWL/Citric HEWL/Malic 
Salmonella Typhimurium LT2 0.03 ± 0.07 0.14 ± 0.23 0.08 ± 0.15 0.07 ± 0.09 
Acinetobacter baumannii 2 0.01 ± 0.09 0.04 ± 0.06 0.10 ± 0.06 0.17 ± 0.15 
Pseudomonas aeruginosa PAO1 0.02 ± 0.10 0.89 ± 0.17 0.24 ± 0.02 2.44 ± 0.52 
Pseudomonas fluorescens 7A 0.04 ± 0.04 0.30 ± 0.38 0.28 ± 0.13 3.77 ± 0.45 
Shigella sonnei ATCC 25931 0.22 ± 0.29 0.01 ± 0.11 0.02 ± 0.07 0.06 ± 0.12 
E. coli O157:H7 CECT 4782 0.04 ± 0.15 0.11 ± 0.12 0.10 ± 0.05 0.09 ± 0.04 
Cronobacter sakazakii CECT 858 0.11 ± 0.18 0.15 ± 0.20 0.30 ± 0.16 0.20 ± 0.13 
Pantoea agglomerans SA5634 0.04 ± 0.10  0.08 ± 0.15 0.20 ± 0.19 0.22 ± 0.29 
Enterobacter amnigenus CECT 4878 0.04 ± 0.07 0.07 ± 0.13 0.18 ± 0.17 0.26 ± 0.04 
Proteus mirabilis SA5445 0.08 ± 0.03 0.09 ± 0.14 0.03 ± 0.25 0.17 ± 0.14 
Salmonella bongori SGSC 3100 0.02 ± 0.10 0.10 ± 0.09 0.09 ± 0.13  0.47 ± 0.19 
Klebsiella oxytoca ATCC 13182 0.01 ± 0.02 0.10 ± 0.05 0.13 ± 0.08 0.26 ± 0.06 
Yersinia enterocolitica SA5429 0.06 ± 0.05 0.18 ± 0.11  0.11 ± 0.12  0.34 ± 0.11  
 
B                             Bacterial Species Lys68/Water Lys68/EDTA Lys68/Citric  Lys68/Malic  
Salmonella Typhimurium LT2 0.14 ± 0.16 0.16 ± 0.12 2.93 ± 0.45 2.65 ± 0.40 
Acinetobacter baumannii 2 0.04 ± 0.12 0.14 ± 0.22 1.01 ± 0.33 2.93 ± 0.59 
Pseudomonas aeruginosa PAO1 0.04 ± 0.34 2.46 ± 0.48 1.48 ± 0.35 3.31 ± 0.21 
Pseudomonas fluorescens 7A 0.02 ± 0.10 1.44 ± 0.67 1.40 ± 0.23  5.91 ± 0.43 
Shigella sonnei ATCC 25931 0.13 ± 0.28 0.35 ± 0.44 1.40 ± 0.33 2.42 ± 0.43 
E. coli O157:H7 CECT 4782 0.02 ± 0.02 0.21 ± 0.14 1.18 ± 0.12 2.37 ± 0.35 
Cronobacter sakazakii CECT 858 0.16 ± 0.06 0.30 ± 0.09 1.09 ± 0.19 1.40 ± 0.30 
Pantoea agglomerans SA5634 0.03 ± 0.18  0.13 ± 0.12 0.32 ± 0.18 1.26 ± 0.18 
Enterobacter amnigenus CECT 4878 0.04 ± 0.11 0.28 ± 0.18 0.68 ± 0.36 1.21 ± 0.27 
Proteus mirabilis SA5445 0.03 ± 0.12 0.09 ± 0.04 0.41 ± 0.29 0.97 ± 0.25 
Salmonella bongori SGSC 3100 0.06 ± 0.10 0.08 ± 0.16 0.13 ± 0.09 0.94 ± 0.05 
Klebsiella oxytoca ATCC 13182 0.07 ± 0.13 0.12 ± 0.17  0.24 ± 0.14 0.30 ± 0.22  
Yersinia enterocolitica SA5429 0.11 ± 0.10 0.03 ± 0.06 0.18 ± 0.08 0.22 ± 0.07 
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C                               Bacterial Species ------  Water/EDTA Water/Citric Water/Malic 
Salmonella Typhimurium LT2  0.09 ± 0.10 0.07 ± 0.05 0.06 ± 0.09 
Acinetobacter baumannii 2  0.04 ± 0.03 0.07 ± 0.05 0.07 ± 0.04 
Pseudomonas aeruginosa PAO1  0.05 ± 0.06 0.60 ± 0.14 1.54 ± 0.47 
Pseudomonas fluorescens 7A  0.42 ± 0.31 0.70 ± 0.14  2.70 ± 0.51 
Shigella sonnei ATCC 25931  0.01 ± 0.14 0.02 ± 0.14  0.14 ± 0.03 
E. coli O157:H7 CECT 4782  0.06 ± 0.04 0.01 ± 0.09 0.18 ± 0.18 
Cronobacter sakazakii CECT 858  0.17 ± 0.12 0.06 ± 0.14 0.28 ± 0.10  
Pantoea agglomerans SA5634  0.07 ± 0.10 0.03 ± 0.18 0.10 ± 0.18 
Enterobacter amnigenus CECT 4878  0.08 ± 0.08 0.15 ± 0.15  0.16 ± 0.18  
Proteus mirabilis SA5445  0.02 ± 0.10 0.01 ± 0.23  0.03 ± 0.12  
Salmonella bongori SGSC 3100  0.07 ± 0.12  0.05 ± 0.14 0.16 ± 0.03  
Klebsiella oxytoca ATCC 13182  0.12 ± 0.12 0.01 ± 0.09  0.18 ± 0.09  
Yersinia enterocolitica SA5429  0.01 ± 0.06 0.30 ± 0.23  0.06 ± 0.07  
 
The activity of both Lys68 and HEWL alone against exponentially growing cells was 
insignificant. However, following permeabilization with OMPs a different outcome 
was observed. Despite being both able to inactivate Pseudomonas cells, 
Lys68/EDTA had a more pronounced killing effect than HEWL/EDTA. Both citric 
and malic acid were significantly better than EDTA in enhancing the access of 
Lys68 to the PG, however this advantageous effect was not observed in 
combination with HEWL. Lys68/citric acid was not only able to kill Pseudomonas 
cells, but also caused a significant reduction of S. Typhimurium LT2 (2.93±0.45 log 
reduction) and A. baumannii (1.01±0.33 log reduction) as well of Shigella sonnei 
(1.40±0.33 log reduction), E. coli O157:H7 (1.18±0.12 log reduction) and 
Cronobacter sakazakii (1.09±0.19 log reduction).  
Interestingly, the effect of Lys68/malic acid was even higher in all strains 
compared to Lys68/EDTA and Lys68/citric acid. Reductions of 2-3 logs units were 
observed on P. aeruginosa (3.31±0.21), S. Typhimurium LT2 (2.65±0.40) and A. 
baumannii (2.93±0.59). Overall, the best log reduction values were consistently 
obtained with malic acid in combination with Lys68 after 30 min of incubation, 
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killing 11 different G- bacterial species. In contrast to the other strains, none of 
the OMPs could sensitize Lys68 to Klebsiella oxytoca and Yersinia enterocolitica 
strains. 
When incubated for longer periods (2 h), the combinatory effect of citric acid and 
Lys68 on S. Typhimurium LT2 increased remarkably, resulting in a 5.05±0.48 log 
reduction of viable cells and was also efficient against stationary cells (1.45±0.15 
log units of viable cells) and biofilms (1.26±0.10 log units of viable cells) (Table 
4.6). 
 
Table 4.6. Influence of different S. Typhimurium LT2 physiological states (planktonic/biofilm) on 
the combinatorial effect of Lys68 and outer membrane permeabilizers (citric and malic acid). 
Marked in bold are significant log reduction units observed (≥ 1 log). 
 
S. Tyhpimurium LT2 Planktonic Biofilm 
 Exponential phase  Stationary phase  
Lys68 + Water 0.11 ± 0.14  0.14 ± 0.07 0.15 ± 0.11 
PBS + Citric acid 0.10 ± 0.11  0.08 ± 0.11 0.09 ± 0.19 
PBS + Malic acid 0.08 ± 0.20  0.19 ± 0.18 0.15 ± 0.25 
Lys68 + Citric acid 5.05 ± 0.48 1.45 ± 0.15 1.26 ± 0.10 
Lys68 + Malic acid 3.19 ± 0.53  0.55 ± 0.28 1.31 ± 0.13 
 
4.3.4.2 OM permeabilization mechanism 
To further investigate whether the permeabilizing effect of citric and malic acid is 
compound- or pH-related, S. Typhimurium LT2 cells were incubated with Lys68 in 
the presence of HCl (to drop the pH to 4.2 and 3.8, similar to citric and malic acid, 
respectively) for a 30 min period (Table 4.7). 
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Table 4.7. S. Typhimurium LT2 log reduction units after incubation with enzymes and acids. 
Marked at bold are significant log reduction units observed (≥ 1 log). 
 
Water HEWL Lys68 Lys68 + MgCl2 
HCl, pH 4.2 0.14 ± 0.18 0.12 ± 0.05 2.44 ± 0.56 0.10 ± 0.18 
HCl, pH 3.8 0.01 ± 0.17 0.11 ± 0.10 2.66 ± 0.42 0.20 ± 0.13 
Citric acid, pH 4.2 0.21 ± 0.14 0.09 ± 0.08 3.08 ± 035 0.24 ± 0.10 
Malic acid, pH 3.8 0.11 ± 0.09 0.13 ± 0.06 2.63 ± 0.47 0.18 ± 0.16 
 
The results summarized in Table 4.7 show that the log reduction units of viable 
cells are mostly due to the acidity. In the presence of HCl, Lys68 is able to kill 
2.44±0.56 log of viable cells at pH 4.2 (3.08±0.35 for citric acid) and a 2.66±0.42 
log reduction of viable cells was obtained at pH 3.8 (2.63±0.47 for malic acid). In 
the case of HEWL, both organic acids and HCl were inactive towards S. 
Typhimurium LT2. 
It has been described that MgCl2 can interact with the LPS layer via divalent 
cations (Mg2+), contributing to the stability of the OM (Alakomi et al, 2000). 
Subsequently, this results in a decrease in permeability of the OM to external 
agents. Consequently, the addition of 5 mM of MgCl2 abolished the Lys68 
antibacterial activity in all tested conditions (Table 4.7).  
To visualise the effect of organic acids as G- OMPs, an experiment was conducted  
incubating S. Typhimurium LT2 cells with citric acid in the presence of a 
fluorescent probe. This fluorescent probe was constructed earlier and consists of 
a Pseudomonas phage KZ144 endolysin binding domain fused with an enhanced 
green fluorescent protein (KZ-EGPF) that has high affinity to G- PG (Briers et al, 
2009). When incubating the cells for a 30-min period, green fluorescent 
Salmonella cells could be observed by epifluorescence microscopy (Figure 4.7), 
indicative of cell permeablization. 
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Figure 4.7. Epifluorescence microscopy of the S. Typhimurium LT2 cells permeabilized with citric 
acid. a) Cells incubated with 2 mM citric acid and 2 µM of KZ-EGFP protein; b) Cells incubated with 
2 mM citric acid and 2 µM of wild-type EGFP protein; and c) Cells incubated with water and 2 µM 
of wild-type EGFP protein for 30 min. Cell pellets were then washed twice and visualized using 
epifluorescence microscopy with a 1500 magnification. This image has been converted to black 
and white. 
 
4.3.4.3 Lys68 PG digestion mechanism 
To assess the Lys68 PG digestion mechanism and explain the activity of the 
endolysin at low pH, an analysis of its presumed essential catalytic residues was 
made. Lys68 is classified as a member of the GH24 family (CAZY, 2014), which has 
a glutamine (Glu) residue as the proton donor. The catalytic nucleophile however 
is yet unknown. To identify a putative nucleophile, BlastP searches were 
conducted. Results showed that, besides Glu-18, a second amino acid residue, 
Thr-35, was highly conserved, which could indicate a role as a putative catalytic 
residue of Lys68. Mutagenesis of both presumably essential catalytic residues 
resulted in one inactive enzyme (Glu18Ala) and one enzyme with similar activity 
(Thr35Ala) compared to the Lys68 wild-type (Figure 4.8 a). Analysis of mutated 
proteins by CD did not provide any evidence for significant structural alterations 
due to the amino acid replacements (Figure 4.8 b). Therefore, the absence of 
activity was entirely attributed to the Glu18Ala substitution. 
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Figure 4.8. Muralytic activity and secondary structure comparisons between Lys68 wild-type and 
mutant variants. a) Circular dichroism spectra of Lys68 wild-type and the two mutants (Glu18Ala 
and Thr35Ala). b) Muralytic activity of same proteins on P. aeruginosa OM permeabilized cells 
measured as optical density decrease. 
 
Based on the experimental data, the BlastP results, and the fact that there is no 
available 3D structure of a Lys68 homolog, a possible second catalytic residue 
could not be identified. Recently, Wohlkönig and coworkers described the 
existence of two subgroups within the GH24 family; one that has a Glu-Asp-Thr 
catalytic triad and another that only consists of Glu as the catalytic residue 
(Wohlkonig et al, 2010). The amino acid Glu has been shown in a the goose egg-
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white lysozyme as the single responsible catalytic residue for the  digestion of PG 
bonds (Weaver et al, 1995). Therefore, it is proposed that Lys68 operates through 
a two-step mechanism involving Glu-18 (Figure 4.9).  
 
 
Figure 4.9. Proposed Lys68 mechanism of action. Lys68 hydrolyse the 1,4-linkages between N-
acetylmuramic acid and N-acetyl-D-glucosamine, through a two-step mechanism involving Glu-18 
catalytic residue to cleave the peptidoglycan.  
 
In the first step N-acetylhexosaminidases, which have an acetamido group, are 
capable of neighboring group participation to form an intermediate oxazolinium 
ion, with acidic assistance provided by the Glu-18 carboxylate. In the second step, 
the now deprotonated acidic carboxylate acts as a base and assists a nucleophilic 
water to hydrolyze the oxazolinium ion intermediate, giving the hydrolyzed 
product (through individual inversions that lead to a net retention of 
configuration).  
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4.4 Discussion 
In recent years, endolysins of phages infecting G+ bacteria have been extensively 
studied (Fischetti, 2010). In contrast, G- phage endolysins have been poorly 
explored, because the impermeable bacterial OM protects the underlying PG layer 
from enzymatic hydrolysis by the exogenous endolysin. In this work, a novel 
endolysin from a G- infecting phage is described. In silico characterization of Lys68 
from the Salmonella phage phi68 shows elevated protein similarity (˃90% 
identity) to other Salmonella phage endolysins belonging to the same lysozyme-
like superfamily. The observed globular structure (ECD alone) is also shared by 
most other G- phage endolysins, contrary to modular archetypes (ECD and CBD) 
typically seen in endolysins from a G+ background (Oliveira et al, 2013). 
A biochemical characterization showed that Lys68 displays some interesting 
characteristics. Regarding substrate specificity, Lys68 degrades the PG of all 20 G- 
organisms tested, however it was ineffective against all included G+ strains, with 
the exception of L. monocytogenes. Consequently, Lys68 displays a broader lytic 
spectrum than the phage from which was derived from, whose spectrum is 
limited to S. Enteritidis strains (Sillankorva et al, 2010). This broader spectrum is 
explained by the common PG A1γ chemotype shared by the sensitive G- species 
and also L. monocytogenes, whereas the remaining insensitive G+ strains like 
Staphylococcus epidermidis 9142 and Staphylococcus aureus 976 presumably have 
an A3α PG chemotype (Schleifer & Kandler, 1972). This chemotype was previously 
shown to be resistant to other muralytic enzymes, like HEWL (Archibald AR, 1993). 
The observed muralytic activity of the globular Lys68 (400 Units/µM) is lower 
compared to other described modular G--like endolysins (e.g. KZ144 and EL188 
with 2058 and 4735 U/µM, respectively, calculated using the same method) 
(Walmagh et al, 2012). This can be explained by the fact that the latter two 
enzymes contain cell wall binding domains that direct the enzymes to the PG 
substrate, increasing the muralytic activity. Nevertheless, when compared to the 
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globular HEWL (35 Units/µM, reported elsewhere), Lys68 is 12 times more active 
(Briers et al, 2007a). In addition to adequate profiles of activity and specificity, 
antimicrobial enzymes require good structural stability. Therefore the pH effect 
on the Lys68’s conformational stability was characterized. The endolysin’s 
secondary structure showed to be highly conserved between pH values of 4.0 to 
10.0. At pH 3.0, more turns and unordered/random coils are formed in Lys68 than 
at higher pH values. Stability tests showed that Lys68 was more stable around pH 
6.0-7.0 (with melting temperatures of 44.7°C and 43.4°C), matching the pH where 
optimal muralytic activity is observed.  
Once subjected to thermostability tests, some endolysins surprisingly maintain 
their activity after long heating periods. Within endolysins from a G- background, 
Pseudomonas phage endolysins KZ144 and EL188 activity still remains high after 
being exposed at 50°C for 10 min (Briers et al, 2007b). In contrast, the phage T4 
lysozyme only retains a minor fraction of its activity after a 5 min treatment at 
65°C (Nakagawa et al, 1985). Recently, a highly thermostable modular endolysin 
(PVPSE1gp146) with resistance to temperatures up to 100°C was described 
(Walmagh et al, 2012). Lys68 is a globular protein where the muralytic activity is 
only completely inactivated after 30 min at 100°C. Because the melting 
temperature of the endolysin at pH 7.0 is 44°C, it seems that under the stress 
caused by higher temperatures, the endolysin is able to gradually regain its 
secondary structure to a point where, at high temperatures and prolonged 
exposures, it cannot refold. Recently, a similar folding/refolding mechanism was 
suggested by Schmelcher and coworkers to explain the high thermostability of the 
G+ L. monocytogenes phage endolysins, HPL118 and HPL511 (Schmelcher et al, 
2012b). In their study, HPL118 and HPL511 retained 35% of activity after 30 min at 
90°C.  
To allow a better passage of endolysins through the OM, a combinatorial 
approach was  used  on G-  bacteria,  combining  the  bacterial  cell wall-degrading  
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enzyme Lys68 or HEWL with an OMP. Both proteins combined with EDTA could 
reduce P. aeruginosa to some extent. A similar effect has been previously 
described with endolysin EL188 from Pseudomonas infecting phage EL only on P. 
aeruginosa strain PAOI (Briers et al, 2011b). The positive effect of EDTA on the 
antibacterial activity is caused by the powerful OM permeabilization capacity of 
EDTA through binding and withdrawal of the stabilizing divalent cations Mg2+ and 
Ca2+, present in the LPS layer of the G- OM (Vaara, 1992). As a result, the bacterial 
PG becomes more prone to the muralytic activity of the externally added 
endolysins. However, the sensitivity of other bacterial species to the destabilizing 
effect of EDTA was much lower, even when EDTA was increased to 5 mM (see 
Supplementary Table S4.1). In seems that the type and structure of the OM plays 
a key role for the antibacterial efficacy of the enzyme/EDTA combinatorial effect. 
Possibly, due to the low number of phosphate groups per LPS molecule and the 
corresponding amount of stabilizing divalent cations in the OM of 
Enterobacteriaceae compared to the Pseudomonadaceae, EDTA turns out to be 
ineffective to the former group. The observed synergetic effects of citric acid and 
malic acid, has never been described for phage endolysins. In this respect, both 
citric acid and malic acid had a better permeabilizing effect than EDTA, and were 
able to permeabilize several G- strains tested enhancing the activity of Lys68. In 
particular against exponential S. Typhimurium LT2 cells, an even more profound 
effect was observed when extending the reaction from 30 minutes to 2 hours, 
although proving to be less efficient against stationary cells and biofilms. The 
lower efficiency in killing stationary cells can be a result of two aspects; i) 
structural changes in the OM (e.g. LPS biosynthesis), compromising the endolysin 
entry or LPS permeabilization through the organic acids, or ii) chemical 
modifications in the PG (e.g. glycosylations or acetylations) known to contribute 
to high levels of resistance to glycosyl hydrolases (Vollmer & Born, 2009; Rolfe et 
al, 2012). As for biofilms, beside the presence of several bacterial physiological 
states that can give rise to similar problems, additional diffusion limitations due to 
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the high density matrix content can hinder the efficacy of endolysins and 
antimicrobials in general (Mah & O'Toole, 2001). Although the permeabilizing 
capacity of citric acid by chelating divalent cations from the OM associated with 
its protonated form has been reported, additional acidity can contribute to OM 
damage. It has been proposed that the LPS disintegration is accomplished by the 
ability of undissociated acid groups to interact/pass through the negatively 
charged LPS (where negatively charged acids are repulsed) and migrate inside the 
cell to cause sublethal damages (e.g. leading to OM membrane disruption) 
(Alakomi et al, 2000; Theron & Lues, 2011). The 2 mM of citric acid (pKa 3.13 at 
25°C) and 5 mM of malic acid (pKa 3.4 at 25°C) used, caused a drop of pH to 4.2 
and 3.8, respectively. Because similar log reduction units were obtained using HCl 
instead of citric or malic acid combined with Lys68, the acidity effect seems to 
play a key role in the OM permeabilization. Because millimolar concentrations of 
these organic acids by themselves did not have antibacterial effect on the cells 
(with exception of Pseudomonas), they seem to be enough to compromise the cell 
wall to a level that allows Lys68 to act on the PG, causing bacterial death. 
Recently, a combined treatment with different organic acids to induce cell 
permeability in E. coli O157:H7 was reported (Kim & Rhee, 2013). Transmission 
electron microscopy images showed clear membrane disintegration that 
potentiated the bactericidal action of medium-chain fatty acids. When bacterial 
suspensions were supplemented with 5 mM of MgCl2, the effect of Lys68 
combined with organic acids was completely abolished. MgCl2 has the ability to 
protect the bacterial OM damaged from the acid challenge, an effect already 
observed in the presence of lactic acid (Alakomi et al, 2000). 
Based on the carbohydrate-active enzymes classification, several amino acids 
have been identified within lysozyme-like proteins to play a key role in the 
glycosidase reaction (CAZY, 2014). HEWL’s (belonging to the GH22 class) active 
site, which cleaves polysaccharide chains in bacterial cell walls, is constituted 
essentially by the two amino acids Glu-35 (pKa, 6.1-6.2) and Asp-52 (pKa, 3.4-4.5), 
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which are only functional if the former is non-ionized and the latter is ionized 
(Webb et al, 2010). Hence, the absence of enzymatic activity in the presence of 
malic and citric acid is related to the deionization of Asp52 in an acidic pH. Lys68 
has a different catalytic system. Since the Thr-35 mutation did not affect Lys68 
antimicrobial activities, it can be concluded that Thr-35 is not involved in the 
catalysis of PG. Therefore, it is tempting to speculate that Lys68 operates through 
a two-step mechanism involving Glu-18, capable of digesting the 1,4-linkages 
between N-acetylmuramic acid and N-acetyl-D-glucosamine residues of the PG in 
a low pH environment (pH around 4.0) through a retaining mechanism. The 
catalytic activity of amino acid Glu-73 in the goose egg-white lysozyme has been 
proved by Weaver and co-workers to be enough to digest the PG bonds (Weaver 
et al, 1995). 
To summarize, G- bacterial pathogens prevail in various surroundings and their 
resilience is aided by the presence of an OM that prevents toxic substances from 
entering the cell. Lys68 demonstrates very good stability properties and its 
efficient combination with EDTA, citric acid and malic acid could be greatly 
explored in many fields to combat G- pathogens. Lys68/EDTA could be used as a 
therapeutic product to control P. aeroginosa, typically present in burn wound 
infections or as food preservative against P. fluorescents. The broad antimicrobial 
effect of Lys68/citric acid and Lys68/malic acid could be explored in food and 
clinical settings as an effective sanitizer to prevent food spoilage and nosocomial 
bacterial infections. Additionally, the powerful effect of Lys68 with the organic 
acids can be used therapeutically to treat for example topical infections as chronic 
wounds, when applied in a cream or ointment. Altogether, this study proposes 
the combination of a bacterial cell wall hydrolase from phage origin (Lys68) with 
EDTA, citric and malic acid for biotechnological and medical applications to fight 
G- pathogens in the agricultural, food and medical industry.  
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5.1 Introduction 
Although chapter 4 demonstrated the efficacy of endolysin/organic acid mixtures 
to control G- pathogens, it is important to validate this technology for other 
endolysins and prove their transversal application. Multidrug-resistant bacteria 
and biofilms are also important factors that need to be addressed in depth, as 
most G- bacteria, like Pseudomonas and Acinetobacter, are naturally resistant to 
antibiotics (e.g. low outer membrane permeability) or able to quickly acquire new 
resistance mechanisms (e.g. horizontal transfer of resistance genes) (Bonomo & 
Szabo, 2006). Their ability to form biofilms is another important aspect that makes 
them more tolerant to varied antimicrobial agents (e.g. related to the limited 
diffusion transport and the presence of different bacterial physiological states) 
(Mah & O'Toole, 2001).  
This chapter describes the isolation of a novel phage-encoded endolysin (ABgp46) 
and a depolymerase (ABgp42) (part of the tail-fiber), originating from an 
Acinetobacter baumannii phage. Depolymerases are polysaccharide-degrading 
enzymes encoded by phages that act against the extracellular polymeric 
substances found in biofilms, increasing their anti-biofilm efficiency (Lu & Collins, 
2007; Cornelissen et al, 2011). ABgp46 was first analyzed for its stability under 
different pH values and then tested against planktonic G- (antibiotic resistant) 
bacteria in the presence and absence of OMPs agents. In this chapter, several 
organic acids were tested (citric, malic, lactic, benzoic and acetic acid) to widen 
novel synergies with substantial biotechnological interest, and compared with 
EDTA, as it is the only agent described so far able to act synergistically with 
endolysins (Walmagh et al, 2012). In the end, it was intended to explore the anti-
biofilm endolysin-organic acid-depolymerase activity formula. Endolysin anti-
biofilm activity is a field that still remains scarcely explored, with only few 
successes reported against G+ Staphyloccocus and Streptococcus biofilms (Sass & 
Bierbaum, 2007; Shen et al, 2013). 
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5.2 Materials and methods 
5.2.1 Bacterial strains, bacteriophage and chemicals 
Bacterial strains used are listed in Table 5.1. Without exceptions, all strains were 
grown in LB (Liofilchem) at 37°C and 120 rpm. E. coli cloning and expression 
strains (Agilent Technologies, Invitrogen and Merck4Biosciences) are shown in 
Table 5.2. E. coli strains BL21-CodonPlus-(DE3)-RIL (30 µg/mL chloramphenicol), 
BL21-CodonPlus-(DE3)-RP, (30 µg/mL chloramphenicol) and Origami™ 2(DE3) 
(12.5 µg/mL tetracycline and 50 µg/mL streptomycin) were grown under the 
specified conditions. E. coli Top10 was used for cloning purposes while the 
remaining strains were used for recombinant expression. E. coli strains were 
transformed as described in chapter 4. A. baumannii phage vb_AbaP_CEB1 
(encoding the ABgp46 endolysin and the ABgp42 depolymerase part of the tail-
fiber) was isolated from waste effluents and belongs to the CEB phage collection.  
 
Table 5.1. Overview of bacterial pathogens strains, references and sources used in chapter 5. 
Bacterial strain Reference(s) Sources  
Salmonella Typhimurium ATCC 19585 (further designated as LT2) NA 
Pseudomonas aeruginosa ATCC 15692 (further designated as PAO1) Infected burn/wounds 
Klebsiella oxytoca ATCC 131821 Pharyngeal tonsil 
Acinetobacter baumannii 1*/ 2* / 3* / 4* / 5* / 6* / 7* / 8* / 10* Infected burn/wounds 
Escherichia coli O157:H7 CECT 47821 Human stool  
 
NA - Not available; * strains kindly provided by Hospital de Braga  
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Table 5.2. Genotypes of E. coli cloning and expression strains used in chapter 5. 
Bacterial strains Genotype 
TOP10 
F
-
 mcrA Δ(mcrCB-hsdSMR-mrr) Ф80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara-
leu)7697 galU galK rpsL(Str
r
) endA1 λ
-
 
BL21(DE3) F
–
 ompT hsdSB(rB
–
  mB
–
) gal dcm (DE3) 
BL21-CodonPlus-(DE3)-RIL F
-
 ompT hsdS(rB
-
mB
-
) dcm + Tet
r
 gal λ(DE3) endA Hte (argU ileY leuW Cam
r
) 
BL21-CodonPlus-(DE3)-Rp F
-
 ompT hsdS(rB
-
mB
-
) dcm + Tet
r
 gal λ(DE3) endA Hte ([argU proL Cam
r
) 
Origami™ 2(DE3) 
Δ (ara-leu)7697 Δ lacX74 Δ phoA PvuII phoR araD139 ahpC galE galK rpsL 
F’[lac
+
 lacI
q
  pro] (DE3) gor522::Tn10 trxB (Str
R
, Tet
R
) 
 
EDTA was acquired from Pronalab while IPTG, HEPES, citric, malic, lactic, benzoic 
and acetic acid were purchased from Sigma-Aldrich. 
 
5.2.2 In silico analysis of endolysins 
The endolysin sequence used was screened by the HHpred webserver (URL 
http://toolkit.tuebingen.mpg.de/hhpred) using Pfam, InterProScan and COG; with 
an E-value cut-off of 1x10-5 and at least 80% of query coverage. The MSA 
generation method used was HHblits (Remmert et al, 2012). Multiple sequence 
alignments were generated through ClustalW online (URL 
http://www.genome.jp/tools/clustalw/). 
 
5.2.3 Cloning, recombinant protein expression and purification 
All primers used to clone the ABgp46 endolysin and ABgp42 depolymerase were 
purchased from Invitrogen. The vector pET15b (Novagen) was used to clone and 
express both proteins, and has the resistant marker gene for ampicillin (100 
µg/mL). Restriction enzymes were purchased from NEB and all DNA cleaning steps 
were performed using DNA Clean & ConcentratorTM-5k (Zymo Research). All final 
constructs were verified by sequencing (Macrogen). 
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5.2.3.1 Cloning methodology  
The standard PCR cloning procedure for the ABgp46 endolysin and the ABgp42 
depolymerase ORFs into pET15b was carried out as explained in chapter 4. For 
ABgp46, specific set of primer 5-GGCAGCCATATGATTCTGACTAAAGACGGGTTTAG 
(forward) and 5- GCAGCCGGATCCCTATAAGCTCCGTAGAGCGC (reverse), with the 
NdeI/BamHI restriction endonuclease sites underlined, and annealing 
temperature of 55°C, were used in a PCR reaction. As for ABgp42, the primers 5- 
GGCAGCCATATGATGCACGCTGACCCATGTTGG (forward) and 5-
CAGCTGTAAACGTTATCCGTTGCTAAGGATCCGGCTGC (reverse), with the 
NdeI/BamHI restriction endonuclease sites underlined and an annealing 
temperature of 56°C were chosen.  
 
5.2.3.2 Protein overexpression and purification 
Both proteins were cloned in pET15b, making use of the present N-terminal His6 
for fused expression. The E. coli expression system, purification using Ni2+-NTA 
chromatography, band purification visualization, dialysis in 10 mM PBS pH 7.2 and 
protein quantification were carried out as explained previously in chapter 4. Only 
proteins with a purity higher than 90%, as judged by SDS-PAGE analysis, were 
considered for in vitro studies. E. coli BL21(DE3) expression strain and 25 mM 
imidazole purification stringency were chosen for ABgp46 endolysin expression 
and purification. For the ABgp42 depolymerase, a set of different optimization 
parameters (E. coli expression strains listed in Table 5.2), inducer concentration 
(from 0.5 to 1.5 mM), expression time (from 4 to 18 h) and temperatures (from 
16°C to 37°C) were conducted, however without being able to express the 
protein. 
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5.2.4 Biochemical characterization 
5.2.4.1 Fluorescence measurements 
Intrinsic ﬂuorescence emission spectra of the ABgp46 endolysin were recorded 
over the 300-400 nm range with a Jasco FP-750 spectroﬂuorimeter equipped with 
a Peltier thermostat. An excitation wavelength of 295 nm was used to minimize 
the mission arising from tyrosine residues. Two µM of protein was used in a 
universal buffer with pH adjusted from 4.0 to 8.0 and thermal denaturation on 
monitor heating the sample from 20 to 70°C. The variation of the tertiary 
structure was analyzed based on parameter a defined as: (IF325/IF360) protein, IF is 
intensity of ﬂuorescence. These experiments were carried out at the ICRM, the 
Istituto di chimica del riconoscimento molecolare, in Italy. 
 
5.2.4.2 Circular dicrhoism 
Endolysin circular dichroism (CD) spectra were recorded in the Far-UV region 
(195-260 nm) with a Jasco 600. Thermal denaturation was recorded with 5°C 
increment steps from 20 to 75°C, using a universal buffer (pH 4.0-8.0). All CD 
signals were baseline corrected and smoothed with the Spectra Analysis JASCO 
software. In all cases, a concentration of 8 µM (0.18 mg/mL) was used in an 
optical path of 0.1 cm. These experiments were carried out at the ICRM, the 
Istituto di chimica del riconoscimento molecolare, in Italy. 
 
5.2.5 Antibacterial assays 
5.2.5.1 In vitro assays on planktonic cells 
In vitro assays on planktonic cells were performed as described in chapter 4 with 
some minor modifications. Mid-exponential phase cells (OD600nm of 0.6), 
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resuspended and 100-fold diluted in 10 mM HEPES/NaOH (pH 7.2), were 
prepared. Each culture (50 μL) was incubated for 2 h at room temperature with 25 
μL of ABgp46 endolysin (final concentration of 2 μM) together with 25 μL of water 
or 25 μL or OMPs (EDTA, citric, malic, lactic, benzoic and acetic acid) dissolved in 
water. The final concentrations used were optimized during this work (see 
concentrations in Table 5.5). As a negative control, 50 μL of cells were incubated 
with 25 μL of PBS (pH 7.2) (instead of ABgp46) or with 25 μL water (instead or 
OMPs). Cell counting and antibacterial activity quantification was done as 
previously described. Averages ± standard deviations are given for n = 4 repeats. 
 
5.2.5.2 In vitro assays on biofilm cells 
Overnight bacterial cells were normalized (OD adjusted to 1.0 in LB medium) after 
which 2 μL of the cell suspension was transferred to 96-well polystyrene plates 
(Orange Scientific) containing 198 μL of LB. To establish mature biofilms the plate 
was incubated for 24 h at 37°C and 120 rpms. Afterwards, the culture medium 
was removed and non-adherent cells were also removed by washing the biofilms 
twice with 200 µL of 10 mM HEPES/NaOH (pH 7.2). Cells were then incubated for 
2 h with 100 µL of HEPES together with 50 µL of ABgp46 endolysin (2 µM final 
concentration) and 50 µL of the best OMP agent selected (EDTA, citric and malic 
acid). Optimized final concentrations used were: 0.5 mM, 3.55 mM and 4.55 mM, 
respectively. As negative controls, cells were incubated with water (instead of 
OMPs) or incubated with PBS (instead of endolysin). After incubation CFUs were 
counted in LB agar plates. Again, the antibacterial activity was quantified as the 
relative inactivation in logarithmic units, as described previously. Averages ± 
standard deviations are given for n = 4 repeats. 
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5.3 Results 
5.3.1 In silico analysis  
The A. baumannii phage vb_AbaP_CEB1 was previously isolated and sequenced 
(unpublished data). ORF 46 (referred to as ABgp46), encoding a 185-amino acid 
protein with a deduced molecular mass of 23.1 kDa, is predicted to act as a 
peptidoglycan hydrolase. HHpred output shows that ABgp46 belongs to the GH19 
of the glycosidase family, a class of enzymes that cleaves the O-glycosidic bond of 
the bacterial PG. In silico analysis through BlastP showed close resemblance to 
five other endolysins from Acinetobacter phages (phiAB2, phiAB3, ABP-01 and 
ABP-04),  with high homology (95%) (Supplementary Figure S5.1). ORF 42 
encodes the tail-fiber gene and a depolymerase that is part of this gene (referred 
to as ABgp42). Through HHpred, the depolymerase domain is predicted to consist 
of 208 amino acids, resulting in a molecular mass of 22.6 KDa, (Supplementary 
Figure S5.2) and resembles a pectate lyase 3 (PF12708) from the Pec lyase clan 
(CLO268). BlastP analysis did not identify other close related phage proteins. 
 
5.3.2 Recombinant expression and purification 
Recombinant expression of ABgp46 endolysin in E. coli BL21(DE3) yielded a 
soluble protein of 20.5 mg/L. The ABgp42 depolymerase encoding domain was 
expressed under several conditions. However, despite numerous attempts to 
express the protein in several E. coli expression strains (derived from both BL21 
and K12 strains) and different induction temperatures (from 37 to 16°C), times (4 
to 16 h) and concentrations (1.5 to 0.5 mM IPTG), no protein was expressed. 
Therefore, the following sections only describe the biochemical characterization 
and in vitro antibacterial assays of the endolysin protein. 
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5.3.3 Biochemical characterization  
An analysis of the ABgp46 secondary and tertiary structure was performed under 
different pH values, using CD and protein intrinsic fluorescence, respectively. This 
exploratory characterization was used to understand the prospect of a hurdle 
approach using ABgpL46 and OMPs, especially at low pH. Finding a stable 
endolysin under these conditions would enable possible combinations with 
organic acids, as an antibacterial formula for clinical or food application against G- 
bacterial pathogens. 
 
5.3.3.1 Circular dicrhoism analysis  
With CD measurements, the ABgp46 secondary structure was monitored. The CD 
spectra of ABgp46 was analyzed as a function of pH with a universal buffer with a 
pH adjusted from 4.0 to 8.0 (Figure 5.1). 
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Figure 5.1. Far-UV Circular dichroism spectra of ABgp46 under different pH values (4.0-8.0). 
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The signal minima around 208 and at 220 nm that prevail in the far-UV CD 
spectra, is indicative of α-helices in this protein. Unfortunately, due to signal noise 
generated in far-UV, CD spectra could only be recorded from 260 to 200 nm and, 
subsequently, it was not possible to estimate the content of the α-helice, β-sheet, 
turns and unordered structures and compare these results with the data obtained 
for the Lys68 endolysin. Ellipticity overlapping signatures indicate an unchanged 
protein secondary structure. To determine more in depth the enzyme’s 
conformational stability, a thermal treatment was employed by increasing 
temperature (5°C steps between 20 to 70°C) of the protein solution at different 
pH values. Secondary structure changes were analyzed by monitoring CD intensity 
at 222 nm where α-helix structures show a negative peak and the melting 
temperatures (Tm) at which the enzyme underwent a secondary structure are 
shown in Table 5.3.  
 
Table 5.3. Apparent melting temperatures (Tm) of ABgp46 as a function of pH (4.0-8.0) and 
temperature monitored by Circular dichroism intensity at 222 nm. Possible renaturation cycles 
were not monitored due to protein aggregation above Tm. 
pH 
Tm 
(Denaturation cycle) 
Tm 
Observations 
4 40-45°C Not aggregated 
5 45-50°C Aggregated 
6 45-50°C Aggregated 
7 45-50°C Aggregated 
8 45-50°C Aggregated 
 
No differences were observed in the pH range 5.0-8.0, where all Tm were recorded 
as being between 45-50°C. Unfortunately, it was not possible to determine the 
precise value of Tm because the spectropolarimeter employed was not equipped 
with a thermostat that allows a variation of the temperature with a constant rate. 
At temperatures above Tm secondary structure changes caused protein 
aggregation. At pH 4.0, a clear shift of Tm, between 40-45°C, was observed 
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indicating a less favourable condition to maintain the secondary structure 
integrity. Interestingly, this was the only pH where protein aggregation did not 
occur. 
 
5.3.3.2  Fluorescence measurements 
Similarly to CD, the ﬂuorescence spectra of ABgp46 were obtained at different pH 
values and temperatures in order to analyse changes in tertiary structure. Taking 
advantage of the two Tryptophans (Trp-95 and Trp-135) present in the sequence, 
an excitation wavelength of 295 nm was used, minimizing the contribution of 
tyrosine ﬂuorescence. As an indication of significant tertiary structure changes, 
Trp ﬂuorescence shifts were analyzed using the Parameter A defined as the 
IF325/IF360 ratio (where IF equals to the intensity of ﬂuorescence) (Figure 5.2).  
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Figure 5.2. Correlation between ﬂuorescence spectra and conformational changes deduced by 
plotting Parameter A as a function of temperature. 
 
Increasing the temperature from 20 to 70°C, parameter A showed an analogous 
trend for all pH values, where a sudden signal shift was identified between 40 to 
50°C. Such spectral variations are typically observed when the medium that 
Acinetobacter phage endolysin
 
109  
surrounds the fluorophore differs in polarity and/or as a consequence of 
conformational changes. Based on CD and parameter A data, it is likely that 
secondary and tertiary structure changes are happening when the protein is 
heated from 40°C to higher temperatures, resulting in an unfolded and denatured 
protein. 
 
5.3.4 In vitro antibacterial activity 
5.3.4.1 ABgp46 against planktonic cells 
The in vitro antibacterial activity of the recombinant Abgp46 was investigated on a 
wide set of G- strains (Table 5.4).  
Table 5.4. Antibacterial activity of ABgp46 against several Gram-negative bacterial pathogens. 
Marked in bold are significant log reduction units observed (≥ 1 log). 
Bacterial Species ABgp46/Water Patterns of antibiotic resistance*  
Pseudomonas aeruginosa PAOI 0.03 ± 0.02 NA 
Salmonella Typhimurium LT2 0.14 ± 0.05 NA 
E. coli O157:H7 CECT 4782 0.17 ± 0.12 NA 
Cronobacter sakazakii CECT 858 0.23 ± 0.26 NA 
Klebsiella oxytoca ATCC 13182 0.18 ± 0.13 NA 
Acinetobacter baumannii 1 1.77 ± 0.06 Resistant to 13 out of 18 tested antibiotics 
Acinetobacter baumannii 2 0.93 ± 0.25 NA 
Acinetobacter baumannii 3 0.43 ± 0.61 Resistant to 14 out of 18 tested antibiotics 
Acinetobacter baumannii 4 1.00 ± 0.32 NA 
Acinetobacter baumannii 5 0.81 ± 0.21 NA 
Acinetobacter baumannii 6 0.51 ± 0.68 NA 
Acinetobacter baumannii 7 0.18 ± 0.11 Resistant to 14 out of 18 tested antibiotics 
Acinetobacter baumannii 8 0.37 ± 0.39 Resistant to 11 out of 18 tested antibiotics 
Acinetobacter baumannii 10 1.20 ± 0.46 Resistant to 11 out of 18 tested antibiotics 
 
*Patterns of antibiotic resistance was provided by Hospital de Braga and were based on susceptibility tests 
performed according to the NCCLS for antibiotic resistance; NA - not available 
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The activity of 2 μM Abgp46 alone on tested cells was insignificant as expected, 
with the exception of A. baumannii strains. Interestingly, some Acinetobacter 
strains were sensitive to the endolysin, causing a log reduction units of viable 
cells, from 0.18±0.11 (lowest effect) to 1.77±0.06 (highest effect), including strains 
resistant to several antibiotics. 
 
5.3.4.2 ABgp46/OMP formula against planktonic cells 
To broaden and enhance the antimicrobial effect of the Abgp46 to other G- 
pathogens, the previous unsensitized E. coli O157:H7 CECT 4782 was chosen as a 
model strain, to test and optimize an ABgp46/OMP formula. In addition to the 
previously characterized OMPs citric and malic acid, other organic agents were 
used (lactic, benzoic and acetic acid) to sensitize the G- OM to the endolysin. Each 
OMP was used in different concentrations (to achieve three distinct reaction pH 
values of 7.0, 5.5 and pH 4.0) and combined with ABgp46 to assess the best 
antibacterial condition after 2 h incubation (illustrated in Table 5.5). At pH 7.0, 
only the ABgp46/citric acid was able to reduce E. coli cells (0.86±0.38 logs). At pH 
5.5, the effect was broadened to ABgp46/citric acid, ABgp46/malic acid and 
ABgp46/lactic acid mixtures reducing approx. 1 log of E. coli cells. Consistently, the 
effect was more pronounced at pH of 4.0. The combinatorial effects of 
ABgp46/citric acid, ABgp46/malic acid and ABgp46/lactic acid mixtures resulted in 
2.98±0.77, 2.18±0.82 and 0.98±0.58 log reductions. In this condition, the 
antibacterial effect was also extended to ABgp46/benzoic acid inactivating 
approx. 1 log of E. coli cells. The ABgp46/acetic acid combination only had a 
moderate effect (0.42±0.29). 
Taken into account the most efficient conditions tested, ABgp46/OMPs mixtures 
(OMPs concentrations used to achieve a pH of 4.0) were tested in the presence of 
5mM MgCl2. MgCl2 provides an extra source of available divalent cations (Mg
2+) 
that can link to the LPS negatively charged phosphate groups, strengthening the 
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LPS monolayer. Therefore, as expected, the addition of 5 mM of MgCl2 abolished 
the activity of all ABgp46/OMP combinations. 
 
Table 5.5. Combinatorial antibacterial activity of ABgp46 with outer membrane permeabilizers 
under different concentrations against E. coli O157:H7. For a specific pH, different concentrations 
(given in mM) of EDTA, citric, malic, lactic, benzoic and acetic acid are used in combination with 2 
µM of ABgp46 to reduce E. coli O157:H7 cells in presence or absence of 5 mM of MgCl2. Marked in 
bold are significant log reduction units observed (≥ 1 log). 
 
pH OMPs Molarity (mM) PBS/OMPs ABgp46/OMPs ABgp46/OMPs 
                                                                                                                                              + 5mM MgCl2 
7.0 ± 0.1 EDTA 
Citric 
Malic 
Lactic 
Benzoic 
Acetic 
0.50 
0.36 
0.60 
1.20 
1.20 
1.20 
0.27 ± 0.11  
0.21 ± 0.14 
0.24 ± 0.11 
0.24 ± 0.14 
0.26 ± 0.15  
0.25 ± 0.14 
0.32 ± 0.15 
0.86 ± 0.38 
0.53 ± 0.28 
0.55 ± 0.31 
0.49 ± 0.34 
0.53 ± 0.30 
- 
      
5.5 ± 0.1 Citric 
Malic 
Lactic 
Benzoic 
Acetic 
1.50 
3.30 
3.45 
3.55 
4.35 
0.20 ± 0.13 
0.17 ± 0.14 
0.31 ± 0.07 
0.27 ± 0.13 
0.26 ± 0.12 
1.55 ± 0.45 
1.13 ± 0.39 
0.95 ± 0.14 
0.44 ± 0.33 
0.21 ± 0.22 
- 
      
4.0 ± 0.1 Citric 
Malic 
Lactic 
Benzoic 
Acetic 
3.65 
4.55 
8.00 
10.00 
20.00 
0.28 ± 0.06 
0.24 ± 0.18 
0.27 ± 0.18 
0.57 ± 0.58 
0.22 ± 0.08 
2.98 ± 0.77 
2.18 ± 0.82 
0.98 ± 0.58 
1.08 ± 0.57 
0.42 ± 0.29 
0.15 ± 0.04 
0.10 ± 0.03 
0.15 ± 0.04 
0.02 ± 0.03 
0.11 ± 0.10 
 
After optimizing, citric acid (at 3.65 mM) and malic acid (at 4.55 mM) were 
selected as the best OMPs to be combined with ABgp46. Therefore, their 
synergistic effect was further tested on the remaining unsensitized G- strains 
tested earlier and compared with the gold standard EDTA (at 0.5 mM) (Table 5.6).  
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Table 5.6. Combinatorial antibacterial activity of the best ABgp46/outer membrane 
permeabilizers (EDTA, citric and malic acid) formula against broad range of planktonic Gram-
negative pathogens. Marked in bold are significant log reduction units observed (≥ 1 log). 
*
the 
detection level of 10 CFU/mL has been reached. 
                Bacterial Species ABgp46/EDTA ABgp46/Citric ABgp46/Malic 
Acinetobacter baumannii 2 >5.50
*
 >5.50
*
 >5.50
*
 
Pseudomonas aeruginosa PAOI >5.50
*
 >5.50
*
 >5.50
*
 
Salmonella Typhimurium LT2 0.57 ± 0.20 4.94 ± 0.39 4.27 ± 0.69 
Cronobacter sakazakii CECT 858 1.21 ± 0.38 2.10 ± 0.59 0.98 ± 0.53 
Klebsiella oxytoca ATCC 13182 0.26 ± 0.48 0.96 ± 0.35  0.81 ± 0.12  
 
No surviving P. aeruginosa and A. baumannii cells could be detected after 
coincubation with the ABgp46 in the presence of all OMPs. In addition, S. 
Typhimurium (up to 4.94±0.38 log) was almost completely eradicated when citric 
or malic acid was used. Lower, but still significant reductions, ranging from 1 to 3 
logs, were observed against Cronobacter sakazakii. In case of Klebsiella oxytoca, 
only the ABgp46/citric acid and ABgp46/malic acid combinations showed a 
bactericidal effect with log reductions of 0.96±0.35 and 0.81±0.12 viable cells, 
respectively. Overall, a powerful antibacterial effect was observed when ABgp46 
is combined with selected OMPs, and its effect was found to be even more 
pronounced in the presence of citric or malic acid than when the chelating agent 
EDTA was used.  
 
5.3.4.3 ABgp46/OMP formula against biofilms 
Given the high synergetic antibacterial effect observed with the ABgp46/OMP 
optimized formula, experiments were conducted to test its efficiency against 
biofilms (Table 5.5). Diffusion limitations are known to arise readily in biofilm 
systems because fluid flow is reduced. Additionally, several types of bacterial 
physiological state are found in the biofilms. Both diffusion limitations and 
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different physiological states are well-known aspects that reduce the 
effectiveness of antimicrobials against biofilms. To anticipate these circumstances 
and improve the antimicrobial efficiency, a depolymerase, encoded by the same 
Acinetobacter phage vb_AbaP_CEB1, was intended to be used. As no protein was 
expressed, as was mentioned before, biofilms antibacterial studies were 
conducted by incubating ABgp46/OMP mixtures against A. baumannii 2 and P. 
aeruginosa PAOI biofilms for 2 hours (Table 5.7). 
 
Table 5.7. Combinatorial antibacterial activity of the best outer membrane permeabilizers in 
absence (A) and presence (B) of ABgp46 against A. baumannii 2 and P. aeruginosa PAOI biofilms.  
   A                                 Bacterial Species PBS/EDTA PBS/Citric PBS/Malic 
Acinetobacter baumannii 2 0.05 ± 0.01 0.08 ± 0.11 0.24 ± 0.19 
Pseudomonas aeruginosa PAOI 0.14 ± 0.01 0.20 ± 0.10 0.21 ± 0.13 
 
  B                                Bacterial Species ABgp46/EDTA ABgp46/Citric ABgp46/Malic 
Acinetobacter baumannii 2 0.48 ± 0.28 0.20 ± 0.11 0.19 ± 0.05 
Pseudomonas aeruginosa PAOI 0.32 ± 0.26 0.10 ± 0.14 0.54 ± 0.06 
 
The results demonstrate an absence of killing effect when OMPs were added 
alone to both bacteria. When ABgp46 was combined with OMPs, a slight 
improvement was observed, although still with an insignificant effect. No major 
differences were observed when ABgp46 was combined with citric or malic acid 
that on average, were only able to reduce 0.3 to 0.5 log of both A. baumannii and 
P. aeruginosa cells. 
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5.4 Discussion 
G- bacterial infections have always been a threat to human health. In particular, 
infections caused by antibiotic resistant bacteria are problematic and their 
incidence is constantly reported worldwide. Phage-encoded endolysins represent 
one promising avenue of investigation to fight all these pathogens. After cloning 
the ABgp46 endolysin, this protein was easily overexpressed in the E. coli 
BL21(DE3) strain. For the heterologous production of the anti-biofilm-degrading 
depolymerase, production efforts remained unsuccessful in several E. coli 
expression strains. As no obvious solubility issues, hydrophobic regions or low E. 
coli codon usage were detected, other expression systems rather than E. coli 
should be considered in the future. 
A biochemical characterization of ABgp46 was carried out in order to evaluate its 
potential applications with organic acids to overcome the most obvious limitation 
- the presence of a bacterial OM diffusion barrier. CD and fluorescent analysis 
showed that pH changes from 4.0 to 8.0 do not have much influence on the 
structure of ABgp46. As for the absence of aggregation only observed at pH 4.0, it 
is possible that positively charged amino acids are repulsing protein interactions 
avoiding aggregation.  
Regarding the potential use of ABgp46 as an antimicrobial compound, the enzyme 
was first tested without the help of any permeabilizer. Interestingly, despite the 
present of the OM protecting the PG layer, externally added ABgp46 was active 
against several Acinetobacter strains, including antibiotic-resistant phenotypes, 
suggesting that the protein can intrinsically destabilize its OM. This is a rare event 
reported for endolysins. The T4 lysozyme (from the T4 phage), was the first 
endolysin described to naturally kill G- cells. It was proved that its C-terminal 
positively charged amphipathic α-helix (named α-4) is responsible to cause OM 
disruption, having a stronger bactericidal effect than the enzymatic PG hydrolysis 
(During et al, 1999). Later, endolysins Lys1521 (from a B. amyloliquefaciens phage) 
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and LysAB2 (from A. baumanni phage) were also reported to spontaneously 
inactivate G- cells. In these cases, it is assumed that their C-terminal side, rich in 
positively charged amino acids surrounded with hydrophobic residues, interact 
with the bacterial LPS. However, in opposite synthetic α-4 of the T4 lysozyme 
bactericidal effect observed, studies conducted showed that Lys1521 and LysAB2 
C-terminal region does not have an antibacterial effect themselves, but rather 
mediate the N-terminal enzymatic domain to enter the cells, allowing them to 
digest the PG and cause bacteriolysis (Morita et al, 2001; Lai et al, 2011). More 
recently, the endolysin OBPgp279 (from A. baumanni and P. fluorescens phages, 
respectively), was shown to lyse Pseudomonas cells (Walmagh et al, 2012), 
although no predicted mechanism was identified. In all cases, it seems that when 
endolysins are able to spontaneously kill G- bacteria (without any OMP), they only 
have a moderate effect, reducing an approximately 1 log of viable cells. This effect 
was also observed for ABgp46, able to reduce on average 1 log of Acinetobacter 
strains. Because this enzyme has 96% identity to the previously characterized 
LysAB2 (see the Supplemental Figure S5.1), the same C-terminal amphipathic 
region (amino acid sequence between 112 and 145) identified can explain its 
spontaneous activity against Acinetobacter cells. 
To improve the antibacterial activity, ABgp46 was combined with different OMP 
agents and concentrations (citric, malic, lactic, benzoic and acetic acid). 
Consistently, an increasing antibacterial effect was observed using OMPs at higher 
concentrations, reaching a maximum at low pH (4.0). Interestingly, besides CD and 
fluorescence analyses predicting low structural stability at pH 4.0, the endolysin 
muralytic activity is not compromised at the same pH, when combined to the 
organic acids. As for the OM permeabilization mechanism, the relation between 
low pH and an antibacterial effect suggests an acidity promoted killing effect. 
However, different Abgp46/OMP outcomes, under the same condition (at pH 4.0), 
were observed. Several aspects can individually potentiate the OM-destabilizing 
effect: i) pKa of each acid, which will determine the percentage of deprotonated 
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(undissociated) and protonated (dissociated) acid groups available outside de 
cells. Only the undissociated forms are able to migrate inside the cells. 
Intracellularly, acids dissociate (intracellular pH (≈7.2) is more alkaline than the 
extracellular pH) and high anion and proton concentrations will 
compromise/inhibit several cellular reactions, among which, the OM 
stabilization/maintenance; ii) the level of hydrophobicity of the undissociated 
groups, that will also influence their translocation through LPS hydrophobic 
interactions to become toxic; iii) the different accumulation of the anions groups 
that will inhibit specific types of cellular reactions, compromising the cells in a 
different extent (Roe et al, 1998; Alakomi et al, 2000; Breidt et al, 2004). Because 
the following bactericidal decreasing effect was observed: citric acid (pKa 3.13) > 
malic acid (pKa 3.4) > lactic acid (pKa 3.86) ≈ benzoic acid (pKa 4.19) > acetic acid 
(pKa 4.76) when combined with the endolysin, we speculate that this is a 
reflection of acid dissociation constant (pKa) increase. This is somehow 
unexpected, as increasing the pKa favours undissociated groups that could 
penetrate into the cytoplasmic membrane potentiating cell damage. In opposite, 
acids with low pKa values would produce more hydrogen ions (not able to 
internalize) when exposed to an aqueous environment. Nevertheless, a similar 
trend was observed when organic acids (with lower pKa values) were incubated 
with medium-chain fatty acids (Kim & Rhee, 2013). These authors speculated that 
the medium-chain fatty acid action, suggested to interact with the bacterial cell 
membranes, results in sublethal injuries allowing hydrogen ions to pass into the 
cell and achieve a marked bactericidal effect. Maybe a similar mechanism is 
happening in the presence of ABgp46, explaining why ABgp46/citric acid and 
ABgp46/malic acid are better combinations than when ABgp46 is combined with 
lactic, benzoic or acetic acid. Additionally, the chelating properties only observed 
in citric and malic acid will likely empower the LPS destabilization compared to the 
remaining non-chelating acids. Indeed, the entire antibacterial effect was 
abolished when the ABgp46/OMP formula was applied in presence of 5 mM of 
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MgCl2. Addition of an extra source of the divalent cation Mg
2+ will strengthen the 
electrostatic interactions between neighbouring LPS components, that seem to 
avoid acid entry and sequential sublethal damage, and protects the LPS network 
from the putative chelation effect. 
After narrowing down an initial large list of OMP candidates, EDTA, citric acid and 
malic acid were selected for further testing against a larger group of G- cells. 
ABgp46/EDTA revealed to be only efficient to Pseudomonas and Acinetobacter 
cells, although eradicating the cultures within 2 hours. Compared with EDTA, the 
combinations of citric acid and malic acid with ABgp46 had a more powerful and 
broaden effect, with an antibacterial effect on all tested strains. The same pattern 
was previously observed with Lys68 in chapter 4. As mentioned before, while 
EDTA acts as a chelating agent, sequestering LPS-stabilizing divalent cations, 
organic acids are predicted to destabilize the bacterial OM by an acidic effect, 
probably by lowering the bacterial internal pH and the accumulation of toxic 
substances (sublethal injury) (Alakomi et al, 2000; Theron & Lues, 2011). P. 
aeruginosa is known to have an LPS with a high phosphate content and 
consequently a higher concentration of stabilizing divalent cations, increasing the 
electrostatic interaction that contributes to LPS stability (Nikaido, 2003). Cation-
binding sites are therefore both the strength and the weakness of the P. 
aeruginosa LPS layer. On the other hand, Enterobacteriaceae, such as E. coli and S. 
Typhimurium, are known to have a lower phosphorylation degree in LPS, 
compensated by increased hydrophobic packing of the lipid A moiety (Nikaido, 
2003). Therefore one could speculate that this variation might explain the specific 
EDTA action against Pseudomonas and Acinetobacter cell wall, which seems to be 
more prone to a chelation effect.  
Regarding biofilm control, diffusion limitations represent one of the major hurdles 
to commonly applied antimicrobials. No antibacterial activity could be detected 
against A. baumanni and P. aeruginosa biofilms when ABgp46 was combined with  
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EDTA, citric acid or malic acid. As mentioned before, besides the obvious diffusion 
problems, several types of bacterial physiological states are found in biofilms 
(Mah & O'Toole, 2001). This physiological heterogeneity can contribute to higher 
resistance to the endolysin/OMP mixtures. For instance, if a higher amount of 
stationary cells is found, they will possess different OM composition (LPS and PG 
chemical modifications), compromising the endolysin entry or LPS 
permeabilization through the OMPs (Rolfe et al, 2012). Also the wide range of 
physiological states found in biofilms can favour phenotypes known to activate 
acid tolerance systems (e.g. consuming or removing excess of protons by 
decarboxylation reactions and ion transporters, changing membrane 
composition), protecting themselves from the organic acids OM-destabilization 
(Warnecke & Gill, 2005). Altogether, these results indicate that ABgp46 is an 
effective endolysin against several planktonic G- bacteria, including multiple drug-
resistant bacteria, in presence of weak acids. Achieving better performance 
against biofilms, by completing the formulation with an efficient anti-biofilm 
compound (using polysaccharides-degrading compounds such as a phage-
encoded-depolymerases or synthetic sodium periodate), will turn this technology 
even more appealing as a therapeutic/disinfectant agent to control these 
pathogens. 
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6.1 Introduction  
Endolysins, when externally administered to G- bacterial cells, are hampered in 
their function to degrade the PG due to the presence of a protective OM. The LPS, 
the major component of the OM, is the most important structure that provides 
diffusion limitations for many external agents, like endolysins (Delcour, 2009). 
Apart from the use of OMPs (described elsewhere in this thesis) or high 
hydrostatic pressure treatments (Nakimbugwe et al, 2006; Briers et al, 2008) to 
permeabilize the OM to endolysins, the covalent modification of endolysins with 
LPS-destabilizing peptides could be an alternative approach. As mentioned before, 
ionic and hydrophobic interactions represent the major LPS-stabilizing forces 
(Vaara, 1999; Nikaido, 2003). Consequently, tagging peptides of polycationic, 
hydrophobic or amphipathic nature, known to interfere with these stabilizing 
forces, could assist endolysins to spontaneously penetrate this barrier and 
become active antimicrobials.  
In parallel, using G--like endolysins to attack G+ bacteria has received less 
attention. In theory, endolysins are also able lyse G+ bacteria that share the same 
A1γ PG chemotype as their G- counterparts. L. monocytogenes, an important 
foodborne pathogen, is an example that contains this PG (Schleifer & Kandler, 
1972). Listeria phage endolysins, known for their modular structure, have CBDs 
described to be essential for their muralytic activity and specificity towards 
Listeria PG (Loessner et al, 2002; Schmelcher et al, 2011; Eugster & Loessner, 
2012). It is expected that G--like endolysins will also be active against Listeria cells 
and their activity improved by inserting these specific CBDs.  
This chapter describes an engineered-class of endolysins (PVP-SE1gp146 and 
Lys68) fused to LPS-destabilizing peptides (chimeric PVP-SE1gp146) or to CBDs 
(chimeric Lys68) to fight G- or G+ (L. monocytogenes), respectively. The list of LPS-
destabilizing and CBD peptides used in the work reported herein is listed in Table 
6.1.  
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Table 6.1. List of selected LPS-destabilizing/Cell binding domain fusion peptides. For each 
peptide, their amino acid sequence and literature reference are depicted. LPS-destabilizing 
peptides can either have a polycationic, hydrophobic, amphipathic nature. Cell binding domains 
(CBDs) here described recognize specific Listeria serovars and come from different Listeria phage 
endolysin sequences. 
Peptide Physiochemical property Amino acid sequence Reference 
LPS-destabilizing    
α 4-helix of  
T4 lysozyme 
Amphipathic PNRAKRVITTFRT (Matthews & Remington, 1974) 
Lycotoxin1 Amphipathic IWLTALKFLGKHAAKKLAKQQLSKL (Yan & Adams, 1998) 
Parasin1 Amphipathic KGRGKQGGKVRAKAKTRSS (Park et al, 1998) 
PP Hydrophobic FFVAP (Ibrahim et al, 1994) 
PK* Polycationic KRKKRKKRK Patent WO/2010/149792 
ArtiMW1* Hydrophobic GFFIPAVILPSIAFLIVP Walmagh, unpubllshed 
ArtiMW2* Amphipathic GKPGWLIKVALKFKKLIRRPLKRLA Walmagh, unpubllshed 
    
 
Serogroups that 
recognize 
From endolysin (protein ID) Reference 
Cell binding domain   
CBDP35 
1/2, 3, 4, 5 and 6  
 
YP_001468812.1 (Schmelcher et al, 2010) 
CBDP40 1/2, 3, 4, 5 and 6  YP_002261442.1 (Schmelcher et al, 2010) 
CBD500 4, 5 and 6 YP_001468411.1 (Schmelcher et al, 2010) 
 
*randomly designed peptides at the Artilysins™ company;  
  Abbreviations: PP, pentapeptide; PK, polycationic peptide.  
 
PVP-SE1gp146 is a previously characterized modular Salmonella phage endolysin 
(Walmagh et al, 2012). This domain configuration is rare among G--like endolysins 
and is associated with a high enzymatic activity. Addition of 0.5 mM EDTA turns 
this enzyme active against multi-drug resistant G- bacteria. Due to these features, 
PVP-SE1gp146 is an optimal candidate for covalent modification tests to further 
improve its activity. To construct chimeric PVP-SE1gp146 proteins with enhanced 
activity, several fusion patterns with (putative) LPS-destabilizing peptides were 
chosen based on their: i) peptide length; ii) anti-G- activity and iii) cationic, 
hydrophobic and amphipathic nature. Based on this rational, the cationic peptide 
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(PK) was designed to permeabilize G- OM by competing with/displacement of the 
LPS stabilizing cation-binding sites. The hydrophobic peptides (PP and ArtiMW1) 
are able to increase OM permeabilization by destabilizing the lipid A acyl chain-
phospholipid hydrophobic stacking (Nikaido, 2003). The PP peptide was previously 
fused to HEWL, enhancing its activity towards G- cells (Ibrahim et al, 1994). Finally, 
anti-G- active peptides (Lycotoxin1, Parasin1 and α4) and the newly designed 
ArtiMW2, are small, linear amphipathic peptides that tend to promote the 
formation of membrane pores. Lyxotoxin1 is a strong haemolytic, membrane pore 
forming peptide, isolated from the venom of the Wolf Spider Lycosa carolinensis 
(Yan & Adams, 1998). Parasin1 is a peptide with a wide antimicrobial spectrum 
and low haemolytic activity, isolated from a catfish Parasilurus asotu (Park et al, 
1998). The α4-helix of T4 lysozyme has a strong membrane disruption mechanism 
that seems to be more active than the PG degradation bactericidal effect of the T4 
lysozyme (During et al, 1999).  
For chimeric Lys68 proteins, CBDs belonging to listerial phage full-length 
endolysins (PlyP35, PlyP40 and Ply500) were selected as fusion patterns (Table 
6.1) to direct and increase endolysin activity towards Listeria cells. These CBD are 
known to confer species- and serovar-specificity to their corresponding 
endolysins. While CBDP35 and CBDP40 are able to recognize a larger group of 
Listeria cells, the CBD500 only confers ligands recognition of serovars belonging to 
groups 4, 5 and 6 (Schmelcher et al, 2010). As mentioned before the presence of a 
CBD can lower, maintain or increase the full-length endolysin activity and this 
effect is protein-dependent (Oliveira et al, 2012). Therefore, besides conferring 
specificity towards Listeria, it was intended to evaluate if the presence of an extra 
CBD would increase the Lys68 muralytic activity (i.e. achieve a steeper slope of a 
resulting lysis curve that measures optical density in function of time - translated 
in a higher killing capacity), as observed with modular G--like endolysins (Walmagh 
et al, 2012).  
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6.2 Materials and methods 
6.2.1 Bacterial strains, bacteriophage and chemicals 
All bacterial strains used in the work described in this chapter are listed in Table 
6.2. With no exceptions, all strains were grown in LB (Liofilchem) at 37°C and 120 
rpm. E. coli cloning and expression strains (Invitrogen, Stratagene or Novagen) are 
listed in Table 6.3. BL21-CodonPlus-(DE3)-RIL and XL1-Blue MRF' were both grown 
in 30 µg/mL chloramphenicol. Salmonella phage phi68 (encoding the Lys68 
endolysin) and the Salmonella phage PVP-SE1 (encoding the PVP-SE1gp146 
endolysin) were isolated from waste effluents and belong to the CEB phage 
collection. EDTA was acquired from Pronalab while IPTG and HEPES were 
purchased from Sigma-Aldrich.  
 
Table 6.2. Overview of bacterial pathogens strains, references and sources used in chapter 6. 
Bacterial strain Reference(s) Sources  
Salmonella Typhimurium ATCC 19585 (further designated as LT2) NA 
Pseudomonas aeruginosa ATCC 15692 (further designated as PAO1) Infected burn/wounds 
Escherichia coli XL1-Blue MRF’ Agilent commercial stain  
Listeria inocua CECT 4030 NA 
Listeria ivanovii CECT 5375 Goat 
Listeria seeligeri CECT 5339 Animal faeces 
Listeria welshimeri CECT 5371 NA 
 
Listeria monocytogenes CECT 5725 / CECT 5873 / CECT 938 /  
CECT 911 / CECT 933 / CECT 934 /  
CECT 937 7 CECT 936 / CECT 4031 /  
923* / 994* 
Chicken; 4c / NA / NA / Spinal 
fluid of man with cerebrospinal 
meningitis / Human / Brain of 
sheep with circling disease / 15 
day old child / NA / Rabbit / 
Canning / Goat Milk 
 
NA - Not available; * strains belonging to the CEB bacterial collection 
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Table 6.3. Genotypes of E. coli cloning and expression strains used in chapter 6. 
Bacterial strains Genotype 
TOP10 
F
-
 mcrA Δ(mcrCB-hsdSMR-mrr) Ф80lacZΔM15 ΔlacX74 recA1 araD139 Δ(ara-
leu)7697 galU galK rpsL(Str
r
) endA1 λ
-
 
JM109 
endA1 glnV44 thi-1 relA1 gyrA96 recA1 mcrB
+
 Δ(lac-proAB) e14- [F' traD36 
proAB
+
 lacI
q
 lacZΔM15] hsdR17(rK
-
mK
+
) 
BL21(DE3) F
–
 ompT hsdSB(rB
–
  mB
–
) gal dcm (DE3) 
BL21-CodonPlus-(DE3)-RIL F
-
 ompT hsdS(rB
-
mB
-
) dcm + Tet
r
 gal λ(DE3) endA Hte (argU ileY leuW Cam
r
) 
XL1-Blue MRF' 
Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173 endA1 supE44 thi-1 recA1 gyrA96 
relA1 lac [F′ proAB lacI
q
ZΔM15 Tn10 (Tet
r
)] 
 
E. coli Top10 and JM109 were used for cloning purposes. All strains, except E. coli 
TOP10, were used for recombinant protein expression. E. coli strains were 
transformed as described in chapter 4. 
 
Table 6.4. Overview of cloning and expression vectors used in chapter 6. Vector name, resistance 
marker and function are given. Amp
r
=ampicillin-resistant; kan
r
=kanamycin resistant 
Vector 
Resistance  
marker 
Function 
pEXP5CT/Topo® Amp
r
 
Cloning and recombinant expression of PVP-SE1gp146 wt and PVP-SE1gp146 
variants 
pET28a Kan
r
 Recombinant expression of Lys68 
pQE-30 Amp
r
 Cloning and recombinant expression of Lys68 variants 
 
6.2.2 Cloning, recombinant protein expression and purification 
A summary of all constructs, expression and purification methodology is given in 
Table 6.5. All primers used were purchased from Invitrogen. The vectors pET28a 
and pEXP5CT/Topo® were purchased from Novagen and Invitrogen, respectively. 
E. coli strains harbouring pET28a (50 µg/mL kanamycin) or pEXP5CT/Topo® (100 
µg/mL ampicillin) were grown in the presence of the indicated antibiotic 
concentrations.  
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6.2.2.1 Cloning methodology 
Cloning procedures for Lys68 wt are described in chapter 4. Lys68 variants were 
cloned in pQE-30 vector using similar standard PCR cloning procedure. DNA 
templates, specific primers, restriction enzymes, and the CBD containing vectors 
(pQE-30-P35, pQE-30-P40 and pQE-30-500) are listed in Table 6.5. 
N-terminal peptide tags (α4 and PP) were fused to PVP-SE1gp146 using a TA 
cloning technique (thymine(T)/adenine(A) complementary base pairs cloning 
technique that avoids the use of restriction enzymes). A tail PCR was first carried 
out using phage PVP-SE1 genomic purified DNA, a Pfu polymerase (1.25 U, 
Thermo Fisher Scientific) and two primers, of which the forward primer is 
harbouring the peptide-coding sequence (α4 and PP). After a PCR reaction and 
product confirmation by agarose gel electroforesis, a second independent 
extension (15 min at 72°C) was done by adding to the mixture 1 µL of Dream Taq 
polymerase (5 U) (Thermo Fisher Scientific), compatible with the previous buffer 
reaction used. This Taq polymerase has a non-template-dependent terminal 
transferase activity and will add a single deoxyadenosine (A) to the 3′ ends of the 
PCR. After this, the insert is cloned into the commercial pEXP5CT-TOPO® 
expression vector (Life Technologies) following manufacturer’s procedures. This 
vector is provided linearized with single 3′-thymidine (T) overhangs for TA cloning 
and a Topoisomerase I covalently bound to the vector. Briefly, the amplified and 
extended PCR product is added to the commercial vector and allowed to incubate 
for 5 min at room temperature. To finalize the process competent E. coli cells 
were transformed with the ligation mixture.  
 
Table 6.5. Overview of all expression constructs used in chapter 6. Plasmid names, cloning 
primers and amplification methodology used (“standard PCR”, T/A cloning or Ligation independent 
cloning), as well as expression and purification conditions optimized for each construct 
(temperature, inducer concentration, induction time, expression strain and purification stringency) 
are depicted. For standard PCR cloning, restriction digestion sites are underlined in the primers.
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Abbreviations: α4, PP, Lycotoxin1, Parasin1 are antibacterial peptides; PK, ArtMW1 and ArtMW2 are rationally design peptides; P35, P40 and P500, are different Listeria phage modular endolysins. Empty spaces detonate tasks not made. 
1 Plasmids containing PVP-SE1gp146 and pEXP5CT/Ecl136II-PVP-SE1gp146 were provided by the Laboratory of Gene Technology from the katholieke universiteit of Leuven 
2 PQ-30 containing three different Listeria phage endolysins were kindly provided by the ETH Zurich, Institute of Food, Nutrition and Health  
CONSTRUCT NAME PRIMER SEQUENCES (5’ → 3’) 
CLONING METHODOLOGY 
(TEMPLATE AND VECTOR) 
EXPRESSION 
CONDITIONS 
PURIFICATION 
STRINGENCY 
PVP-SE1gp146 PREPARATION CONSTRUCT PROVIDED 1 - - - 
Ecl136II-PVP-SE1gp146 PREPARATION CONSTRUCT PROVIDED 1 - - - 
α4-PVP-SE1gp146 
TTGGAATGGGGAGCCCGAACCGTGCAAAACGTGTAATCA  
CATTGGAGGAGCCGGTACGGAAGGTGGTGATTACACGTT 
Phage PVP-SE1 genomic DNA 
T/A cloning in pEXP5CT 
16°C-18h  
BL21(DE3)-RIL 
60 mM 
Imidazole 
PP-PVP-SE1gp146 
ATGGGATCCTTCTTCGTAGCACCGGGCTCCTCCAATGCTGCAAT 
CGAGGTTAGAACAGATTTTGCCT 
Phage PVP-SE1 genomic DNA 
T/A cloning in pEXP5CT 
16°C-18h  
BL21(DE3)-RIL 
70 mM 
Imidazole 
Lycotoxin1-PVP-
SE1gp146 
GGAATGGGGAGCATCTGGCTGACCGCACTGAAATTCCTCGGCAAACACGCCGCAA 
CATTGGAGGAGCCCAGTTTGGATAATTGCTGTTTTGCCAGTTTCTTTGCGGCGTGTT 
pEXP5CT/Ecl136II-PVP-SE1gp146 template 
Ligation independent cloning 
16°C-18h  
BL21(DE3)-RIL 
60 mM 
Imidazole 
Parasin1-PVP-SE1gp146 
TTGGAATGGGGAGCAAAGGCCGTGGCAAGCAGGGAGGCAAAGTACGTG 
CATTGGAGGAGCCTGAGGAACGGGTCTTTGCTTTTGCACGTACTTTGC 
pEXP5CT/Ecl136II-PVP-SE1gp146 template 
Ligation independent cloning 
16°C-18h  
BL21(DE3)-RIL 
60 mM 
Imidazole 
ArtMW1-PVP-SE1gp146 
TTATGGGCTTCTTCATCCCGGCAGTAATCCTGCCCTCCA 
CATTGGAGGAGCCCGGTACGATCAGGAATGCGATGGAGGGCAGGATT 
pEXP5CT/Ecl136II-PVP-SE1gp146 template 
Ligation independent cloning 
16°C-18h  
BL21(DE3)-RIL 
65 mM 
Imidazole 
ArtMW2-PVP-SE1gp146 
TTATGGGCAAACCGGGCTGGCTGATCAAAGTAGCACTGAAGTTCAAGA 
CATTGGAGGAGCCTGCCAGTCTCTTCAGCGGACGACGGATCAGTTTCTTGAACTTCAG 
pEXP5CT/Ecl136II-PVP-SE1gp146 template 
Ligation independent cloning  
16°C-18h  
BL21(DE3)-RIL 
70 mM 
Imidazole 
Lys68 
AGATATCATATGTCAAACCGAAACATTAGC 
GTGGTGCTCGAGCTACTTAG 
phi68 genomic DNA 
Standard PCR, pET28a NdeI/XhoI 
16°C-18h 
BL21(DE3) 
85 mM 
Imidazole 
pQE-30-P35 PREPARATION CONSTRUCT PROVIDED IN JM109 2 - - - 
pQE-30-P40  PREPARATION CONSTRUCT PROVIDED IN XL1-Blue MRF’ 2 - - - 
pQE-30-500  PREPARATION CONSTRUCT PROVIDED IN JM109 - - - 
Lys68-CBDP35 
GGGGGGGATCCATGTCAAACCGAAACATTAGC 
GGGGGGAGCTCGGAGGAGCCGGAGGTACCCTTAGCGCCACGGC 
pQE-30-P35 template  
Standard PCR, pQE-30 BamHI/SacI 
16°C-18h 
JM109 
25 mM 
Imidazole 
Lys68-CBDP40 
GGGGGGGATCCATGTCAAACCGAAACATTAGC 
GGGGGGAGCTCGGAGGAGCCGGAGGTACCCTTAGCGCCACGGC 
pQE-30-P40 template 
Standard PCR, pQE-30 BamHI/SacI 
16°C-18h 
JM109 
25 mM 
Imidazole 
Lys68-CBD500 
GGGGGGGATCCATGTCAAACCGAAACATTAGC 
GGGGGGAGCTCGGAGGAGCCGGAGGTACCCTTAGCGCCACGGC 
pQE-30-500 template 
Standard PCR, pQE-30 BamHI/SacI 
16°C-18h 
JM109 
25 mM 
Imidazole 
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For the remaining constructs, N-terminal peptide tags (ArtMW1, ArtMW2, 
Lycotoxin1 and Parasin1) were fused to PVP-SE1gp146 endolysin by an adapted 
version of the Ligation Independent Cloning (LIC) technique (Haun et al, 1992), 
using pEXP5CT/Ecl136II-PVP-SE1gp146 as a template (having a C-terminal His6). 
First, two complementary peptide-encoding cassettes (20 µM each, Table 6.5) 
were hybridized (heated at 95°C and allowed to gradually cool down to 40°C). In 
parallel, pEXP5CT/Ecl136II-PVP-SE1gp146 (≈200 ng) was linearized by the Ecl136II 
digestion (introduced unique restriction endonuclease site present) for 2 h at 
37°C. Both peptide-encoding cassette and linearized pEXP5CT/Ecl136II-PVP-
SE1gp146 vector were then incubated with a T4 DNA polymerase (Fermentas) 
with a 3’→5’ exonuclease activity, in the presence of a dCTP mixture (Promega). 
The T4 exonuclease activity stops at the first dCTP present in the sequence, 
creating LIC-compatible sticky ends. A short 20 min incubation step at room 
temperature of the LIC-compatible hybridized peptide-encoding cassettes and 
vectors completes the cloning process, without the necessity of a ligase. As 
described before, all constructs were first verified by colony PCR. Afterwards, 
plasmid of positive transformants were extracted and verified by sequencing 
(Macrogen or using Big Dye polymerase, ABI3130 Sequencer, Life Technologies).  
 
6.2.2.2 Protein overexpression and purification 
All expression vectors used contained an N-terminal (pET28a, pQE-30) or C-
terminal (pEXP5CT/Topo®) His6 tag for downstream expression. E. coli expression 
system, expression conditions and the purification stringency for Ni2+-NTA affinity 
chromatography, were individually optimized and are illustrated in Table 6.5. 
Protein recombinant expression, purification and quantification procedures were 
explained previously in chapter 4. Only proteins with a higher than 90% purity, as 
judged by SDS-PAGE analysis, were considered for dialysis in 10 mM PBS pH 7.2 
and to perform in vitro studies. 
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6.2.3 Antibacterial assays of endolysins with LPS-destabilizing peptides 
The antibacterial assay was executed in a similar way as described in chapter 4. 
Briefly, mid-exponential phase cells (listed in Table 6.2) with an OD600nm of 0.6, 
were resuspended in 10 mM HEPES/NaOH (pH 7.2) and then 100-fold diluted to a 
final density of 106 CFU/mL. Each culture (50 μL) was incubated for 30 min at 
room temperature with 25 μL of PVP-SE1gp146 wild-type (wt) and variants 
dialyzed in PBS pH 7.2 (5 μM final concentration) together with 25 μL of water or 
25 μL of EDTA. As a negative control, 50 μL of cells were incubated with 25 μL 
water or 25 μL of PBS pH 7.2. After a 30 min incubation period, CFUs were 
counted and the antibacterial activity assessed as previously described in chapter 
4. Averages ± standard deviations are given for n = 3 repeats. 
 
6.2.4 Antibacterial assays of endolysins with cell binding domains 
Antibacterial assays of endolysins with CBDs were measured in terms of relative 
activity. Listeria cells (listed in Table 6.2) were grown to mid-exponential phase 
with an OD600nm of 0.6, resuspended in 10 mM HEPES/NaOH (pH 7.2) to achieve a 
final OD600nm of 1.0. Turbidity measurements were then performed through the 
decrease in OD by adding a 20-μL drop of each protein (2 μM) onto 180 μL of 
different Listeria serovar cells (with an initial OD600nm of 1.0) for 2 h. As a negative 
control 20 μL of PBS (pH 7.2) was used. Final OD values were categorized to 
indicate the sensitivity of the reaction: -, non-sensitive (OD from 1.0 to 0.8); +, 
sensitive (OD from 0.8 to 0.3) and ++, very sensitive (OD from 0.3 to 0.0).  
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6.3 Results 
6.3.1 Modified endolysins recombinant expression 
A range of LPS-destabilizing peptides and CBDs were tagged to PVP-SE1gp146 and 
Lys68, respectively. After optimization of different expression parameters, as 
described in materials and methods, each construct was expressed differently, as 
demonstrated in Table 6.6.  
 
Table 6.6. Recombinant purification yields of Lys68 and PVP-SE1 wild-type proteins and their C-
or N-terminal modified variants. The total yield for each protein is indicated in amount of purified 
protein (in mg) per liter of E. coli expression culture. For a given yield, a reduction percentage (%) 
of soluble protein is given compared to the wild-type protein. 
Fusion Fusion side PVP-SE1gp146               Lys68 
  
Yield 
(mg/L) 
Reduction 
percentage 
Yield 
(mg/L) 
Reduction 
percentage 
            Wild-type protein 38.2 -- 11.2 -- 
      LPS-destabilizing peptide     
α4 N-terminal 1.5 96 % NC  
Lycotoxin1 N-terminal 4.3 89 % NC  
Parasin1 N-terminal 5.1 87 % NC  
PK N-terminal 65.2 (70%)*   
ArtiMW1 N-terminal 3.2 92 % NC  
ArtiMW2 N-terminal 2.4 94 % NC  
      
          Cell binding domain     
CBDP35 C-terminal NC  6.5 42 % 
CBDP40 C-terminal NC  9.1 19 % 
CBD500 C-terminal NC  5.8 48 % 
 
 
NC – Not constructed; * Increased (not reduction) of expression yield 
 
N-terminal LPS-destabilizing peptides were inserted to give a final construct type 
of peptide-PVP-SE1gp146-His6. In most of the cases, recombinant expressions 
yields of modified proteins drastically decreased compared to the wt (reductions 
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of more than 87%). The amount of soluble protein however, was still sufficient to 
perform the antibacterial assays (results presented in the 6.3.2 Antibacterial 
assays of endolysins with LPS-destabilizing peptides section). Interestingly, the PK-
SE1gp146-His6 construct was the only fusion, for which a higher expression yield 
(70% more compared to the wt) was obtained.  
Lys68 was C-terminally tagged with different CBDs to give the construct type of 
His6-Lys68-CBD. While the introduction of LPS-destabilizing peptides (AMPs or 
newly design) significantly reduced the expression yields, Lys68-CBD fusions 
expression levels were influenced to a much lesser extent (with only 19% to 48% 
reductions), albeit still lower than the protein wt. For all chimeras tested no 
insoluble proteins were obtained (data not shown). 
 
6.3.2 Antibacterial assays of endolysins with LPS-destabilizing peptides  
After cloning and recombinant expression, PVP-SE1gp146 wt and its N-terminal 
variants were incubated with mid-exponentially grown cells (P. aeruginosa PAO1, 
S. Typhimurium LT2 and E. coli XL1-Blue MRF`) in the presence and absence of 0.5 
mM of EDTA for 30 min. To determine the antibacterial activity in log reduction 
units, cells suspensions were serially diluted and CFUs were counted (Table 6.7). 
 
Table 6.7. Antibacterial activity of PVP-SE1gp146 (wt and variants) against P. aeruginosa PAO1, 
S. Typhimurium LT2 and E. coli XL1-Blue MRF´ in absence (A) and presence (B) of EDTA. For each 
protein, log reduction units are depicted and significant reductions (≥ 1 log) are marked in bold. 
A        Peptide P. aeroginosa PAO1 S. Typhimurium LT2 E.coli XL1-Blue MRF´ 
Wild-type 0.19 ± 0.01  0.13 ± 0.02  0.14 ± 0.04  
PK 1.56 ± 0.10 0.30 ± 0.10 0.69 ± 0.09 
α4 1.26 ± 0.12 0.14 ± 0.12 0.42 ± 0.21 
PP 1.16 ± 0.17  0.24 ± 0.16 0.26 ± 0.09 
ArtiMW1 1.26 ± 0.07  0.10 ± 0.07 0.20 ± 0.05 
ArtiMW2 0.63 ± 0.11  0.12 ± 0.12 0.10 ± 0.09 
Lycotoxin1 1.00 ± 0.24  0.20 ± 0.22 0.59 ± 0.39 
Parasin1 0.52 ± 0.12 0.04 ± 0.03 0.49 ± 0.15 
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In the absence of OMP, PVP-SE1gp146 displayed no antibacterial activity on the 
three tested strains, as was expected. Once equipping the endolysin with different 
LPS-destabilizing peptides, a bactericidal effect emerged against P. aeruginosa and 
S. Typhimurium. The PK peptide proved to be the best fusion, not only able to 
cause a log reduction of 1.56±0.10 of P. aeruginosa, but also inactivating 
0.69±0.09 of E. coli cells in 30 min. As for α4, PP and ArtiMW2 peptides, they were 
exclusively active against P. aeruginosa, reducing an approximate 1 log of viable 
cells. 
In the presence of EDTA (0.5 mM), all endolysin variants had a much stronger 
effect. While the wt protein was able to reduce 3.68±0.13 logs of viable P. 
aeruginosa cells, the PK, α4, ArtiMW1 and ArtiMW2 fusion peptides improved the 
killing effect (log reductions of 4.92±0.23, 4.22±0.30, 3.95±0.09 and 3.99±0.17, 
respectively). Regarding the antibacterial impact against S. Typhimurium and E. 
coli, a much lower effect was observed. The Lycotoxin1 and α4 peptides were 
shown to be active against two strains. Compared to the wt protein, these 
peptides were similarly active towards P. aeruginosa, but could also reduce S. 
Typhimurium or E. coli cells by almost 1 log after 30 min incubation. Remarkably, 
the PK peptide not only gave the highest log reduction units of all proteins, but 
was also the only peptide able to kill all three tested strains in combination with 
EDTA (log reductions of 4.92±0.23, 0.73±0.30 and 0.85±0.17 for P. aeruginosa, S. 
Typhimurium and E. coli, respectively).  
B        Peptide P. aeroginosa PAO1 S. Typhimurium LT2 E.coli XL1-Blue MRF´ 
EDTA 0.28 ± 0.02 0.05 ± 0.05 0.29 ± 0.11 
Wild-type 3.68 ± 0.13  0.14 ± 0.21  0.34 ± 0.02  
PK 4.92 ± 0.23 0.73 ± 0.30 0.85 ± 0.17 
α4 4.22 ± 0.30 0.47 ± 0.24 0.85 ± 0.17 
PP 3.69 ± 0.11  0.47 ± 0.07 0.54 ± 0.10 
ArtiMW1 3.95 ± 0.09  0.27 ± 0.15 0.36 ± 0.11 
ArtiMW2 3.99 ± 0.17  0.41 ± 0.25 0.16 ± 0.10 
Lycotoxin1 3.79 ± 0.07  0.87 ± 0.28 0.34 ± 0.15 
Parasin1 3.85 ± 0.08 0.59 ± 0.38 0.69 ± 0.24 
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6.3.3 Antibacterial assays of the endolysins with cell binding domains 
In order to improve the application potential of the G--like endolysin against L. 
monocytogenes, Lys68 was equipped with three different Listeria CBDs. After 
recombinant expression, all constructed endolysins were evaluated in terms of 
relative lysis activity (Table 6.8, Figure 6.1).  
 
Table 6.8. Endolysins relative lysis activity. Turbidity measurements were performed through the 
decrease in OD by adding a 20-μL drop of each protein (2 μM) onto 180 μL of different Listeria 
serovar cells (with an initial OD600nm of 1.0) for 2 h. As a negative control 20 μL of PBS (pH 7.2) was 
used. Relative activity is given depending on the final OD value: -, non-sensitive (OD from 1.0 to 
0.8); +, sensitive (OD from 0.8 to 0.3) and ++, very sensitive (OD from 0.3 to 0.0). The most 
sensitive strain is highlighted in bold. 
 
 
 
Relative lysis activity 
Listeria species  Serotype Lys68 Lys68-P35 Lys68-P40 Lys68-500 
L. monocytogenes CECT 4031T 1a ++ + + + 
 CECT 5873 1/2a ++ + + + 
 CECT 936 1/2b ++ + + + 
 CECT 911 1/2c ++ + - + 
 CECT 933 3a ++ + + + 
 CECT 937 3b ++ + + + 
 CECT 938 3c ++ + - - 
 CECT 934 4a ++ + - - 
 923* 4b ++ + - - 
 CECT 5725 4c ++ ++ ++ ++ 
 994* 4ab ++ + + + 
Listeria welshimeri CECT 5371 6a ++ + - + 
Listeria seeligeri CECT 5339 6b ++ + + + 
Listeria inocua CECT 4030 Unknown + - - - 
Listeria ivanovii CECT 5375 Unknown + - - - 
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Figure 6.1. Turbidity measurements of Lys68 and CBD variants against L. monocytogenes CECT 
5725.  
 
Results show that Lys68 was able to digest the cell wall of all Listeria cells. As 
expected, being a globular endolysin displaying a single ECD, Lys68 activity 
revealed to be unspecific towards Listeria cells. While the relative activity of Lys68 
demonstrated the ability of killing all 15 strains tested, Lys68-P35, Lys68-P40 and 
Lys68-500 (containing different Listeria-specific CBDs) could only reduce the OD of 
13, 8 and 10 strains, respectively. Lys68 alone consistently remained more active 
than its variants, and always reached lower OD values after incubation with the 
different Listeria cells for 2 hours. Figure 6.1 shows the turbidity assay of Lys68 
and its fusion variants against the most sensitive Listeria strain (CECT 5725). With 
this strain, OD reductions from OD 1.0 to 0.2-0.3 were obtained within only 30 
seconds. Kinetics curves demonstrate that the Lys68 wt displayed the steepest 
lysis curve (i.e. highest muralytic activity). For all tested serovars a consistent 
higher muralytic activity of Lys68 wt compared to the CBD variants was observed. 
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6.4 Discussion 
After a careful selection of peptides for the covalent modification of endolysins, 
their recombinant expression revealed to be, in most cases, critical in obtaining 
large amounts of soluble proteins to test. Several aspects can interfere with 
protein E. coli recombinant expression (e.g. preferential codon usage, 
physicochemical properties of its amino acid sequence, including hydrophobicity, 
electrostatic charge, its toxicity) (Price et al, 2011; Gopal & Kumar, 2013). 
Generally, it was possible to heterologously produce the endolysins fused to LPS-
destabilizing peptides, however the obtained production yield was very low (87% 
to 96% reductions). Production levels decreased to a lower extent when fused to 
CBD domains (47% of maximum reductions). This decrease in protein production 
may indicate that inherent toxicity of the LPS-destabilizing peptides is 
determinant for the lower recombinant expression levels of these proteins. A 
unique event happened with the PK fusion, as it was the only protein expressed in 
higher quantity (more 70% increased than the wt) and therefore seems to favour 
protein synthesis. Expressed proteins were then tested in two separate parts; 
PVP-SE1gp146 tagged with LPS-destabilizing peptides was tested against G- 
bacteria and CBD-fused Lys68 was tested for enhanced antibacterial performance 
against G+ Listeria cells.  
When PVP-SE1gp146 was fused to different LPS-destabilizing peptides, an 
increase of activity could be observed for most of the proteins. However, this 
effect seems to be bacteria- and peptide-related. In general, when fused to PVP-
SE1gp146 the intrinsic LPS-destabilizing peptides were only able to inactivate 
Pseudomonas cells. The polycationic peptide PK had the strongest effect 
(1.56±0.10). When combined with EDTA, the effect could be increased and 
extended to Salmonella and E. coli. Peptides such as the PK, α4, PP and 
Lycotoxin1, could increase PVP-SE1gp146 wt activity towards Pseudomonas (max. 
reductions of 4.92±0.23 logs), but also against Salmonella (max. reductions of 
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0.87±0.28 logs) and E. coli (max. reductions of 0.85±0.17 logs). The structure and 
composition of the different LPS can explain the higher sensitivity of 
Pseudomonas over the Salmonella and E. coli. Pseudomonas LPS is strongly 
dependent on high phosphate ionic interactions with surrounding divalent cations 
(Nikaido, 2003). On the other hand, Salmonella and E. coli LPS is more stabilized 
by hydrophobic interactions of the Lipid A moieties (and lower phosphorylation 
degree) (Nikaido, 2003). The combined effect of the polycationic peptide PK and 
EDTA had the strongest effect against Pseudomonas. They both act in a different 
manner on the cations responsible for Pseudomonas LPS integrity, namely by 
cation displacement (PK) and removal (EDTA). Peptides selected to increase the 
cationic, hydrophobic and amphipatic strength of the PVP-SE1gp146 proved to be 
effective against Salmonella and E. coli, although to a lesser extent. Nevertheless, 
the results obtained should be taken in careful consideration. The addition of 
extra amino acids may interfere differently with the chimeric protein folding and 
influence its function. This could explain the different synergistic, additive and 
antagonistic effects observed with the different peptides and EDTA combinations. 
Overall, it was shown that this rational design of phage-encoded endolysins is able 
to increase the antibacterial activity. However, unless in silico analysis could be 
used to anticipate the chimeric endolysins expression, folding, function and 
activity, only experimental validations will determine the best peptide fusion 
partner.  
A similar approach was pursued to clone CBD peptides into Lys68. CBDs were 
tested to turn the Lys68 more specific and active against Listeria cells. Lys68 wt 
demonstrated to have a broader lytic range compared to the Lys68-CBD variants. 
These results were expected, as Lys68 is a globular protein (only containing an 
ECD) that should behave unspecifically. For Lys68 tagged with CBPP35 or CBDP40 
its lytic spectra still remained high as they also do not confer serovar-specificity. 
However for Lys68-500, 10 different serovars were sensitive to this protein, 
including serovars where CBD500 did not recognize in the Listeria phage endolysin 
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Ply500 (e.g. type 1/2 and 3) (Schmelcher et al, 2010). Therefore, this Listeria CBD 
is not displaying the same antibacterial specificity. In terms of activity, with no 
exceptions, none of the CBDs assisted Lys68 in reducing the OD of the Listeria cells 
worked in a faster way (i.e. higher muralytic activity). One can speculate, as 
described earlier, that the presence of a CBD is hindering (instead of improving) 
the muralytic activity of the catalytic domain (Cheng & Fischetti, 2007; Horgan et 
al, 2009). Another aspect to take into account is that modified proteins might not 
fold properly, thereby hindering ECD or CBD functionality. Either one of those 
factors may hamper proper ECD muralytic activity and CBD recognition. 
Additionally, a shift of ionic strength and pH condition for an optimal activity can 
also be impairing the enzyme activity, as demonstrated before to different Listeria 
phage modular endolysins (Schmelcher et al, 2012b). Therefore, to exclude 
previous theories, future tests covering a range of different protein 
concentrations, pH values and ionic strengths should be carried out to clarify the 
role of the CBDs on the Lys68 activity. 
Taking everything into consideration, (modified) G--like endolysins can become a 
new generation of powerful antimicrobials to fight bacterial pathogens either 
from food to veterinary and medical settings. 
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7.1 General conclusions 
The main goal of this work was to expand the knowledge of phage-encoded 
endolysins and explore their bactericidal properties against bacterial pathogens, 
with particular emphasis on G- bacteria. Finding strategies to overcome the 
presence of a highly protective OM that makes G- bacteria less accessible for 
externally added antimicrobials, such as endolysins, represented the most 
important scientific challenge of this study (described in chapter 1). 
In silico analysis of all available endolysins sequences, showed an enormous 
diversity of endolysins with different molecular structures and functions (chapter 
3). This diversity is driven by the dynamic adaptation of phages that continuously 
need to co-evolve with a diverse group of bacterial hosts. Therefore, endolysins 
represent a varied group of antimicrobials that could be of use in fighting bacterial 
infections. Additionally, through an ever increasing knowledge on protein design 
and better available molecular biology tools, tailor-made enzymes can still be 
developed to achieve the desired or enhanced properties for industrial and 
medical use.  
In vitro, the biochemical characterization of two different G- phage endolysins 
(Lys68 and ABgp46) contributed to enlarge the knowledge of a group of enzymes 
until recently scarcely explored (chapter 4 and 5). It was shown that an endolysin 
from a G-- background can have a prolonged shelf-life (up to 2 months with no 
significant activity lost), be stable and active under a broad range of pH values 
(from acidic to basic conditions) and also be thermostable (withstanding 
temperatures up to 100°C). The fact that the characterized Lys68 is able to refold 
after thermal denaturation (>Tm) explains its high thermostability. A PG digestion 
mechanism was also proposed for Lys68, explaining its muralytic activity in an 
acidic environment. This biochemical characterization is of great importance to 
discover new desirable traits that can be used for biotechnological applications. 
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To overcome the bacterial OM diffusion limitation, both endolysins (Lys68 and 
ABgp46) were combined with different OMPs against a vast panel of G- bacterial 
pathogens (chapter 4 and 5). The observed specific antibacterial bacterial effect is 
correlated with the bacterial LPS structure and composition. EDTA, which acts by 
chelation, was able to permeabilize the OM for the penetration of endolysins, but 
only in a few bacterial species, namely Pseudomonas and Acinetobacter species. 
The organic acids citric and malic acids were able to promote a broader OM 
permeabilization, acting synergistically with our endolysins to kill most of the G- 
strains tested. The low pH present was recognized to be important for the OM 
destabilization and subsequent permeabilization to endolysins. However, we 
speculate that undissociated acid groups from organic acids tested, can penetrate 
differently through the bacterial LPS, damaging or inhibiting several OM-
stabilizing enzymatic processes, explaining the differences in synergy observed 
when combining endolysins with different weak acids at the same pH. We further 
demonstrated that endolysins were not only efficient antimicrobials in the 
presence of OMPs, but also that they were occasionally able to kill specific groups 
of bacteria without the aid of any OM permeabilization, including antibiotic 
resistant phenotypes (chapter 5). Overall, this endolysin-based antimicrobial 
approach also has its limitations: some bacteria (K. oxytoca and Y. enterocolitica) 
remain less sensitised by the endolysin/OMP formula; its efficiency decreased in 
the presence of different bacterial physiological states and against biofilms; the 
strategy of using weak acids (that mostly act at low pH) could limit future 
biotechnological applications in sectors where these substances are prohibited or 
allowed in very low concentrations. A certain concentration of these weak acids 
must be present, in order to provide acidity needed to permeabilize the OM to 
endolysins. Nevertheless, other OMPs, enzymes or combinations can still be 
searched in order optimize and expand their use. 
To boost the previous endolysin/OMP antibacterial efficiency, a rational design of 
introducing specific LPS-destabilizing peptides (with different cationic, 
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hydrophobic and amphipathic nature) was performed, to allow a spontaneous 
endolysin penetration of the OM (chapter 6). This strategy revealed to be in most 
cases efficient, however proved to be peptide- and bacteria- dependent. In the 
absence of EDTA, peptide fusions could increase the PVP-SE1gp146 wt 
antibacterial activity mostly against P. aeruginosa, from a minimum of 0.33 (for 
Parasin1 peptide) to a maximum of 1.37 logs reductions (for PK peptide). When 
combined with EDTA, the effect was in general more pronounced and broader 
against all Pseudomonas, Salmonella and E. coli strains. The variation of the 
primary LPS-stabilizing forces between Pseudomonas (mostly based on ionic 
interactions) and Salmonella and E. coli (mostly based on hydrophobic packing) 
appears to be determinant for the sensitivity observed to the different LPS-
destabilizing peptides tested (Raetz & Whitfield, 2002). However, this approach 
implicates covalent modifications of the native protein. This is not only limiting 
their recombinant expression, but also only small increased bactericidal effects 
are observed in a few cases, that might limit their future biotechnology 
application. Since it is likely that conformational changes of the fusion protein by 
steric hindrance of the tagged peptides are hampering the endolysin`s action, it is 
desirable to perform a preliminary bioinformatics analysis that might predict 
upfront the protein folding, before advancing with the construction of the 
envisaged fusions. Another option is to randomly select OM-destabilizing peptides 
followed by a high-throughput screening procedure to speed up the process, as 
rational design is a time-consuming process. This would allow to generate and 
screen several LSP-destabilizing peptides with good potential before expressing 
and purifying them at large scale. Despite all the covalent endolysin modifications, 
this strategy still proved to be efficient in enhancing the endolysins`s antibacterial 
performance, effect further improved in the presence of an OMP agent.  
With a different purpose, endolysin covalent modifications with CBDs intended to 
improve the activity of a G--like endolysin against L. monocytogenes. Several 
examples are known in which the CBD is reported to be crucial for the endolysin’s 
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specificity/activity (Loessner et al, 2002; Schmelcher et al, 2011; Eugster & 
Loessner, 2012). However, fusing a CBD to Lys68 did not make the endolysin 
specific or enhance its muralytic activity against Listeria cells. Similar folding issues 
predicted to be happening with the endolysin tagged with different LPS-
destabilizing peptides, might explain the results obtained. To be sure of this, 
changing the experimental conditions should be first considered, like modifying 
the ionic strength or the pH and buffer composition. In theory, modifying these 
enzymes can cause a shift in the optical physiological conditions in which they 
perform the best, compared to the Lys68 wt conditions. Also, other antibacterial 
specificity tests, such as spotting an endolysin drop into bacterial lawns, could be 
performed to assess its lytic spectrum and to help establish the CBD functionality 
in Lys68. Alternatively, CBD fusions can be tagged to other interesting endolysins 
of G- origin (e.g. ABgp46 or PVP-SE1gp146) to accomplish the desired objective of 
efficiently kill Listeria cells. 
 
7.2 Future perspectives 
With the expertise built up by previous studies that involved phage-encoded 
endolysins to target G- pathogens, it is proposed some strategies to further 
optimize the endolysin-based technology developed so far.  
 
Widen the screening efforts to select better OMPs and endolysins 
We have previously seen G--like endolysins with extraordinary characteristics. For 
instance, the T4 lysozyme has a dual antibacterial activity; i) a bactericidal effect 
owned by its amphipathic nature in disrupting the bacteria cellular membranes 
and ii) lethal PG enzymatic digestion (During et al, 1999). Other enzymes have also 
impressed us for their intrinsic ability to enter the OM, becoming active 
antimicrobials against G- cells without the aid of OMPs (e.g. LysAB2, OBPgp279 
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and ABgp46) or for their high thermostability (e.g. Lys68) (Lai et al, 2011; 
Walmagh et al, 2012). Additionally, novel domains here described in silico (within 
dsNA phages and even identified in Tectiviridae and Cystoviridae phages) can 
represent valuable properties worth exploring. Therefore, a continuous search for 
new phage-encoded endolysins in the enormous reservoir of phages is a 
recommended strategy, combined with the exploitation of a more “friendly and 
broad use” of OMPs. Although most of the OMPs here described are naturally 
occurring compounds, their versatility can be compromised depending on their 
use, type of bacteria and infection. This endolysin/OMP technology is more 
efficient to certain groups of bacteria and, in case of organic acids, their use is 
restricted to situations where low pH can be applied. 
 
Improving anti-biofilm activity 
Biofilms are microbial communities responsible for several infectious diseases 
related to their ubiquitous nature. They are hard-to-treat cell populations that 
have become highly tolerant to varied antimicrobial agents (Lewis, 2008). In order 
to efficiently kill biofilms, a cocktail of different polysaccharides-degrading 
compounds (e.g. cocktail phage-encoded depolymerases, synthethic sodium 
periodate and dispersin B), DNases (like the Dornase from Pulmozyme®) and 
proteases can be combined with endolysins to decompose the polysaccharides, 
extracellular DNA and proteins typically present in biofilms, enhancing the anti-
biofilm activity. Dispersin B, an enzyme isolated from Aggregatibacter 
actinomycetemcomitans (Kaplan et al, 2003) that possesses an anti-biofilm 
activity, seems to be a good candidate. While many phage depolymerases are only 
able to degrade specific biofilm matrix components, limiting the type of bacterial 
biofilm (Hughes et al, 1998; Cornelissen et al, 2011), the poly-N-
acetylglucosamine-degrading activity of dispersin B is able to digest structural 
poly-acetyl glucosamines present in both G+ (e.g. S. epidermidis) and G- bacteria 
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biofilms (e.g. E. coli, P. fluorescens, Yersinia pestis,) (Kaplan et al, 2004; Itoh et al, 
2005; Lu & Collins, 2007). Therefore, dispersin B is considered to be a broad 
spectrum anti-biofilm agent and could be combined with the endolysin/OMP 
formula to overcome the biofilm diffusion limitation problems. Additionally, 
dispersin B detaches biofilms in a few minutes (<10 min) and has an optimal pH 
value for activity around 4.0-5.0 (Kaplan et al, 2004). This is the range of pH where 
the endolysin/OMP mixtures are more efficient.  
 
Tailoring endolysins with LPS-destabilizing peptides 
Three alternatives are proposed to the rational LPS-destabilising peptide design 
addressed here. Rather than using AMPs, endolysins tagged with cell-penetrating 
peptides (CPPs) could be constructed. CPPs, also known as protein transduction 
domains, are short peptides (generally not exceeding 30 amino acids) found 
within proteins that are able to cross cellular membranes (Bechara & Sagan, 
2013). TAT (12 residues between the 48-60 region) and Penetratin (16 residues 
between the 53-58 region) from the Trans-Activator of Transcription (from HIV 
virus) and Antennapedia homeodomain (from the Drosophilia melanogaster 
insect) proteins, respectively, were the first CPPs found to be responsible for 
spontaneous translocation over the cell membrane (Derossi et al, 1994; Vives et 
al, 1997). Although CPPs, like AMPs, have similar characteristics (physiochemical 
properties, secondary structure), they are considered to have low toxicity and 
haemolytic effect (manifested only at higher concentrations) (Zhu & Shin, 2009; 
Splith & Neundorf, 2011). CPPs (like TAT and penetratin) are well-known peptides 
able to interact with G- bacterial membranes (Bourre et al, 2010; Bahnsen et al, 
2012; Garro et al, 2013). Their inherent low toxicity should improve the protein 
recombinant expression (showed to be generally limited for AMPs containing 
proteins). CPP-endolysin proteins could then be tested in the similar way as was 
done with the PVP-SE1gp146 chimeras. 
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A randomized strategy could be used to quickly generate and find novel AMPs or 
CPPs. The rational design developed here is a time-consuming process that 
sometimes creates low expression yields and results in enzymes with a moderate 
antibacterial effect. For this, PVP-SE1gp146 gene for example, could be amplified 
using a circular PCR approach, in which a forward primer (carrying the putative 
LPS-destabilizing signal inserted in the protein N-terminal side) contains an N-
randomized domain. By linearizing the vector, each PCR cycle would generate a 
protein with a different peptide. A high-throughput screening process could then 
be used to identify the protein with the best LPS-destabilizing property.  
One of the major hurdles of using LPS-destabilizing peptides in endolysins to 
target G- cells is their lack of specificity, which is a crucial aspect when only certain 
groups of bacteria need to be targeted. To narrow the action of endolysins, 
understanding and exploring the bacteriocins` mode of action could provide 
important information. For example, endolysins could be tagged with microcin 
uptake domains. Microcins are gene-encoded peptides produced by 
Enterobacteriaceae. After synthesis, they occasionally undergo post-translation 
modifications, thus converting to mature molecules, with the aim to kill closely 
related competitor strains that threat their survival (Morin et al, 2011). Their 
narrow activity spectrum is exerted intracellularly, after translocation across the 
OM through specific TonB-dependent receptors, involved in the energy-
dependent iron uptake. Once inside the cell, they can behave as bactericidal (e.g. 
targeting the mannose permease) or bacteriostatic agents (e.g. inhibiting the 
bacterial RNA polymerase) (Vincent et al, 2004; Bieler et al, 2006). Some of the 
microcin uptake domains (e.g. Colicin V), that are responsible for their 
internalization, have been identified (Azpiroz & Lavina, 2007). These domains 
could be tagged to endolysins in order to target them to a specific group of 
bacteria. An excellent example in which this strategy was applied is the creation of 
a hybrid T4 lysozyme, coupled to a pesticin domain (Lukacik et al, 2012). This 
engineered endolysin was able to reduce 1 log in 24 hours of TonB dependent 
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Yersinia and E. coli species. This “slow mode of action” however, may lead to the 
appearance of resistant phenotypes. Nevertheless, other endolysin/microcin 
combinations must be constructed in order to evaluate their efficiency and 
resistance development. 
 
Tailoring endolysins with cell binding domains 
Once modifying the molecular structure of a certain protein, its function can be 
altered or shifted to different performance conditions. Lys68 was engineered into 
a modular protein with three different listerial CBDs, however no improvement in 
activity was observed. Some listeria endolysins possessing different CBDs are 
known to acquire specific pH, ionic strength conditions (Schmelcher et al, 2012b). 
To evaluate this possibility, photometric lysis assays could be performed on the 
Lys68 mutants to calculate the range of concentration needed to perform 
additional studies. Afterwards, all proteins could be tested to determine the pH 
range (e.g. 3.0-10.0) and ionic strength (e.g. 10-1000 mM of NaCl) requirements 
for optical muralytic activity of each protein. Additionally, the same modifications 
can be applied to other endolysins (such ABgp46 or PVP-SE1gp146) or even by 
inserting other CBDs, specific to other G+ bacteria that harbours similar A1γ PG 
chemotype (such as Bacillus species). 
Currently, G+ phage endolysins are recognized as useful antimicrobial or bacterial 
specific recognition tools to fight bacterial pathogens, soon expected to make the 
first R&D transitions into real commercial products. In fact, Micreos already has a 
commercial endolysin-based product named Staphefekt™ to prevented or control 
skin infections. In recent years, efforts have been made to fully explore the 
biotechnological potential of endolysins by also tackling G- bacteria. This work 
proves the enormous potential of G--like endolysins, once selecting proper 
enzymes, OMPs and covalent modification. With an ever increasing knowledge, it 
is expected that this endolysin-based technology can soon also make transitions 
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from the proof-of-principle stage to food, agricultural and medicinal use. Such 
antimicrobials are gaining particular and intensified interest in an era where 
policies involving non-synthetic food preservatives and the threat of antibiotic and 
multi-resistant bacteria are increasing and solutions are becoming scarce. 
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Figure S4.1. Circular dichroism spectrum of HEWL at pH (7.0) and acidic pH (4.0).  
 
Table S4.1. Combinatorial effect of Lys68 with EDTA against different 
Enterobacteriaceae species. Overnight bacterial cells were 1:100 diluted in fresh 
LB, grown for approx. 3 h to reach exponential phase (OD600nm of 0.6). Cells 
resuspended in 10 mM HEPES/NaOH (pH 7.2) were then 100-fold diluted to a final 
density of 106 CFU/mL. Each cell (50 µL) was incubated with 25 µL Lys68 (2 µM 
final concentration) together with 25 µL of EDTA (5 mM final concentration) for 30 
min. Cells incubated with PBS (instead of Lys68) or with water (instead of EDTA) 
were used as a negative control. After incubation CFUs were counted. Averages ± 
standard deviations are given for n = 3 repeats.  
Bacterial Species Lys68/Water PBS/EDTA Lys68/EDTA 
S. Tyhpimurium LT2 0.08 ± 0.07 0.07 ± 0.08 0.18 ± 0.10 
E. coli O157:H7 CECT 4782 0.14 ± 0.05 0.11 ± 0.12 0.10 ± 0.00 
Cronobacter sakazakii CECT 858 0.09 ± 0.05 0.14 ± 0.05  0.13 ± 0.12  
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Figure S5.1. ClustalW multiple sequence alignment of ABgp46 with top five 
close-related sequences. The query ABgp46 (boxed) is aligned to five endolysin 
sequences belonging to Acinetobacter phages: phiAB2 (HM755898), phage AB3 
(YP_008060133.1 and YP_008060134.1), phage ABP-01 (AHG30899.1) and phage 
ABP-04 (AHG30900.1). For each protein the accession numbers are given. 
Comparison shows conserved (*) and positive (:/.) amino acid matches. 
Highlighted at grey is the putative amphipathic helices region found in the C-
terminus of the LysAB2 that matches 100% with ABgp46. Positively charged amino 
acids are shown are shown in bold. 
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Figure S5.2. Amino acid sequence of ABgp42. A depolymerase-related domain 
(Pectate_lyase_3), from the Pec lyase clan (CLO268), was found using HHpred 
webserver (URL: http://toolkit.tuebingen.mpg.de/hhpred.html) using Pfam, 
InterProScan and COG; with an E-value of 0.041 and 96.6% of query coverage 
(amino acids 4-207 underlined). 
 
 
 
 
 
 
 
 
 
 
 
 
 
